Bibliographie - new - Stabilis 4.0

Last update :
21/03/2023

Filters

Authors :		Type :
Title :
Publication :		Année :
Research teams :
Pharmacological Class :
Galenic forms :

References

Reference

Type
Publication

Title
Authors

Year

3205	Journal AAPS Pharm Sci 2011 ; 15, 2 : 264-272.	in vitro stability and compatibility of tenecteplase in central venous access devices. Lentz, Y.K. , Joyce, M., Lam, X.	2011
4	Journal Act Pharm Biol Clin 1995 ; 8: 525-528.	Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité. Zazempa V, Morgenszejn J, Paul M, Astier A.	1995
1730	Journal Act Pharm Nord 1991 ; 3: 251.	Chemical compatibility of mitoxantrone and etoposide (VP-16). Bj?rkman S, Roth B.	1991
1980	Journal Act Pharm Nord 1991 ; 3, 3: 131-136.	Loss of nitroglycerin during passage through two different infusion sets. Hansen HC, Spillum A.	1991
1875	Journal Acta Anaesthesiol Scand 2000 ; 44: 864-867.	Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl. Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W.	2000
3159	Journal Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.	Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution. Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z.	2010
4264	Journal Acta Ophtalmol 2008	Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus. Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V.	2008
2890	Journal Acta Pharm 2000 ; 50: 219-228.	Stability and compatibility of thiamine hydrochloride in liquid dosage forms et various temperatures. El-Khawas M, Boraie NA.	2000
837	Journal Acta Pharm Suec 1986 ; 23: 115-124.	Stability of carmustine - kinetics and compatibility during administration. Fredriksson K, Lundgren P, Landersjo L.	1986
3041	Journal Acta Pol Pharm 2006 ; 63: 293-299.	Physicochemical and microbiological properties of eye drops containing cefuroxime. Kodym A, Zawiswa T, Taberska J , Kukula H.	2006
3289	Journal Acta Pol Pharm 2011 ; 68, 1: 99-107.	Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method. Kodym A, Hapka-Zmich D, Golab M, Gwizdala M.	2011
3290	Journal Acta Pol Pharm 2011 ; 68, 4: 555-564.	Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method. Kodym A, Wisniewski A, Kniola D, Olejniczak M.	2011
3291	Journal Acta Pol Pharm 2012 ; 69, 1: 95-105.	Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method. Kodym A, Bilski P, Domanska A, Lukasz Helminiak, Jablonska M, Jachymska A.	2012
3840	Journal Acta Pol Pharm 2016 ; 73, 1: 23-27.	Stability of cefpirome sulfate in aqueous solutions. Zalewski P, Jelinska A, Paczkowska M, Garbacki P, Talaczynska A, Step-niak P, Cielecka- Piontek J.	2016
3722	Journal Acta Pol Pharm 2014 ; 71, 4: 661-666.	Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms. Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska.	2014
4271	Journal Adv Ther 2019	Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties Yun J, Kim J, Chung J, Hwang S-J, Park S-J.	2019
4525	Journal Adv Ther 2020 ; 37: 4308–4324.	Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Park D, Kim J, Yun J, Park S.J.	2020
4627	Journal Adv Ther 2019 36:442–450	Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature. Park D, Yun J, Hwang S-J, Park SJ.	2019
4644	Journal Adv Ther 2021 ; 38 : 5609–5622	Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17. Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A.	2021
3190	Journal Advance in Haematology 2009 Article ID 704928, 5 page	An NMR Study of the Bortezomib Degradation under Clinical Use Conditions. Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M,	2009
4034	Journal Afr J Pharm Pharmacol 2012 ;27,6:2055-2060	Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions. Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y.	2012
1424	Journal Am J Emerg Med 1999 ; 17: 333-337.	Prehospital stability of diazepam and lorazepam. Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK.	1999
1600	Journal Am J Health-Syst Pharm 2001 ; 58: 1850-1851.	Stability of tirofiban hydrochloride in 0.9% sodium chloride injection for 30 days. Garabito MJ, Jimenez L, Bautista J, Santos-Rubio MD, Perez Rodrigo I.	2001
1603	Journal Am J Health-Syst Pharm 2001 ; 58: 1218-1223.	Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs. Bergquist PA, Manas D, Hunke WA, Reed RA.	2001
1606	Journal Am J Health-Syst Pharm 2001 ; 58: 594-598.	Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection. Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.	2001
1611	Journal Am J Health-Syst Pharm 2001 ; 58: 504-506.	Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Chalmers JR, Bobek MB, Militello MA.	2001
1617	Journal Am J Health-Syst Pharm 2002 ; 59: 539-544.	Stability of irinotecan hydrochloride in aqueous solutions. Li WY, Koda RT.	2002
1618	Journal Am J Health-Syst Pharm 2002 ; 59: 846-848.	Stability of fenoldopam in two infusion solutions. Trissel LA, Zhang Y, Baker MB.	2002
1620	Journal Am J Health-Syst Pharm 2001 ; 58: 1753-1756.	Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration. Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM.	2001
1622	Journal Am J Health-Syst Pharm 2001 ; 58: 238-241.	Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers. Favier M, De Casanove F, Coste A, Cherti N, Bressolle F.	2001
1624	Journal Am J Health-Syst Pharm 2000 ; 57: 760-762.	Activity of dalteparin sodium in polypropylene syringes. Louie S, Chin A, Gill MA.	2000
1635	Journal Am J Health-Syst Pharm 2002 ; 59: 1351-1356.	Stability of dacarbazine in amber glass vials and polyvinyl chloride bags. El Aatmani M, Poujol S, Astre C, Malosse F, Pinguet F.	2002
1739	Journal Am J Health-Syst Pharm 1990 ; 47: 519.	Incompatibility of cefperazone and promethazine. Scott SM.	1990
1744	Journal Am J Health-Syst Pharm 1999 ; 56: 384.	Incompatibility of ceftriaxone sodium with lactated Ringer’s injection. Burkiewicz JS.	1999
1745	Journal Am J Health-Syst Pharm 1992 ; 49: 836-838.	Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate. Thompson DF, Heflin NR.	1992
3	Journal Am J Health-Syst Pharm 1995 ; 52: 2208-2212.	Compatibility of amifostine with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1995
10	Journal Am J Health-Syst Pharm 1997 ; 54: 412-421.	Stability of meropenem in intravenous solutions. Patel PR, Cook SE.	1997
11	Journal Am J Health-Syst Pharm 1997 ; 54: 424-427.	Stability of ceftriaxone sodium and metronidazole hydrochloride. Bailey LC, Orosz ST.	1997
13	Journal Am J Health-Syst Pharm 1997 ; 54: 1068-1070.	Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Stiles ML, Allen LV.	1997
16	Journal Am J Health-Syst Pharm 1995 ; 52: 1554-1556.	Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration. Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA.	1995
26	Journal Am J Health-Syst Pharm 1997 ; 54: 915-920.	Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags. Stewart JT, Warren FW, King DT, Venkateshwaran TG, Ponder GW, Fox JL.	1997
32	Journal Am J Health-Syst Pharm 1996 ; 53: 1171-1173.	Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs. Nyhammar EK, Johansson SG, Seiving BE.	1996
43	Journal Am J Health-Syst Pharm 1997 ; 54: 1106-1108.	Stability of caffeine citrate injection in polypropylene syringes at room temperature. Fraser BD, Berod T, Whitney HAK.	1997
46	Journal Am J Health-Syst Pharm 1996 ; 53: 1588-1590.	Stability of ranitidine hydrochloride in water for injection in glass vials and plastic syringes. Nahata MC, Morosco RS, Fox JL.	1996
48	Journal Am J Health-Syst Pharm 1996 ; 53: 2744-2746.	Stability of granisetron hydrochloride in polypropylene syringes. Quercia RA, Zhang J, Fau C, Chow MSS.	1996
49	Journal Am J Health-Syst Pharm 1995 ; 52: 208.	Compatibility of granisetron hydrochloride with selected alkaline drugs. Trissel LA, Martinez JF.	1995
51	Journal Am J Health-Syst Pharm 1995 ; 52: 1541-1543.	Stability of granisetron hydrochloride in a disposable elastomeric infusion device. Chung KC, Chin A, Gill MA.	1995
52	Journal Am J Health-Syst Pharm 1995 ; 52: 1557-1558.	Stability of ondansetron hydrochloride in a total parenteral nutrient admixture. Kirkham JC, Rutherford ET, Cumingham GN, Daneshmand KA, Falls AL.	1995
57	Journal Am J Health-Syst Pharm 1996 ; 53: 294-304.	Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs. Mayron D, Gennaro AR.	1996
93	Journal Am J Health-Syst Pharm 1996 ; 53: 2185-2188.	Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery. Hutchings SR, Rusho WJ, Tyler LS.	1996
99	Journal Am J Health-Syst Pharm 1995 ; 52: 1086-1090.	Compatibility of aztreonam with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1995
103	Journal Am J Health-Syst Pharm 1995 ; 52: 1347.	Incompatibility of cefotetan disodium and promethazine hydrochloride. Erickson SH, Ulici D.	1995
108	Journal Am J Health-Syst Pharm 1996 ; 53: 2309-2313.	Stability of levofloxacin in intravenous solutions in polyvinyl chloride bags. Williams NA, Bornstein M, Johnson K.	1996
111	Journal Am J Health-Syst Pharm 1996 ; 53: 1608,1610.	Stability of cefazolin sodium and meperidine hydrochloride. Lee DKT, Wong CY, Wang DP.	1996
127	Journal Am J Health-Syst Pharm 1995 ; 52: 1910-1911.	Stability of octreotide acetate in polypropylene syringes at 5 and -20°C. Ripley RG, Ritchie DJ, Holstad SG.	1995
132	Journal Am J Health-Syst Pharm 1997 ; 54: 181-184.	Compatibility of commonly used bone marrow transplant drugs during Y-site delivery. Najari Z, Rusho WJ.	1997
138	Journal Am J Health-Syst Pharm 1997 ; 54: 1845-1848.	Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint. Corbrion V, Crauste-Manciet S, Allain P, Brossard D.	1997
153	Journal Am J Health-Syst Pharm 1995 ; 52: 98-99.	Stability of fluorouracil-metoclopramide hydrochloride admixture. Wang DP, Chang LC, Lee DK.	1995
180	Journal Am J Health-Syst Pharm 1996 ; 53: 1300-1302.	Stability of metoclopramide hydrochloride in plastic syringes. Zhang Y, Trissel LA, Martinez JF, Gilbert DL.	1996
182	Journal Am J Health-Syst Pharm 1997 ; 54: 56-60.	Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1997
184	Journal Am J Health-Syst Pharm 1996 ; 53: 1297-1300.	Stability of ondansetron hydrochloride and five antineoplasic medications. Stewart JT, Warren FW, King DT, Fox JL.	1996
193	Journal Am J Health-Syst Pharm 1997 ; 54: 1293-1295.	Stability of propafenone hydrochloride in IV solutions. Dupuis LL, Wong B, Trope A.	1997
198	Journal Am J Health-Syst Pharm 1995 ; 52: 516-520.	Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Gayed AA, Kheshary PR, Hinkle RL.	1995
205	Journal Am J Health-Syst Pharm 1996 ; 53: 184.	Incompatibility of amiodarone hydrochloride and evacuated glass bottles. Strozyk WR, Williamson R, Thompson D.	1996
206	Journal Am J Health-Syst Pharm 1996 ; 53: 186.	Stability of dopamine hydrochloride and of dobutamine hydrochloride in plastic syringes and administration sets. Sautou-Miranda V, Gremeau I, Chamard I, Cassagnes J, Chopineau J.	1996
220	Journal Am J Health-Syst Pharm 1997 ; 54: 61-64.	Compatibility of bupivacaine hydrochloride and morphine sulfate. Johnson CE, Christen C, Perez MM, Ma M.	1997
237	Journal Am J Health-Syst Pharm 1996 ; 53: 432.	Stability of cefmetazole and famotidine. Lee DKT, Wong CY, Wang DP, Chang LC, Wu KH.	1996
240	Journal Am J Health-Syst Pharm 1995 ; 52: 1904-1909.	Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy. Lam XM, Ward CA, de C du M?e CPR.	1995
265	Journal Am J Health-Syst Pharm 1995 ; 52: 1463-1464.	Amphotericin B does not mix with fat emulsion. Trissel LA.	1995
267	Journal Am J Health-Syst Pharm 1996 ; 53: 1046-1048.	Stability of metronidazole and ceftizoxime sodium in ready-to-use metronidazole bags stored at 4 and 25°C. Nahata MC, Edmonds JJ, Morosco RS.	1996
268	Journal Am J Health-Syst Pharm 1996 ; 53: 1850-1851.	Ciprofloxacin and sodium phosphate not compatible during actual Y-site injection. Benjamin BE.	1996
269	Journal Am J Health-Syst Pharm 1996 ; 53: 84-85.	Concentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactate. Trissel LA.	1996
270	Journal Am J Health-Syst Pharm 1997 ; 54: 1449.	Precipitation of amphotericin B from IV fat emulsion. Heide PE.	1997
273	Journal Am J Health-Syst Pharm 1996 ; 53: 1302-1305.	Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir. Van Doorne V, Bernaards J, DeJonge P.	1996
278	Journal Am J Health-Syst Pharm 1995 ; 52: 521-523.	Stability of nafcillin sodium in the presence of lidocaine hydrochloride. Hagan RL, Carr-Lopez S, Strickland JS.	1995
280	Journal Am J Health-Syst Pharm 1995 ; 52: 2427-2433.	Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection. Allen LV, Stiles ML, Prince SJ, Sylvestri MF.	1995
281	Journal Am J Health-Syst Pharm 1995 ; 52: 1561-1563.	Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags. Belliveau PP, Nightingale CH, Quintiliani R.	1995
282	Journal Am J Health-Syst Pharm 1995 ; 52: 2568-2570.	Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags. Rivers TE, Webster AA.	1995
287	Journal Am J Health-Syst Pharm 1995 ; 52: 1912-1914.	Stability of ceftazidime (with arginine) in an elastomeric infusion device. Bednar DA, Klutman NE, Henry DW, Fox JL, Strayer AH.	1995
295	Journal Am J Health-Syst Pharm 1996 ; 53: 1048-1051.	Compatibility of selected critical care drugs during Y-site administration. Yamashita SK, Walker SE, Choudhury T, Iazzetta J.	1996
298	Journal Am J Health-Syst Pharm 1995 ; 52: 320-321.	Compatibility of mannitol and sodium bicarbonate in injectable fluids. Matuschka PR, Smith WR, Vissing RS.	1995
299	Journal Am J Health-Syst Pharm 1997 ; 54: 1735-1741.	Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF, Gilbert DL.	1997
301	Journal Am J Health-Syst Pharm 1997 ; 54: 1295-1300.	Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.	1997
303	Journal Am J Health-Syst Pharm 1998 ; 55: 154-158.	Stability of reconstituted indomethacin sodium trihydrate in original vials and polypropylene syringes. Walker SE, Gray S, Schmidt B.	1998
306	Journal Am J Health-Syst Pharm 1996 ; 53: 170-173.	Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration. Christen C, Johnson CE, Walters JR.	1996
309	Journal Am J Health-Syst Pharm 1995 ; 52: 192-196.	Stability of propofol with parenteral nutrient solutions during simulated Y-site injection. Bhatt-Mehta V, Paglia RE, Rosen DA.	1995
311	Journal Am J Health-Syst Pharm 1996 ; 53: 167-169.	Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours. Newborn AL, Kessler JM, Joyner KA.	1996
312	Journal Am J Health-Syst Pharm 1997 ; 54: 570-571.	Compatibility of iron dextran with neonatal parenteral nutrient solutions. Mayhew SL, Quick MW.	1997
314	Journal Am J Health-Syst Pharm 1997 ; 54: 64-65.	Visual compatibility of injectable drugs used in the intensive care unit. Chiu MF, Schwartz ML.	1997
315	Journal Am J Health-Syst Pharm 1997 ; 54: 2599-2600.	Visual compatibility of warfarin sodium injection with selected medications and solutions. Bahal SM, Lee TJ, McGinnes M, Dobler GL.	1997
316	Journal Am J Health-Syst Pharm 1996 ; 53: 2611-2613.	Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs. Veltri M, Lee CKK.	1996
321	Journal Am J Health-Syst Pharm 1997 ; 54: 205.	Compatibility of ketamine hydrochloride and meperidine hydrochloride. Ambados F.	1997
322	Journal Am J Health-Syst Pharm 1996 ; 53: 2639.	More on compatibility of mannitol and sodium bicarbonate in injectable fluids. Matuschka PR, Hill LJ.	1996
533	Journal Am J Health-Syst Pharm 1998 ; 55: 1037-1041.	Stability of cisatracurium besylate in vials, syringes and infusion admixtures. Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL.	1998
12	Journal Am J Health-Syst Pharm 1997 ; 54: 683-686.	Stability of amphotericin B 0.05 and 0.5 mg/ml in 20% fat emulsion. Owens LC, Fleming RA, Restino MS, Cruz JM, Hurd DD.	1997
14	Journal Am J Health-Syst Pharm 1997 ; 54: 1193-1195.	Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration. Gilbert DL, Trissel LA, Martinez JF.	1997
71	Journal Am J Health-Syst Pharm 1997 ; 54: 2204-2206.	Stability of cidofovir in 0.9% sodium chloride injection for five days. Ennis RD, Dahl TC.	1997
100	Journal Am J Health-Syst Pharm 1996 ; 43: 2320-2323.	Stability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20°C. Plumridge RJ, Rieck AM, Annus TP, Langton SR.	1996
104	Journal Am J Health-Syst Pharm 1997 ; 54: 185-189.	Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. Hall PD, Yui D, Lyons S, Bosso JA.	1997
155	Journal Am J Health-Syst Pharm 1995 ; 52: 710-715.	Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Trissel LA, Martinez JF, Xu QA.	1995
225	Journal Am J Health-Syst Pharm 1995 ; 52: 511-513.	Stability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministration. Bhatt-Mehta V, Johnson CE, Leininger N, Agarwal M.	1995
239	Journal Am J Health-Syst Pharm 1996 ; 53: 655-658.	Loss of quinidine gluconate injection in a polyvinyl chloride infusion system. Darbar D, Dell'Orto S, Wilkinson GR, Roden DM.	1996
275	Journal Am J Health-Syst Pharm 1996 ; 53: 1461-1462.	Cephalosporin-pentamidine isethionate incompatibilities. Lewis JD, El-Gendy A.	1996
284	Journal Am J Health-Syst Pharm 1995 ; 52: 2560-2564.	Compatibility and stability of aztreonam and vancomycin hydrochloride. Trissel LA, Xu QA, Martinez JF.	1995
1	Journal Am J Health-Syst Pharm 1996 ; 53: 1939-1943.	Stability of cidofovir in 0.9% sodium chloride and in 5% dextrose injection. Yuan LC, Samuels GJ, Visor GC.	1996
5	Journal Am J Health-Syst Pharm 1996 ; 53: 1583-1588.	Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Stiles ML, Allen LV Jr, Prince SJ.	1996
23	Journal Am J Health-Syst Pharm 1997 ; 54: 1065-1068.	Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride and in 5% dextrose injection. Evrard B, Ceccato A, Gaspard O, Delattre L, Delporte JP.	1997
27	Journal Am J Health-Syst Pharm 1996 ; 53: 1174-1176.	Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days. Chin A, Moon YSK, Chung KC, Gill MA.	1996
30	Journal Am J Health-Syst Pharm 1996 ; 53: 1431-1435.	Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days. Hagan RL, Mallett MS, Fox JL.	1996
33	Journal Am J Health-Syst Pharm 1996 ; 53: 1457-1458.	Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs. Baud-Camus F, Crauste-Manciet S, Klein E, Richard L, Brossard D.	1996
35	Journal Am J Health-Syst Pharm 1995 ; 52: 2128-2130.	Long term stability of interferon alfa-2b diluted to 2 million units/mL. Schepart BS, Burns BA, Evans S, Poleon G.	1995
36	Journal Am J Health-Syst Pharm 1995 ; 52: 2423-2426.	Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.	1995
41	Journal Am J Health-Syst Pharm 1997 ; 54: 913-915.	Stability of midazolam hydrochloride in syringes and IV fluids. Pramar YV, Loucas VA, El-Rachidi A.	1997
42	Journal Am J Health-Syst Pharm 1997 ; 54: 422-423.	Stability of bumetanide in 5% dextrose injection. Cornish LA, Montgomery PA, Johnson CE.	1997
44	Journal Am J Health-Syst Pharm 1996 ; 53: 1701-1705.	Stability of nicardipine hydrochloride in intravenous solutions. Baaske DM, DeMay JF, Latona CA, Mirmira S, Sigvardson KW.	1996
50	Journal Am J Health-Syst Pharm 1995 ; 52: 514-516.	Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions. Fleming RA, Olsen DJ, Savage PD, Fox JL.	1995
53	Journal Am J Health-Syst Pharm 1995 ; 52: 2570-2573.	Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion. Henry DW, Marshall JL, Nazzar OD, Fox JL, Leff RD.	1995
59	Journal Am J Health-Syst Pharm 1997 ; 54: 2192-2196.	Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF, Kim MC.	1997
125	Journal Am J Health-Syst Pharm 1996 ; 53: 1576-1579.	Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C. Chernin EL, Stewart JT, Smiler B.	1996
126	Journal Am J Health-Syst Pharm 1996 ; 53: 2606-2610.	Physicochemical compatibility of propofol with thiopental sodium. Prankerd RJ, Jones RD.	1996
176	Journal Am J Health-Syst Pharm 1995 ; 52: 2567-2568.	Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection. Mantong ML, Marquardt ED.	1995
177	Journal Am J Health-Syst Pharm 1995 ; 52: 2213-2216.	Avaibility of lorazepam after simulated administration from glass and polyvinyl chloride containers. Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR.	1995
185	Journal Am J Health-Syst Pharm 1995 ; 52: 2018-2020.	Stability of midazolam hydrochloride in polyvinyl chloride bags under fluorescent light. McMullin ST, Burns Schaiff RA, Dietzen DJ.	1995
186	Journal Am J Health-Syst Pharm 1995 ; 52: 2020-2022.	Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Swart EL, Mooren RAG, Van Loenen AC.	1995
192	Journal Am J Health-Syst Pharm 1997 ; 54: 1417-1419.	Stability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride, and nitroglycerin in 5% dextrose injection. Peddicord TE, Olsen KM, ZumBrunnen TL, Warner DJ, Webb L.	1997
200	Journal Am J Health-Syst Pharm 1995 ; 52: 2340.	Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections. Korth-Bradley JM, Ludwig S, Callaghan C.	1995
207	Journal Am J Health-Syst Pharm 1995 ; 52: 2024-2025.	Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. Ku YM, Min DI, Kumar V, Noormohamed SE.	1995
208	Journal Am J Health-Syst Pharm 1997 ; 54: 1304-1306.	Stability of ranitidine hydrochloride and human insulin in 0.9% sodium chloride injection. Nolan PE, Hoyer GL, Ledoux JH, Fox JL.	1997
233	Journal Am J Health-Syst Pharm 1996 ; 53: 1850.	Precipitation of lorazepam during infusion by volumetric pump. Grillo JA, Barie PS.	1996
241	Journal Am J Health-Syst Pharm 1996 ; 53: 2639.	Incompatibility between ceftriaxone sodium and labetolol hydrochloride. Leader WG, Jones JM.	1996
249	Journal Am J Health-Syst Pharm 1996 ; 53: 1041-1045.	Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1996
250	Journal Am J Health-Syst Pharm 1997 ; 54: 566-569.	Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.	1997
251	Journal Am J Health-Syst Pharm 1997 ; 54: 2708-2713.	Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1997
266	Journal Am J Health-Syst Pharm 1996 ; 53: 2853-2855.	Compatibility of meropenem with commonly used injectable drugs. Patel PR.	1996
274	Journal Am J Health-Syst Pharm 1995 ; 52: 999-1001.	Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags. Moon YSK, Chung KC, Chin A, Gill MA.	1995
300	Journal Am J Health-Syst Pharm 1997 ; 54: 1287-1292.	Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1997
302	Journal Am J Health-Syst Pharm 1997 ; 54: 2588-2591.	Stability of thiotepa (lyophilized) in 0.9% sodium chloride injection. Murray KM, Erkkila D, Gombotz WR, Pankey S.	1997
319	Journal Am J Health-Syst Pharm 1995 ; 52: 997-999.	Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Hadzija BW, Lubarsky DA.	1995
486	Journal Am J Health-Syst Pharm 1998 ; 55: 602, 604.	Stability of carboplatin in polyvinyl chloride bags. Diaz Amador F, Sevilla Azzati E, Herreros de Tajeda y Lopez-Coterilla A.	1998
765	Journal Am J Health-Syst Pharm 1998 ; 55: 2013-2015.	Stability of lorazepam 1 and 2 mg/ml in glass bottles and polypropylene syringes. Share MJ, Harrison RD, Folstad J, Fleming RA.	1998
795	Journal Am J Health-Syst Pharm 1996 ; 53: 2338-2339.	21-day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a cassette. Henderson F.	1996
811	Journal Am J Health-Syst Pharm 1998 ; 55: 1296-1298.	Activity of enoxaparin sodium in tuberculin syringes for 10 days. Charland SL, Davis DD, Tillman DJ.	1998
813	Journal Am J Health-Syst Pharm 1999 ; 56: 63-68.	Stability of milrinone lactate in the presence of 29 critical care drugs and 4 IV solutions. Akkermann SR, Zhang H, Mullins RE, Yaughn K.	1999
814	Journal Am J Health-Syst Pharm 1999 ; 56: 164-169.	Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration. Johnson CE, VandenBussche HL, Chio CC, Jacobson PA.	1999
815	Journal Am J Health-Syst Pharm 1998 ; 55: 2630-2634.	Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL.	1998
816	Journal Am J Health-Syst Pharm 1998 ; 55: 466-470.	Stability of undiluted and diluted adenosine at three temperatures in syringes and bags. Kektar VA, Kolling WM, Nardviriyakul N, VanDer Kamp K, Wurster DE.	1998
817	Journal Am J Health-Syst Pharm 1998 ; 55: 683-685.	Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device. Stendal TL, Klem W, Tonnesen HH, Kjonniksen I.	1998
818	Journal Am J Health-Syst Pharm 1998 ; 55: 1042-1043.	Stability of torsemide in 5% dextrose injection. Montgomery PA, Cornish LA, Johnson CE, Fitzpatrick KA.	1998
820	Journal Am J Health-Syst Pharm 1998 ; 55: 1161-1164.	Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution. Naud C, Marti B, Fernandez C, Astier A, Paul M.	1998
821	Journal Am J Health-Syst Pharm 1998 ; 55: 1194,1197.	Visual compatibility of fentanyl citrate with parenteral nutrient solutions. Moshfeghi M, Ciuffo JD.	1998
822	Journal Am J Health-Syst Pharm 1998 ; 55: 574-577.	Stability of acyclovir sodium 1, 7, and 10 mg/ml in 5% dextrose injection and in 0.9% sodium chloride injection. Zhang Y, Trissel LA, Martinez JF, Gilbert DL.	1998
823	Journal Am J Health-Syst Pharm 1998 ; 55: 1584-1587.	Microbial inhibitory properties and stability of topotecan hydrochloride injection. Patel K, Craig SB, McBride MG, Palepu NR.	1998
824	Journal Am J Health-Syst Pharm 1998 ; 55: 1602-1605.	Stability of albumin-free interferon alfa-2b for 42 days. Appenheimer MM, Schepart BS, Poleon GP, Evans SS.	1998
1026	Journal Am J Health-Syst Pharm 1999 ; 56: 875-881.	Stability and compatibility of topotecan hydrochloride with selected drugs. Mayron D, Gennaro AR.	1999
1029	Journal Am J Health-Syst Pharm 1999 ; 56: 983-985.	Stability of sumatriptan succinate in polypropylene syringes. Nii LJ, Chin A, Cao TM, Gill MA.	1999
1033	Journal Am J Health-Syst Pharm 1999 ; 56: 985-989.	Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection. Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK.	1999
1046	Journal Am J Health-Syst Pharm 1999 ; 56: 1134.	Stability of cefepime hydrochloride in polypropylene syringes. Stewart JT, Maddox FC, Warren FW.	1999
1061	Journal Am J Health-Syst Pharm 1999 ; 56: 2047-2051.	Urokinase after freezing : Implications for thrombolysis in intraventricular hemorrhage. Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM.	1999
1068	Journal Am J Health-Syst Pharm 1999 ; 56: 457-459.	Stability of cefepime hydrochloride in polypropylene syringes at -20°C, 4°C and 22-24°C. Stewart JT, Warren FW, Maddox FC.	1999
1069	Journal Am J Health-Syst Pharm 1999 ; 56: 1835-1838.	Stability and compatibility of promethazine hydrochloride and dihydroergotamine mesylate in combination. Peek BT, Webster KD, Da Camara CC.	1999
1070	Journal Am J Health-Syst Pharm 1999 ; 56: 1891.	Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium. Balthasar JP.	1999
1071	Journal Am J Health-Syst Pharm 1999 ; 56: 1627-1629.	Stability of tirofiban hydrochloride in three commonly used IV solutions and polyvinyl chloride administration sets. Bergquist PA, Zimmermann J, Kenney RR, Han RYH, Hunke WA.	1999
1072	Journal Am J Health-Syst Pharm 1999 ; 56: 1458-1459.	Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.	1999
1416	Journal Am J Health-Syst Pharm 1999 ; 56: 246-248.	Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions. Stamatakis MK, Leader G, Tracy TS.	1999
1454	Journal Am J Health-Syst Pharm 2000 ; 57: 992-995.	Stability of meropenem in a portable infusion device in a cold pouch. Grant EM, Zhong MK, Ambrose PG, Nicolau DP, Nightingale CH, Quiniliani R.	2000
1800	Journal Am J Health-Syst Pharm 2002 ; 59: 853-855.	Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery. Voytilla KL, Tyler LS, Rusho WJ.	2002
1801	Journal Am J Health-Syst Pharm 2003 ; 60: 1271-1272.	Physical compatibility of vasopressin with medications commonly used in cardiac arrest. Feddema S, Rusho WJ, Tyler LS, Barker B.	2003
1802	Journal Am J Health-Syst Pharm 2003 ; 60: 193-194.	Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery. Bell MS, Nolt DH.	2003
1803	Journal Am J Health-Syst Pharm 2003 ; 60: 80-85.	Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.	2003
1804	Journal Am J Health-Syst Pharm 2003 ; 60: 464-468.	Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks. Naughton CA, Duppong LM, Forbes KD, Sehgal I.	2003
1805	Journal Am J Health-Syst Pharm 2002 ; 59: 2362-2364.	Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution. Lin YF, Wu CC, Lin SH, Wang DP, Wang CN.	2002
1822	Journal Am J Health-Syst Pharm 2003 ; 60: 1650-1652.	Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate. Trissel LA, Seanz C.	2003
1904	Journal Am J Health-Syst Pharm 2003 ; 60: 916-922.	Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents. Phares KR, Weiser WE, Miller SP, Myers MA, Wade M.	2003
1906	Journal Am J Health-Syst Pharm 2004 ; 61: 38-45.	Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions. McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.	2004
1926	Journal Am J Health-Syst Pharm 2004 ; 61: 394-396.	Stability of zidovudine with oxytocin in a simulated Y-site injection. Anderson PL, Miller S, Bushman LR.	2004
1934	Journal Am J Health-Syst Pharm 2004 ; 61: 1438-1445.	Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes. Ambados F, Brealey J.	2004
1935	Journal Am J Health-Syst Pharm 2004 ; 61: 1039-1041.	Stability of lorazepam in 0.9% sodium chloride stored in polyolefin bags. Norenberg JP, Achusim LE, Steel TH, Anderson TL.	2004
1940	Journal Am J Health-Syst Pharm 2004 ; 61: 1596-1598.	Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration. Xu QA, Trissel LA.	2004
1941	Journal Am J Health-Syst Pharm 2004 ; 61: 1586-1589.	Potency and stability of frozen urokinase solutions in syringes. Dedrick SC, Ramirez-Rico J.	2004
1942	Journal Am J Health-Syst Pharm 2004 ; 61: 1682-1685.	Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device. Smith DL, Bauer SM, Nicolau DP.	2004
1943	Journal Am J Health-Syst Pharm 2004 ; 61: 1924-1927.	Compatibility and stability of ceftazidime sodium and tenoxicam in 5% dextrose injection. Wang DP, Chiou AHJ, Lee DKT.	2004
1944	Journal Am J Health-Syst Pharm 2004 ; 61: 1774.	Visual compatibility of bivalirudin with selected drugs. Hartman CA, Faria CE, Mago K.	2004
1953	Journal Am J Health-Syst Pharm 2004 ; 61: 2289-2293.	Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Trissel LA, Saenz CA, Ogundele AB, Ingram DS.	2004
1963	Journal Am J Health-Syst Pharm 2004 ; 61: 2415-2418.	Compatibility of argatroban with selected cardiovascular agents. Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS.	2004
1964	Journal Am J Health-Syst Pharm 2002 ; 59: 1784-1785.	Visual compatibility of argatroban with selected drugs. Hartman CA, Baroletti SA, Churchill WW et al.	2002
1979	Journal Am J Health-Syst Pharm 2002 ; 59: 1537-1538.	Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions. Wu CC, Wang DP, Wong CY, Lin YF.	2002
1981	Journal Am J Health-Syst Pharm 2002 ; 59: 2434-2439.	Stability of i.v. mycophenolate mofetil in 5% dextrose injection in polyvinyl chloride infusion bags. Certain E, Beteta F, Goudou-Sinha C, Darbord JC, Prognon P, Jacquot C.	2002
1982	Journal Am J Health-Syst Pharm 2005 ; 62: 834-837.	Compatibility of anidulafungin with other drugs during simulated Y-site administration. Trissel LA, Ogundele AB.	2005
1984	Journal Am J Health-Syst Pharm 2005 ; 62: 182-188.	Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions. Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J.	2005
1985	Journal Am J Health-Syst Pharm 2005 ; 62: 630-633.	Stability of ibuprofen in injection solutions. Volonté MG, Valora PD, Congolani A, Ferrara M.	2005
1986	Journal Am J Health-Syst Pharm 2005 ; 62: 896-899.	Stability and sterility of dolasetron mesylate in syringes stored at room temperature. Steiner ME, Lensmeyer G, Vermeulen LC.	2005
1987	Journal Am J Health-Syst Pharm 2005 ; 62: 289-291.	Stability of roxatidine acetate in parenteral nutrient solutions containing different amino acid formulations. Oh J, Gwak H, Moon H, Choi I.	2005
1988	Journal Am J Health-Syst Pharm 2005 ; 62: 88-92.	Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration. Sprandel KA, Styrszula DE, Deyo K, Sibley C, Rodvold KA.	2005
1989	Journal Am J Health-Syst Pharm 2005 ; 62: 506-509.	Stability of cidofovir in extemporaneously prepared syringes. Hennere G, Havard L, Bonan B, Prognon P.	2005
1993	Journal Am J Health-Syst Pharm 2005 ; 62: 1190-1192.	Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags. Lee DKT, Wang DP, Harsono R, Wong CY.	2005
1995	Journal Am J Health-Syst Pharm 2005 ; 62: 1073-1074.	Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection. Chin A, Liu S, Ting-Chan J, Gill MA.	2005
1998	Journal Am J Health-Syst Pharm 1998 55: 1315-1316.	Fluorouracil precipitate. Allwood MC.	1998
2002	Journal Am J Health-Syst Pharm 2005 ; 62: 1299-1302.	Compatibility of tramadol hydrochloride injection with selected drugs and solutions. Abanmy NO, Zaghloul IY, Radwan MA.	2005
2004	Journal Am J Health-Syst Pharm 2005 ; 62: 1381-1384.	Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration. Patel K, Hursting MJ.	2005
2005	Journal Am J Health-Syst Pharm 2005 ; 62: 1347-1348.	Influence of temperature and drug concentration on nafcillin precipitation. Chan V.	2005
2012	Journal Am J Health-Syst Pharm 2005 ; 62: 2001-2005.	Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers. Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M.	2005
2016	Journal Am J Health-Syst Pharm 2005 ; 62: 1998-2000.	Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration. Xu QA, Trissel LA.	2005
2017	Journal Am J Health-Syst Pharm 2005 ; 62: 1969-1976.	Visual compatibility of vasopressin with other injectable drugs. Barker B, Feddema S, Rusho WJ, Dengg R.	2005
2018	Journal Am J Health-Syst Pharm 2005 ; 62: 1968-1969.	Visual compatibility of clonidine with selected drugs. Veggeland T.	2005
2019	Journal Am J Health-Syst Pharm 2005 ; 62: 1548-1550.	Visual compatibility of gentamicin sulfate and 4% sodium citrate solutions. Wazny L, Walker S, Moist L.	2005
2030	Journal Am J Health-Syst Pharm 2005 ; 62: 2410-2412.	Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes. Johnson CE.	2005
2116	Journal Am J Health-Syst Pharm 2006 ; 63: 906-908.	Visual compatibility of furosemide with phenylephrine and vasopressine. Faria CE, Fiumara K, Patel N, Tran DC.	2006
2131	Journal Am J Health-Syst Pharm 2006 ; 63: 1423-1426.	Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections. Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE.	2006
2146	Journal Am J Health-Syst Pharm 2006 ; 63: 2379-2382.	Drug compatibility with new polyolefin infusion solution containers. Trissel LA, Xu QA, Baker M.	2006
2192	Journal Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.	Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs. Cochran BG, Sowinski KM, Fausel C, Overholser BR.	2007
2194	Journal Am J Health-Syst Pharm 2007 ; 64, 10: 1092-1095.	Stability of phenylephrine hydrochloride injection in polypropylene syringes. Kiser TH, Oldland AR, Fish DN.	2007
2196	Journal Am J Health-Syst Pharm 2007 ; 64, 11: 1209-1213.	Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration. Trissel LA, Trusley C, Ben M, Kupiec TC.	2007
2206	Journal Am J Health-Syst Pharm 2015 ; 72:1292-1297	Stability of chlorothiazide sodium in polypropylene syringes McCluskey S.V, Gardner B, . Graner K.K, Nicole Vu N.	2015
2207	Journal Am J Health-Syst Pharm 2007 ; 64, 18: 1950-1954.	Stability of oxaliplatin in infusion bags containing 5% dextrose injection. Andr? A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E.	2007
2209	Journal Am J Health-Syst Pharm 2007 ; 64, 22: 2356-2358.	Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days. Johnson CE, Petrea Cober M.	2007
2221	Journal Am J Health-Syst Pharm 2007 ; 64, 23: 2480-2482.	Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy. Cober M.P, Johnson C.E.	2007
2233	Journal Am J Health-Syst Pharm 2008 ; 65, 5: 454-457.	Visual compatibility of caspofungin acetate with commonly used drugs during simulated Y-site delivery Condie C.K, Tyler L.S, Barker B, Canann D.M.	2008
2262	Journal Am J Health-Syst Pharm 2008 ; 65: 1261-1265.	Compatibility of doripenem with other drugs during simulated Y-site administratioN Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.	2008
2267	Journal Am J Health-Syst Pharm 2008 ; 65, 7: 636-638.	Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection. Kraft MD, Johnson CE, Chung C, Julian F.	2008
2269	Journal Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.	Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.	2008
2279	Journal Am J Health-Syst Pharm 2008 ; 65, 18: 1735-1759.	Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration. Kupiec T, Trusley C, Ben M, Trissel LA.	2008
2334	Journal Am J Health-Syst Pharm 2009 ; 66, 9: 860-863.	Stability of fentanyl 5 µg/mL diluted with 0.9% sodium chloride injection and stored in polypropylene syringes McCluskey S.V, Graner K.K, Kemp J, Aloumanis V, Ben M, Kupiec T, Nicole Vu N.	2009
2335	Journal Am J Health-Syst Pharm 2009 ; 66, 8: 727-729	Visual compatibility of i.v. medications routinely used in bone marrow transplant recipients Canann D, Tyler L.S, Barker B, Condie C.	2009
2346	Journal Am J Health-Syst Pharm 2009 ; 66: 986-987.	Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents Newland A.M, Mauro V.F, Alexander K.S.	2009
2349	Journal Am J Health-Syst Pharm 2009 ; 66: 1253-1254.	Incompatibility of imipenem–cilastatin and amoxicillin Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B.	2009
2382	Journal Am J Health-Syst Pharm 1999 ; 56: 547-550.	Stability of fumagillin in an extemporaneously prepared ophthalmic solution Abdel-Rahman SM, Nahata MC.	1999
2383	Journal Am J Health-Syst Pharm 2009 ; 66: 1105-1109.	Stability of zonisamide in extemporaneously compounded oral suspensions Abobo CV, Wei B, Liang D.	2009
2384	Journal Am J Health-Syst Pharm 2002 ; 59: 1267-1270.	Stability of valganciclovir in an extemporaneously compounded oral liquid Anaizi NH, Dentinger PJ, Swenson CF.	2002
2385	Journal Am J Health-Syst Pharm 2002 ; 59: 953-956.	Stability of pantoprazole in an extemporaneously compounded oral liquid Dentinger PJ, Swenson CF, Anaizi NH.	2002
2386	Journal Am J Health-Syst Pharm 203 ; 60: 687-690.	Stability of valganciclovir in extemporaneously compounded liquid formulations Henkin CC, Griener JC, Ten Eick AP.	203
2387	Journal Am J Health-Syst Pharm 2003 ; 60: 1268-1270.	Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL.	2003
2388	Journal Am J Health-Syst Pharm 2003 ; 60: 75-77.	Stability of tiagabine in two oral liquid vehicles Nahata MC, Morosco RS.	2003
2389	Journal Am J Health-Syst Pharm 2003 ; 60: 69-74.	Characterization of an extemporaneous liquid formulation of lisinopril Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.	2003
2392	Journal Am J Health-Syst Pharm 2000 ; 57: 1340-1342.	Stability of famotidine in an extemporaneously compounded oral liquid Dentinger PJ, Swenson CF, Anaizi NH.	2000
2394	Journal Am J Health-Syst Pharm 2009 ; 66: 665-667.	Stability of extemporaneously prepared moxifloxacin oral suspensions Hutchinson DJ, Johnson CE, Klein KC.	2009
2395	Journal Am J Health-Syst Pharm 2008 ; 65: 558-561.	Stability of a flavored formulation of acetylcysteine for oral administration Siden R, Johnson CE.	2008
2396	Journal Am J Health-Syst Pharm 2008 ; 65: 441-447.	Effect of buffer and antioxidant on stability of a mercaptopurine suspension Aliabadi HM, Romanick M, Desai S, Lavasanifar A.	2008
2397	Journal Am J Health-Syst Pharm 2007 Dentinger PJ, Swenson CF	Stability of codeine phosphate in an extemporaneously compounded syrup Dentinger PJ, Swenson CF.	2007
2399	Journal Am J Health-Syst Pharm 2007 ; 64: 1513-1515.	Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions Caruthers RL, Johnson CE.	2007
2400	Journal Am J Health-Syst Pharm 2007 ; 64: 762-766.	Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings Kiser TH, Oldland AR, Fish DN.	2007
2401	Journal Am J Health-Syst Pharm 2007 ; 64: 644-646.	Stability of an extemporaneously prepared alcohol-free phenobarbital suspension Cober MP, Johnson CE.	2007
2402	Journal Am J Health-Syst Pharm 2006 ; 63: 2240-2247.	Stability and viscosity of a flavored omeprazole oral suspension for pediatric use Burnett JE, Balkin ER.	2006
2403	Journal Am J Health-Syst Pharm 2004 ; 61: 1493-1496.	Stability of nimodipine solution in oral syringes Green AE, Banks S, Jay M, Hatton J.	2004
2405	Journal Am J Health-Syst Pharm 2002 ; 59: 1853-1855.	Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations VandenBussche HL, Johnson CE, Yun J, Patel SA.	2002
2406	Journal Am J Health-Syst Pharm 2003 ; 60: 1268-1270	Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL.	2003
2407	Journal Am J Health-Syst Pharm 2004 ; 61: 54-57.	Stability of tramadol hydrochloride--acetaminophen (Ultracet) in strawberry syrup and in a sugar-free vehicle Johnson CE, Wagner DS, DeLoach SL, Cichon-Hensley BK.	2004
2408	Journal Am J Health-Syst Pharm 2003 ; 60: 1019-1022.	Stability of nifedipine in an extemporaneously compounded oral solution Dentinger PJ, Swenson CF, Anaizi NH.	2003
2409	Journal Am J Health-Syst Pharm 1999 ; 56: 2316-2318.	Stability of levofloxacin in an extemporaneously compounded oral liquid VandenBussche HL, Johnson CE, Fontana EM, Meram JM.	1999
2410	Journal Am J Health-Syst Pharm 2002 ; 59: 361-363.	Stability of oral suspensions of ursodiol made from tablets Johnson CE, Streetman DD.	2002
2412	Journal Am J Health-Syst Pharm 2001 ; 58: 577-579.	Stability of norfloxacin in an extemporaneously prepared oral liquid Johnson CE, Price J, Hession JM.	2001
2413	Journal Am J Health-Syst Pharm 1999 ; 56: 1957-1960	Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids Fish DN, Vidaurri VA, Deeter RG.	1999
2414	Journal Am J Health-Syst Pharm 1999 ; 56: 2224-2226.	Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid Swenson CF, Dentinger PJ, Anaizi NH.	1999
2415	Journal Am J Health-Syst Pharm 2000 ; 57: 1141-1143.	Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C Nahata MC, Morosco RS, Trowbridge JM.	2000
2416	Journal Am J Health-Syst Pharm 1999 ; 56: 240-242.	Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C Nahata MC, Morosco RS, Hipple TF.	1999
2417	Journal Am J Health-Syst Pharm 1999 ; 56: 243-245.	Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C Abdel-Rahman SM, Nahata MC.	1999
2419	Journal Am J Health-Syst Pharm 1999 ; 56: 333-336.	Stability of rifabutin in two extemporaneously compounded oral liquids Haslam JL, Egodage KL, Chen Y, Rajewski RA, Stella V.	1999
2420	Journal Am J Health-Syst Pharm 1998 ; 55: 1386-1388	Stability of vancomycin in an extemporaneously compounded ophthalmic solution Fuhrman LC, Jr, RT Stroman	1998
2421	Journal Am J Health-Syst Pharm 1998 ; 55: 1804-1809.	Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids Allen LV, Jr, MA Erickson	1998
2422	Journal Am J Health-Syst Pharm 1998 ; 55: 1915-1920.	Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1998
2423	Journal Am J Health-Syst Pharm 1998 ; 55: 2511-2513.	Stability of granisetron hydrochloride in two oral suspensions Nahata MC, Morosco RS, Hipple TF.	1998
2425	Journal Am J Health-Syst Pharm 1998 ; 55: 1155-1157.	Stability of enalapril maleate in three extemporaneously prepared oral liquids Nahata MC, Morosco RS, Hipple TF.	1998
2426	Journal Am J Health-Syst Pharm 1997 ; 54: 549-553.	Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution Anaizi NH, Swenson CF, Dentinger PJ.	1997
2427	Journal Am J Health-Syst Pharm 1997 ; 54: 1404-1406.	Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid Quercia RA, Zhang J, Fan C, Chow MS.	1997
2428	Journal Am J Health-Syst Pharm 1997 ; 54: 1619-1622	Stability of sumatriptan succinate in extemporaneously prepared oral liquids Fish DN, Beall HD, Goodwin SD, Fox JL.	1997
2429	Journal Am J Health-Syst Pharm 1997 ; 54: 1404-1406.	Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid Quercia RA, Zhang J, Fan C, Chow MS.	1997
2430	Journal Am J Health-Syst Pharm 1997 ; 54: 1833-1836.	Stability of omeprazole in an extemporaneously prepared oral liquid Quercia RA, Fan C, Liu X, Chow MS.	1997
2431	Journal Am J Health-Syst Pharm 1997 ; 54: 2073-2078.	Stability of phenoxybenzamine hydrochloride in various vehicles Lim LY, Tan LL, Chan EW, Yow KL, Chan SY, Ho PC.	1997
2432	Journal Am J Health-Syst Pharm 1997 ; 54: 2483-2487.	Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC.	1997
2433	Journal Am J Health-Syst Pharm 1996 ; 53: 2179-2184.	Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1996
2434	Journal Am J Health-Syst Pharm 1996 ; 53: 1944-1949.	Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1996
2435	Journal Am J Health-Syst Pharm 1996 ; 53: 2304-2309.	Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1996
2436	Journal Am J Health-Syst Pharm 1997 ; 54: 178-180.	Stability of tacrolimus in an extemporaneously compounded oral liquid Jacobson PA, Johnson CE, West NJ, Foster JA.	1997
2437	Journal Am J Health-Syst Pharm 1996 ; 53: 659-662.	Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine Larson TA, Uden DL, Schilling CG.	1996
2440	Journal Am J Health-Syst Pharm 1996 ; 53: 407-409.	Stability of flucytosine in an extemporaneously compounded oral liquid Wintermeyer SM, Nahata MC.	1996
2441	Journal Am J Health-Syst Pharm 1996 ; 53: 2073-2078.	Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1996
2442	Journal Am J Health-Syst Pharm 1995 ; 52: 189-191.	Stability of itraconazole in an extemporaneously compounded oral liquid Jacobson PA, Johnson CE, Walters, JR.	1995
2443	Journal Am J Health-Syst Pharm 1995 ; 52: 2433-2436.	Stability of ramipril in water, apple juice, and applesauce Allen LV, Jr, Stiles ML, Prince SJ, McLaury HJ, Sylvestri MF.	1995
2444	Journal Am J Health-Syst Pharm 1995 ; 52: 2204-2207.	Stability of cyclosporine in an extemporaneously compounded paste Ghnassia LT, Yau DF, Kaye KI, Duggin GG.	1995
2445	Journal Am J Health-Syst Pharm 1995 ; 52: 2011-2014.	Stability of ondansetron hydrochloride injection in various beverages Yamreudeewong W, Danthi SN, Hill RA, Fox JL.	1995
2446	Journal Am J Health-Syst Pharm 1998 ; 55: 1299-1301.	Content uniformity and stability of nifedipine in extemporaneously compounded oral powders Helin MM, Kontra KM, Naaranlahti TJ, Wallenius KJ.	1998
2447	Journal Am J Health-Syst Pharm 1997 ; 54: 2714-2716.	Stability of pyrimethamine in a liquid dosage formulation stored for three months Nahata MC, Morosco RS, Hipple TF.	1997
2448	Journal Am J Health-Syst Pharm 1998 ; 55: 926-929.	Stability of mycophenolate mofetil in an extemporaneously compounded oral liquid Anaizi NH, Swenson CF, Dentinger PJ.	1998
2449	Journal Am J Health-Syst Pharm 1995 ; 52: 1798-1800.	Stability of ursodiol in an extemporaneously compounded oral liquid Johnson CE, Nesbitt J.	1995
2450	Journal Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.	Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution Manduru M, Fariello A, White RL, Fox JL, Bosso JA.	1996
2451	Journal Am J Health-Syst Pharm 1995 ; 52: 2022 - 2024.	Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions Park TW, Le-Bui LP, Chung KC, Rho JP, Gill MA.	1995
2453	Journal Am J Health-Syst Pharm 1997 ; 54: 1301-1303.	Stability of pentoxifylline in an extemporaneously prepared oral suspension Abdel-Rahman S, Nahata MC.	1997
2454	Journal Am J Health-Syst Pharm 1995 ; 52: 1558-1560.	Stability of pyrazinamide in two suspensions Nahata MC, Morosco RS, Peritore SP.	1995
2455	Journal Am J Health-Syst Pharm 2002 ; 59: 1853-1855.	Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations VandenBussche HL, Johnson CE, Yun J, Patel SA.	2002
2785	Journal Am J Health-Syst Pharm 2005 ; 62, 11: 1192-1194.	Stability of misoprostol in suppositories. Hafirassou H, Chaidmi F, Schlatter J, Ratiney R, Fontan JE.	2005
2786	Journal Am J Health-Syst Pharm 2005 ; 62, 5: 485-491.	Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus. Ungphaiboon S, Nittayananta W, Vuddhakul V, Maneenuan D, Kietthubthew S, Wongpoowarak W, Phadoongsombat N.	2005
2787	Journal Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.	Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Lee TY, Chen CM, Lee CN, Chaing YC.	2005
2827	Journal Am J Health-Syst Pharm 2009 ; 66: 1722-1725.	Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S.	2009
2883	Journal Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.	Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags. Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F.	2009
2925	Journal Am J Health-Syst Pharm 2005 ; 62: 2518-2520.	Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions. Johnson CE, vanDe Koppel S, Myers E.	2005
2926	Journal Am J Health-Syst Pharm 2006 ; 63: 254-257.	Extemporaneous sildefanil citrate oral suspensions for the treatment of pulmonary hypertension in children. Nahata MC, Morosco RS, Brady MT.	2006
2940	Journal Am J Health-Syst Pharm 2001 ; 58: 1021-1024.	Stability of amphotericin B in an extemporaneously compounded oral suspension. Dentinger PJ, Swenson CF, Anaizi NH.	2001
3083	Journal Am J Health-Syst Pharm 2009 ; 66: 1478-1483.	Stability of extemporaneously prepared voriconazole ophthalmic solution Al-Badriyeh D, Li J, Stewart K, Kong DCM, Leung L, Davies GE, Robert Fullinfaw R.	2009
3095	Journal Am J Health-Syst Pharm 2010 ; 67: 287-289.	Stability of extemporaneously prepared rifaximin oral suspensions. Cober MP, Johnson CE, Lee J, Currie K.	2010
3116	Journal Am J Health-Syst Pharm 2010 ;67: 1026-1029.	Stability of sodium bicarbonate solutions in polyolefin bags. Wear J, McPherson TB, Kolling WM.	2010
3121	Journal Am J Health-Syst Pharm 2010 ; 67: 1191-1194.	Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 °C He J, Figueroa DA, Lim TP, Chow DS, Tam VH.	2010
3122	Journal Am J Health-Syst Pharm 2010 ; 67: 1195-1198.	Physical compatibility of 4% sodium citrate with selected antimicrobial agents. Dotson B, Lynn S, Savakis K, Churchwell MD.	2010
3135	Journal Am J Health-Syst Pharm 2010 ; 67, 3: 223-226.	Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags. Ikesue H, Vermeulen LC, Hoke R, Kolesar JM.	2010
3145	Journal Am J Health-Syst Pharm 2010 ; 67: 1539-1544.	Stability of doripenem in polyvinyl chloride bags and elastomeric pumps. Crandon JL, Sutherland C, Nicolau DP.	2010
3152	Journal Am J Health-Syst Pharm 2010 ; 67: 1640-1644.	Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration. Kumar A, Mann HJ.	2010
3165	Journal Am J Health-Syst Pharm 2011 ; 68: 69-72.	Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus Fohl AL, Johnson CE, Cober P.	2011
3254	Journal Am J Health-Syst Pharm 2011 ; 68: 2265-2270.	Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.	2011
3185	Journal Am J Health-Syst Pharm 2011 ; 68:519-521.	Stability of extemporaneously prepared oxandrolone oral suspensions. Johnson CE, Cober MP, hawkins KA, Julian JD.	2011
3186	Journal Am J Health-Syst Pharm 2011 ; 68:377-378.	Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin. Bryan Dotson B, Churchwell MD.	2011
3187	Journal Am J Health-Syst Pharm 2011 ; 68:420-423.	Stability of an extemporaneous alcohol-free melatonin suspension. Johnson CE, Cober MP, Thome T, Rouse E.	2011
3202	Journal Am J Health-Syst Pharm 2011 ; 68: 900-908.	Stability of compounded thioguanine oral suspensions Montazeri Aliabadi H, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A	2011
3203	Journal Am J Health-Syst Pharm 2011 ; 68:843-845.	Stability of extemporaneously prepared glycopyrrolate oral suspensions. Cober MP, Johnson CE, Sudekum D, Penprase K	2011
3268	Journal Am J Health-Syst Pharm 2012 ;69: 98.	Physical compatibility of calcium gluconate and magnesium sulfate injections. Beauregard N, Bertrand N, Dufour A, Blaizel O, Leclair G	2012
3222	Journal Am J Health-Syst Pharm 2011 ;68:1537-1540.	Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags Karlage K, Earhart Z, Green-Boesen K, . Myrdal PB	2011
3223	Journal Am J Health-Syst Pharm 2011 ;68:1533-1536.	Stability of diluted adenosine solutions in polyvinyl chloride infusion bags Kaltenbach M, Hutchinson DJ, Bollinger JE, Zhao F.	2011
3228	Journal Am J Health-Syst Pharm 2011 ;68:1723-1728.	Stability of levothyroxine injection in glass, polyvinyl chloride, and polyolefin containers Frenette AJ, MacLean RD, Williamson D, Marsolais P, . Donnelly RF	2011
3229	Journal Am J Health-Syst Pharm 2011 ;68:1646-1650.	Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes Li M, Forest JM, Coursol C, Leclair G	2011
3249	Journal Am J Health-Syst Pharm 2011 ; 68: 2163-2169.	Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.	2011
3269	Journal Am J Health-Syst Pharm 2012 ; 69:56-58.	Stability of an extemporaneously prepared thalidomide suspension. Kraft S, . Johnson C.E, Tyler R.P.	2012
3275	Journal Am J Health-Syst Pharm 2012 ; 69: 232-240.	Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate D'Hondt M, Vangheluwe E, Van Dorpe S, Boonen J, Bauters T, Pelfrene B, Vandenbroucke J, Robays H, De Spiegeleer B	2012
3298	Journal Am J Health-Syst Pharm 2012 ; 69: 592-594	Stability of an extemporaneously prepared tadalafil suspension Pettit R.S, Johnson C.E, Caruthers R.L.	2012
3299	Journal Am J Health-Syst Pharm 2012 ; 69:595-597.	Stability of dexmedetomidine 4 µg/mL in polypropylene syringes. Anderson C.R, Mackay M.W, Holley M, Kay B.A	2012
3821	Journal Am J Health-Syst Pharm 2015 ; 72:2182-2188	Stability of furosemide and chlorothiazide stored in syringes. Cies J.J, Moore W.S, Chopra A, Lu G, Mason R.W.	2015
3327	Journal Am J Health-Syst Pharm 2012 ; 69:1405-1409	Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. LaPlante K.L, Woodmansee S, Mermel L.A.	2012
3333	Journal Am J Health-Syst Pharm 2012 ; 69:1509-1512.	Stability of infliximab in polyvinyl chloride bags. Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M.	2012
3350	Journal Am J Health-Syst Pharm 2012 ; 69:1999-2001	Extended stability of intravenous acetaminophen in syringes and opened vials. Kwiatkowski J.L, Johnson C.E, Wagner D.S.	2012
3364	Journal Am J Health-Syst Pharm 2012 ; 69:2130.	Visual compatibility of micafungin sodium and levofloxacin injections. Fleischbein E, Montgomery P.A, Zhou C.Z.	2012
3378	Journal Am J Health-Syst Pharm 2013 ; 70:515-519.	Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection Chen F-C, Fang B-X, Li P, Yang J-G, Zhou B-H.	2013
3379	Journal Am J Health-Syst Pharm 2013 ;70:520-524.	Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Fox L.M, Wilder A.G, Foushee J.A.	2013
3409	Journal Am J Health-Syst Pharm 2013 ; 70:894-899.	Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags Kaushal G, Sayre B.E, Prettyman T.	2013
3416	Journal Am J Health-Syst Pharm 2013 ; 70: 932-937	Physical compatibility of sodium citrate with alcohol and cefepime. Csaba M, Boddu,S.H.S , Churchwell M.D.	2013
3421	Journal Am J Health-Syst Pharm 2013 ;70:1163-1166.	Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions. Leung E, Venkatesan N, Ly S.C, Scheetz M.H.	2013
3429	Journal Am J Health-Syst Pharm 2015 ; 72:483-486	Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration Foushee J.A, Fox L.M, Gormley L.R, Lineberger M.S.	2015
3433	Journal Am J Health-Syst Pharm 2013 ; 70:1336-1341	Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection. Preslaski C.R, Mueller S.W, Wempe M.F, Robert MacLaren R.	2013
3475	Journal Am J Health-Syst Pharm 2013 ;70:1966-1970.	Incompatibility of ciprofloxacin and meropenem injections. Chen L.Y, Chen J, Waters V, Boodhan S.	2013
3476	Journal Am J Health-Syst Pharm 2013 ;70:1970-1972.	Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers. Li M, Coursol C, Leclair G.	2013
3534	Journal Am J Health-Syst Pharm 2013 ; 70:2137-2142	Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.	2013
3542	Journal Am J Health-Syst Pharm 2015 ; 72:390-395	Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion Berti A.D, Hutson P.R, Schulz L.T, Webb A.P, Rose W.E.	2015
3561	Journal Am J Health-Syst Pharm 2015 ; 72:479-482	Stability of frozen 1% voriconazole ophthalmic solution. Amoros-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner D, Lopez-Cabezas C.	2015
3568	Journal Am J Health-Syst Pharm 2014 ;71:219-222	Stability of levetiracetam oral solution repackaged in oral plastic syringes. Prohotsky D.L, Hughes S.E, Zhao F.	2014
3648	Journal Am J Health-Syst Pharm 2014 ; 71:669-673.	Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers. Hossain M.A, Friciu M, Aubin S, Leclair G.	2014
3649	Journal Am J Health-Syst Pharm 2014 ; 71:657-661.	Stability of clonidine suspension in oral plastic syringes. Ma C, Decarie D, Ensom M.H.H.	2014
3664	Journal Am J Health-Syst Pharm 2014 ; 71:901-902.	Incompatibility of esmolol hydrochloride and furosemide in a central venous access port Zhao B, Sun W.	2014
3665	Journal Am J Health-Syst Pharm 2014 ; 71:956-959	Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and -20°C. Ortega R, Salmer?n-Garc?a A, Cabeza J, Capit?n-Vallvey L.F, Navas N.	2014
3715	Journal Am J Health-Syst Pharm 2014 ; 71:1534-1535	Compatibility of conivaptan injection with select cardiovascular medications. Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D.	2014
3717	Journal Am J Health-Syst Pharm 2014 ; 71:1480-1484	Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C. Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.	2014
3728	Journal Am J Health-Syst Pharm 2014 ; 71: 1288-1291.	Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.	2014
3764	Journal Am J Health-Syst Pharm 2014 2014; 71: 1831-1832.	Compatibility of argatroban injection with select antiarrhythmic drugs Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S.	2014
3777	Journal Am J Health-Syst Pharm 2015 ; 72:13-14	Stability of ampicillin and amoxicillin in peritoneal dialysis solutions Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D.	2015
3779	Journal Am J Health-Syst Pharm 2014 ; 71:2061-2065	Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection Kintzel P.E, Zhao T, Wen B, Sun D.	2014
3805	Journal Am J Health-Syst Pharm 2015 ; 72:1374-1378.	Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags. Chen F.C, Xiong H, Liu H.M, Fang B.X, Li P.	2015
3841	Journal Am J Health-Syst Pharm 2016 ; 73:241-246	Visual and absorbance analyses of admixtures containing vancomycin and piperacillin–tazobactam at commonly used concentrations. Nicholas O?Donnell J, Venkatesan N, Manek M, Rhodes N.J, Scheetz M.H.	2016
3842	Journal Am J Health-Syst Pharm 2016 ; 73:137-142.	Stability of tacrolimus solutions in polyolefin containers. Lee J.H, Goldspiel B.R, Ryu S, Potti G.K.	2016
3873	Journal Am J Health-Syst Pharm 2016 ; 73:755.	Incompatibility between irinotecan and fluorouracil injections Tan X, Hu J.	2016
3915	Journal Am J Health-Syst Pharm 2016 ; 73,24: 2083-2088.	Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A.	2016
3923	Journal Am J Health-Syst Pharm 2017 ; 74, 1: e64-e71	Stability of sildenafil in combination with heparin and dopamine. Luu Y, Thigpen J, Brown S.D.	2017
3942	Journal Am J Health-Syst Pharm 2017 ; 74, 5: 280-281.	Physical compatibility of valproate sodium injection with dobutamine and dopamine. Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D.	2017
3976	Journal Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218	Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.	2017
3978	Journal Am J Health-Syst Pharm 2017 ; 74,9: 202-210	Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations. Kirk L.M, Brown S.D, Luu Y, Ogle A, Huffman J, O. Lewis P.O.	2017
3980	Journal Am J Health-Syst Pharm 2017 ; 74,9: e211-e223	Stability study of methotrexate in 0.9% sodium chloride injection and 5% dextrose injection with limit tests for impurities. Nissen K.B, Jorgensen L.B, Berg D.L, Andersen G.	2017
3988	Journal Am J Health-Syst Pharm 2017 ; 74:13 : 1002-1006	Stability of tacrolimus ophthalmic solution. Ezquer-Garin C, Ferriols-Lisart R, Al?s-Almi?ana M.	2017
4113	Journal Am J Health-Syst Pharm 2018 ; 75, 10: 622-626.	Stability of isoniazid injection in i.v. solutions. Lee J, Moriyama B, Henning S, Danner R, Walsh T, Penzak S, Grimes G, Gopal K.	2018
3997	Journal Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102	Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration. Katip W.	2017
4022	Journal Am J Health-Syst Pharm 2017 ; 74,19: 1579-1583	Stability of extemporaneously prepared rosuvastatin oral suspension. Zaid A.N, Shtayah R, Qadumi A, Ghanem M, Qedan R, Daibes M, Abu Awwad S, Jaradat N, Kittana N.	2017
4033	Journal Am J Health-Syst Pharm 2017 ;74,22:1887-1894	Stability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assay. Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S.	2017
4053	Journal Am J Health-Syst Pharm 2017 ;74,24:2060-2064	Stability of a pyrimethamine suspension compounded from bulk powder. Lewis P, Cluck D, Huffman J, Ogle A, Brown S.	2017
4054	Journal Am J Health-Syst Pharm 2018 , 75, 1: 28-35	Stability of extemporaneously prepared preservative-free prochlorperazine nasal spray. Yellepeddi V.	2018
4055	Journal Am J Health-Syst Pharm 2018 , 75, 1:36-44	Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.	2018
4075	Journal Am J Health-Syst Pharm 2018 ;75,5: 309-315	Stability of an extemporaneously compounded minoxidil oral suspension. Song Y, Whey Chin Z, Ellis D, Mon Phyo Lwin E, Turner S, Williams D, Garg S.	2018
4108	Journal Am J Health-Syst Pharm 2018 ;75;8:510-512	Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine. Cruz K, Chrchwell M, Mauro V, Boddu.	2018
4109	Journal Am J Health-Syst Pharm 2018 ;75,9:241-245	Stability of milrinone in continuous ambulatory delivery devices. Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.	2018
4111	Journal Am J Health-Syst Pharm 2018 ;75,9:231-235	Stability of extemporaneously prepared ophtalmic solutions for mydriasis. Camp N, Nadra J, Hughes S, Gilbert J, Zhao F.	2018
4145	Journal Am J Health-Syst Pharm 2018 ;75,14:1048-1056	Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.	2018
4176	Journal Am J Health-Syst Pharm 2018 ;75:1467-1477	Compatibility of linezolid with commercial peritoneal dialysis solutions Poeppl W, Rainer-Harbach E, Kussmann M, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Reznicek G.	2018
4189	Journal Am J Health-Syst Pharm 2022 ;79,12: 1011-1018	Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration. Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S,	2022
4201	Journal Am J Health-Syst Pharm 2020 ; 77, 9: 681-689.	Long-term stability of ready-to-use 1-mg/mL midazolam solution. Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P.	2020
4407	Journal Am J Health-Syst Pharm 2020 ;77,8:649–657.	Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration. Bustin A, Ramsey Z, Hanna B, Kaushal G.	2020
4465	Journal Am J Health-Syst Pharm 2020 ;77,14:1144-1148	Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients. Foushee A, Meredith P, Fox Laura, Wilder A.	2020
4506	Journal Am J Health-Syst Pharm 2020 ;77,23:1938-1940.	Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration. Griffith S, Stapleton E, Padilla S, Mruk A, Thomas C.	2020
4507	Journal Am J Health-Syst Pharm 2020 ;77,23:1980-1985	Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Ross E, Salinas A, Petty K, Her C, Carpenter J.	2020
4573	Journal Am J Health-Syst Pharm 2021 ;78, 9:806–812,	Long-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparation. Legeron R, Bougueon G, Berroneau A, De-Germay S, Bernadou JM, Djabarouti S, Crauste-Manciet S, Xuereb F.	2021
4596	Journal Am J Health-Syst Pharm 2021 ;78,15:444–1447	Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days. Roura-Turet J, Rodriguez-Reyes M, Guerrero-Molina L, Soy-Muner D, López-Cabezas C.	2021
4655	Journal Am J Health-Syst Pharm 2022 ;79,1:27-33	Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Holyk A, Lindner A, Lindner S, Shippert B	2022
4723	Journal Am J Health-Syst Pharm 2022 https://doi.org/10.1093/a	Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration. Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H	2022
1741	Journal Am J Hosp Pharm 1993 ; 50: 2518-2521.	Precipitation of paclitaxel during infusion by pump. Pfeifer RW, Hale KN, Cronquist SE, Daniels M.	1993
18	Journal Am J Hosp Pharm 1994 ; 51: 391-394.	Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration. Pompilio FM, Fox JL, Inagaki K, Burm JP, Jhee S, Gill MA.	1994
19	Journal Am J Hosp Pharm 1986 ; 43: 1444-1453.	Stability of intravenous admixtures of aztreonam and cefoxitin, gentamicin, metronidazole, or tobramycin. Bell RG, Lipford LC, Massanari MJ, Riley CM.	1986
20	Journal Am J Hosp Pharm 1986 ; 43: 2732,2738.	Stability of erythromycin in intravenous admixtures. Pluta PL, Morgan PK.	1986
21	Journal Am J Hosp Pharm 1986 ; 43: 2803-2809.	Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions. Bigley FP, Forsyth RJ, Henley MW.	1986
45	Journal Am J Hosp Pharm 1991 ; 48: 501-506.	Stability of succinylcholine chloride injection. Schmutz CW, Mühlbach SF.	1991
60	Journal Am J Hosp Pharm 1990 ; 47: 2037-2040.	Stability of fentanyl citrate and bupivacaine hydrochloride in portable pump reservoirs. Tu YH, Stiles ML, Allen LV Jr.	1990
67	Journal Am J Hosp Pharm 1991 ; 48: 1538-1539.	Visual compatibility of ganciclovir sodium and parenteral nutrient solution during simulated Y-site injection. Outman WR, Mitrano FP, Baptista RJ.	1991
72	Journal Am J Hosp Pharm 1994 ; 51: 503-508.	Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions. Johnson CE, Jacobson PA, Chan E.	1994
86	Journal Am J Hosp Pharm 1994 ; 51: 2812-2815.	Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration. Johnson CE, Bhatt-Mehta V, Mancari SC, McKown JA.	1994
87	Journal Am J Hosp Pharm 1991 ; 48: 108-110.	Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection. Lee DKT, Lee A, Wang DP.	1991
94	Journal Am J Hosp Pharm 1990 ; 47: 1970.	Aztreonam-vancomycin incompatibility. Chandler SW, Folstad J, Trissel LA.	1990
95	Journal Am J Hosp Pharm 1991 ; 48: 77.	Incompatibility of ceftriaxone with vancomycin. Pritts D, Hancock D.	1991
106	Journal Am J Hosp Pharm 1990 ; 47: 519.	Incompatibility of cefoperazone and promethazine. Scott SM.	1990
113	Journal Am J Hosp Pharm 1993 ; 50: 1918-1920.	Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4°C. Jhee SS, Jeong EW, Chin A, Inagaki K, Fox JL, Gill MA.	1993
115	Journal Am J Hosp Pharm 1992 ; 49: 2785-2786.	Stability of morphine sulfate in bacteriostatic 0.9% sodium chloride injection stored in glass vials at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1992
142	Journal Am J Hosp Pharm 1992 ; 49: 619-623.	Stability of fluorouracil, cytarabine, or doxorubicin hydrochloride in ethylene vinylacetate portable infusion-pump reservoirs. Rochard EB, Barthes DMC, Courtois PY.	1992
151	Journal Am J Hosp Pharm 1994 ; 51: 2704-2706.	Stability of paclitaxel and fluconazole during simulated Y-site administration. Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA.	1994
170	Journal Am J Hosp Pharm 1975 ; 62: 44-45.	Effect of briefly heating cyclophosphamide solutions. Brooke D, Scott JA, Bequette RJ.	1975
174	Journal Am J Hosp Pharm 1990 ; 47: 1567-1571.	Stability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochloride. Schaaf LJ, Robinson DH, Vogel GJ, Wulf BG, Drda KD, Moses JO.	1990
179	Journal Am J Hosp Pharm 1992 ; 49: 1471-1473.	Stability of ondansetron hydrochloride in portable infusion-pump reservoirs. Stiles ML, Allen LV Jr, Fox JL.	1992
183	Journal Am J Hosp Pharm 1992 ; 49: 2223-2225.	Stability of ondansetron hydrochloride in injectable solutions at -20, 5, and 25°C. Bosso JA, Prince RA, Fox JL.	1992
190	Journal Am J Hosp Pharm 1986 ; 43: 1945-1950.	Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets. Lee MG.	1986
191	Journal Am J Hosp Pharm 1988 ; 45: 2079-2091.	Stability of milrinone and digoxin, furosemide, procainamide hydrochloride, propranolol hydrochloride, quinidine gluconate, or verapamil hydrochloride in 5% dextrose injection. Riley CM.	1988
194	Journal Am J Hosp Pharm 1990 ; 47: 1559-1562.	Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set. Loucas SP, Maager P, Mehl B, Loucas ER.	1990
199	Journal Am J Hosp Pharm 1994 ; 51: 2143-2145.	Stability of labetalol hydrochloride with selected critical care drugs during simulated Y-site injection. Hassan E, Leslie J, Martir-Herrero ML.	1994
201	Journal Am J Hosp Pharm 1990 ; 47: 2530-2531.	Visual compatibility of enalaprilate with selected intravenous medications during simulated Y-site injection. Thompson DF, Allen LV, Stiles ML.	1990
204	Journal Am J Hosp Pharm 1994 ; 51: 2693-2696.	Stability of esmolol hydrochloride in intravenous solutions. Baaske DM, Dyskstra SD, Wagenknecht DM, Karnatz NN.	1994
213	Journal Am J Hosp Pharm 1990 ; 47: 1580-1584.	Stability of ranitidine hydrochloride at dilute concentration in intravenous infusion fluids at room temperature. Galante LJ, Stewart JT, Warren FW, Johnson SM, Duncan R.	1990
214	Journal Am J Hosp Pharm 1990 ; 47: 1606-1610.	Stability of ranitidine hydrochloride with eight medications in intravenous admixtures. Galante LJ, Stewart JT, Warren FW, Edgar JW, Huff AJ.	1990
217	Journal Am J Hosp Pharm 1993 ; 50: 714-715.	Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs. Allen LV, Stiles ML, Wang DP, Tu YH.	1993
218	Journal Am J Hosp Pharm 1993 ; 50: 2311.	Compatibility of magnesium sulfate and morphine sulfate in 0.9% sodium chloride injection. Vogt C, Ruggaber S.	1993
258	Journal Am J Hosp Pharm 1994 ; 51: 901-904.	Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection. Belliveau PP, Nightingale CH, Quintiliani R.	1994
260	Journal Am J Hosp Pharm 1993 ; 50: 2054, 2057.	Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration. Szof C, Walker PC.	1993
261	Journal Am J Hosp Pharm 1993 ; 50: 715-716.	Visual compatibility of ciprofloxacin with selected components of total parenteral nutrient solutions during simulated Y-site injection. Percy LA, Rho JP.	1993
286	Journal Am J Hosp Pharm 1992 ; 49: 1459-1462.	Stability of fluconazole and amino acids in parenteral nutrient solutions. Couch P, Jacobson P, Johnson CE.	1992
293	Journal Am J Hosp Pharm 1993 ; 50: 2364-2365.	Stability of bupivacaine hydrochloride in polypropylene syringes. Jones JW, Davis AT.	1993
294	Journal Am J Hosp Pharm 1993 ; 50: 2356-2358.	Stability of octreotide acetate in polypropylene syringes. Stiles ML, Allen LV, Resztak KE, Prince SJ.	1993
304	Journal Am J Hosp Pharm 1992 ; 49: 1455-1458.	Stability, potency, and preservative effectiveness of epoetin alfa after addition of a bacterostatic diluent. Corbo DC, Suddith RL, Sharma B, Naso RB.	1992
307	Journal Am J Hosp Pharm 1994 ; 51: 1792-1799.	Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1994
310	Journal Am J Hosp Pharm 1991 ; 48: 510-514.	Compatibility and pH variability of four injectable phenytoin sodium products. Markowsky SJ, Kohls PR, Ehresman D, Leppik I.	1991
313	Journal Am J Hosp Pharm 1992 ; 49: 2233-2235.	Compatibility of iron dextran with total nutrient admixtures. Tu YH, Knox NL, Biringer JM, Eichman ML, Schweinsberg PD, Howard JR.	1992
317	Journal Am J Hosp Pharm 1993 ; 50: 1360-1362.	Visual compatibility of premixed theophylline or heparin with selected drugs for IV administration. Kershaw BP, Monnier HL, Mason JH.	1993
318	Journal Am J Hosp Pharm 1994 ; 51: 512-514.	Stability of citrated caffeine injectable solution in glass vials. Donnelly RF, Tirona RG.	1994
331	Journal Am J Hosp Pharm 1988 ; 45: 2127.	Visual compatibility of hydroxyzine hydrochloride with various antineoplasic agents. Marquardt ED.	1988
334	Journal Am J Hosp Pharm 1991 ; 48: 988-992.	Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Trissel LA, Tramonte SM, Grilley BJ.	1991
337	Journal Am J Hosp Pharm 1988 ; 45: 2532-2533.	Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Bashaw ED, Amantea MA, Minor JR, Galleli JF.	1988
338	Journal Am J Hosp Pharm 1991 ; 48: 280-282.	Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection. Lam NP, Kennedy PE, Jarosinski PF, Galleli JF.	1991
339	Journal Am J Hosp Pharm 1990 ; 47: 377-381.	Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.	1990
340	Journal Am J Hosp Pharm 1985 ; 42: 1087-1094.	Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation. Macias JM, Martin WJ, Lloyd CW.	1985
341	Journal Am J Hosp Pharm 1985 ; 42: 1352-1355.	Compatibility of heparin sodium and morphine sulfate. Baker DE, Yost GS, Craig VL, Campbell RK.	1985
342	Journal Am J Hosp Pharm 1985 ; 42: 339-342.	Stability of an analgesic-sedative combination in glass and plastic single-dose syringes. Conklin CA, Kerege JF, Christensen JM.	1985
347	Journal Am J Hosp Pharm 1991 ; 48: 2627-2630.	Effect of syringe filter and IV administration set on delivery of propofol emulsion. Bailey LC, Tang KT, Rogozinski BA.	1991
348	Journal Am J Hosp Pharm 1985 ; 42: 335-339.	Effect of a polyethylene-lined administration set on the avaibility of diazepam injection. Hancock BG, Black CD.	1985
350	Journal Am J Hosp Pharm 1990 ; 47: 369-373.	Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Martens HJ, De Goede PN, Van Loenen AC.	1990
363	Journal Am J Hosp Pharm 1989 ; 46: 101-104.	Stability of esmolol hydrochloride and sodium nitroprussiate in intravenous admixtures. Karnatz NN, Wong J, Baaske DM, Johnson JH, Speicher ER, Herbranson DE.	1989
364	Journal Am J Hosp Pharm 1989 ; 46: 97-100.	Compatibility of aminophylline and verapamil in intravenous admixtures. Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ.	1989
366	Journal Am J Hosp Pharm 1986 ; 43: 2218-2220.	Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections. Wilson TD, Forde MD, Crain AVR, Dombrowski LJ, Joyce MA.	1986
367	Journal Am J Hosp Pharm 1985 ; 42: 116-119.	Compatibility of furosemide with aminoglycoside admixtures. Thompson DF, Allen LV, Desai SR, Rao PS.	1985
370	Journal Am J Hosp Pharm 1988 ; 45: 2513-2517.	Stability of procainamide hydrochloride in neutralized 5% dextrose injection. Raymond GG, Reed MT, Teagarden JR, Story K, Geberbauer CW.	1988
371	Journal Am J Hosp Pharm 1988 ; 45: 142-145.	Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection. Thompson DF, Stiles ML, Allen LV, Tu YH.	1988
372	Journal Am J Hosp Pharm 1988 ; 45: 609-612.	Compatibility of premixed theophylline and verapamil intravenous admixtures. Johnson CE, Lloyd CW, Aviles AI, Rybarz KL.	1988
375	Journal Am J Hosp Pharm 1991 ; 48: 1511-1514.	Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes. Patel JP, Tran LT, Sinai WJ, Carr LJ.	1991
377	Journal Am J Hosp Pharm 1988 ; 45: 1350-1352.	Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry. Pereira-Rosario R, Utamura T, Perrin JH.	1988
379	Journal Am J Hosp Pharm 1985 ; 42: 2679-2683.	Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets. Weir SJ, Szucs Myers VA, Bengtson KD, Ueda CT.	1985
384	Journal Am J Hosp Pharm 1988 ; 45: 630-632.	Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection. Colucci RD, Cobuzzi LE, Halpern NA.	1988
385	Journal Am J Hosp Pharm 1988 ; 45: 1117-1118.	Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection. Benedict MK, Roche VF, Banakar UV, Hilleman DE.	1988
386	Journal Am J Hosp Pharm 1988 ; 45: 1357-1358.	Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection. Colucci RD, Cobuzzi LE, Halpern NA.	1988
398	Journal Am J Hosp Pharm 1988 ; 45: 1556-1557.	Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection. Jay GT, Fanikos J, Souney PF.	1988
402	Journal Am J Hosp Pharm 1990 ; 47: 820-821.	Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection. Savitsky ME.	1990
403	Journal Am J Hosp Pharm 1991 ; 48: 1539-1541.	Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection. Outman WR, Monolakis J.	1991
404	Journal Am J Hosp Pharm 1987 ; 44: 2298-2299.	Visual compatibility of midazolam hydrochloride with common preoperative injectable medications. Forman JK, Souney PF.	1987
405	Journal Am J Hosp Pharm 1985 ; 42: 1108-1109.	Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection. Nieves-Cordero AL, Luciw HM, Souney PF.	1985
406	Journal Am J Hosp Pharm 1990 ; 47: 819-820.	Visual compatibility of narcotic analgesics with selected intravenous admixtures. Smythe MA, Patel MA, Gasloli RA.	1990
407	Journal Am J Hosp Pharm 1985 ; 42: 1750-1754.	Stability of mitomycin admixtures. Quebberman EJ, Hoffman NE, Ausman RK, Hamid AAR.	1985
408	Journal Am J Hosp Pharm 1986 ; 43: 3022-3027.	Stability of intravenous admixtures of doxorubicin and vincristine. Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM.	1986
409	Journal Am J Hosp Pharm 1987 ; 44: 124-130.	Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions. Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP.	1987
412	Journal Am J Hosp Pharm 1991 ; 48: 1520-1524.	Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Waugh WN, Trissel LA, Stella VJ.	1991
414	Journal Am J Hosp Pharm 1989 ; 46: 2500-2505.	Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes. Den Hartigh J, Brandenburg HCR, Vermeij P.	1989
422	Journal Am J Hosp Pharm 1985 ; 42: 1095-1100.	Stability of intravenous admixtures of aztreonam and ampicillin. James MJ, Riley CM.	1985
431	Journal Am J Hosp Pharm 1975 ; 33: 1010-1013.	Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures. McRae MP, King JC.	1975
432	Journal Am J Hosp Pharm 1986 ; 43: 1732-1736.	Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions. Marble DA, Bosso JA, Townsend RJ.	1986
434	Journal Am J Hosp Pharm 1991 ; 48: 2166-2171.	Compatibility of ciprofloxacin injection with selected drugs and solutions. Goodwin SD, Nix DE, Heyd A, Wilton JH.	1991
440	Journal Am J Hosp Pharm 1989 ; 46: 1408-1412.	Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Stiles ML, Tu YH, Allen LV.	1989
442	Journal Am J Hosp Pharm 1989 ; 46: 732-737.	Stability of a concentrated trimethoprim-sulfamethoxazole admixtures. Jarosinski PF, Kennedy PE, Gallelli JF.	1989
443	Journal Am J Hosp Pharm 1992 ; 49: 2761-2764.	Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs. Stiles ML, Allen LV, Fox JL.	1992
444	Journal Am J Hosp Pharm 1992 ; 49: 2756-2760.	Stability of an ofloxacin injection in various infusion fluids. Bornstein M, Kao SH, Mercorelli M, Verma S.	1992
445	Journal Am J Hosp Pharm 1992 ; 49: 2765-2768.	Stability of ceftazidime in plastic syringes and glass vials under various storage conditions. Stewart JT, Warren FW, Johnson SM, Fox JL, Mullaney J.	1992
448	Journal Am J Hosp Pharm 1986 ; 43: 1760-1762.	Stability of terbutaline sulfate admixtures stored in polyvinyl chloride bags. Mehta J, Searcy CJ, Jung DT.	1986
449	Journal Am J Hosp Pharm 1987 ; 44: 2291-2293.	Stability of terbutaline sulfate repackaged in disposable plastic syringes. Glascock JC, DiPiro JT, Cadwallader DE, Perri M.	1987
456	Journal Am J Hosp Pharm 1987 ; 44: 2524-2527.	Stability of papaverine hydrochloride and phentolamine mesylate in injectable mixtures. Tu YH, Allen LV, Wang DP.	1987
460	Journal Am J Hosp Pharm 1987 ; 44: 358-360.	Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection. Parasrampuria J, Das Gupta V, Stewart KR.	1987
464	Journal Am J Hosp Pharm 1986 ; 43: 2209-2213.	Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insuline from an infusion system. Furberg H, Kruse Jensen A, Salbu B.	1986
466	Journal Am J Hosp Pharm 1991 ; 48: 2172-2175.	Activity of octreotide acetate in a total nutrient admixture. Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM.	1991
467	Journal Am J Hosp Pharm 1991 ; 48: 2442-2443.	Visual compatibility of indomethacin sodium trihydrate with drugs given to neonates by continuous infusion. Ishisaka DY, van Vleet J, Marquardt E.	1991
469	Journal Am J Hosp Pharm 1990 ; 47: 1097-1100.	Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets. Floy BJ, Royko CJ, Fleitman JS.	1990
475	Journal Am J Hosp Pharm 1992 ; 49: 119-122.	Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.	1992
476	Journal Am J Hosp Pharm 1992 ; 49: 2960-2962.	Incompatibility of ketorolac tromethamine with selected postoperative drugs. Knapp AJ, Mauro VF, Alexander KS.	1992
496	Journal Am J Hosp Pharm 1991 ; 48: 744-746.	Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Lor E, Sheybani T, Takagi J.	1991
500	Journal Am J Hosp Pharm 1988 ; 45: 1910-1911.	Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection. Tucker DR, Sieradzan R.	1988
501	Journal Am J Hosp Pharm 1985 ; 42: 129-130.	Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection. Senholzi CS, Kerns MP.	1985
503	Journal Am J Hosp Pharm 1985 ; 45: 1987-1988.	Stability of tobramycin sulfate in admixtures with calcium gluconate. Nahata MC, Durrell DE.	1985
517	Journal Am J Hosp Pharm 1992 ; 49: 838-839.	Visual compatibility of magnesium sulfate with narcotic analgesics. Letourneau M.	1992
518	Journal Am J Hosp Pharm 1988 ; 45: 1278.	Visual compatibility of nalbuphine hydrochloride and promethazine hydrochloride. Jimenez MD.	1988
523	Journal Am J Hosp Pharm 1987 ; 44: 2740.	Visual compatibility of esmolol hydrochloride and furosemide in 5% dextrose or 0.9% sodium chloride injections. Thompson DF, Thompson GD.	1987
524	Journal Am J Hosp Pharm 1992 ; 49: 1911.	Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration. Farquhar Zanetti LA.	1992
563	Journal Am J Hosp Pharm 1978 ; 35: 1386-1387.	Stability of frozen solutions of doxycycline hyclate for injection. Petrick RJ, Wolleben JE, Vargas TA.	1978
566	Journal Am J Hosp Pharm 1983 ; 40: 91-94.	Compatibility and stability of clindamycin phosphate with intravenous fluids. Porter WR, Johnson CA, Cohon MS, Gillespie W.	1983
574	Journal Am J Hosp Pharm 1980 ; 37: 1087-1088.	Stability of antibiotics frozen and stored in disposable hypodermic syringes. Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.	1980
575	Journal Am J Hosp Pharm 1982 ; 39: 104-108.	Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags. Holmes CJ, Ausman RK, Kundsin RB, Walter CW.	1982
580	Journal Am J Hosp Pharm 1972 ; 29: 687-689.	Stability of frozen solutions of sodium cephalothin and cephaloridine. Boylan JC, Simmons JL, Winely CL.	1972
581	Journal Am J Hosp Pharm 1976 ; 33: 639-641.	Stability of frozen solutions of cefazolin sodium. Carone SM, Bornstein M, Coleman DL, Thomas PN, Boylan JC.	1976
582	Journal Am J Hosp Pharm 1980 ; 37: 211-215.	Stability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiation. Tomecko GW, Kleinberg ML, Latiolais CL, Proior RB, Pesko LJ, Jones BC.	1980
587	Journal Am J Hosp Pharm 1983 ; 40: 1024-1025.	Effect of storage temperature and time stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection. Smith BR.	1983
64	Journal Am J Hosp Pharm 1992 ; 49: 1672.	Additional data on visual compatibility of foscarnet sodium with morphine sulfate. DiStefano JE, Outman WR.	1992
354	Journal Am J Hosp Pharm 1989 ; 46: 2329-2332.	Stability of famotidine 20 and 40 mg/L in total nutrient admixtures. Montoro JB, Pou L, Salvador P, Pastor C, Cano SM.	1989
355	Journal Am J Hosp Pharm 1989 ; 46: 2326-2329.	Stability of famotidine 20 and 50 mg/L in total nutrient admixtures. Bullock L, Fitzgerald JF, Glick MR.	1989
356	Journal Am J Hosp Pharm 1989 ; 46: 2321-2325.	Stability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutions. Bullock LS, Fitzgerald JF, Glick MR, Parks RB, Schnabel JG, Hancock BG.	1989
357	Journal Am J Hosp Pharm 1988 ; 45: 1100-1102.	Stability of ranitidine hydrochloride in total nutrient admixtures. Cano SM, Montoro JB, Pastor C, Pou L, Sabin P.	1988
359	Journal Am J Hosp Pharm 1985 ; 42: 2683-2687.	Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions. Bullock LS, Parks RB, Lampasona V, Mullins RE.	1985
361	Journal Am J Hosp Pharm 1991 ; 48: 1507-1510.	Stability of nizatidine in total nutrient admixtures. Hatton J, Holstad SG, Rosenbloom AD, Westrich T, Hirsch J.	1991
362	Journal Am J Hosp Pharm 1985 ; 42: 2208-2210.	Stability of cimetidine hydrochloride in a total nutrient admixture. Baptista RJ, Palombo JD, Tahan SR, Valicenti AJ, Bistrian BR, Arkin CF, Blackburn GL.	1985
390	Journal Am J Hosp Pharm 1986 ; 43: 1482-1485.	Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures. Johnson CE, Cohen IA, Craft DA, Lizer MH.	1986
394	Journal Am J Hosp Pharm 1989 ; 46: 2333-2335.	Long-term stability of famotidine 20 mg/L in a total parenteral nutrient solution. DiStefano JE, Mitrano FP, Baptista RJ, Der MM, Silvestri Ap, Palombo JD, Bistrian BR.	1989
396	Journal Am J Hosp Pharm 1989 ; 46: 2057-2058.	Visual compatibility of ranitidine hydrochloride with commonly used critical-care medications. Chilvers MR, Lysne JM.	1989
397	Journal Am J Hosp Pharm 1989 ; 46: 125-126.	Visual compatibility of intravenous famotidine with selected drugs. Fong PA, Ward J.	1989
63	Journal Am J Hosp Pharm 1994 ; 51: 811-812.	Visual compatibility of fentanyl citrate with selected drugs during simulated Y-site injection. Marquardt Ed, Lam SSY.	1994
85	Journal Am J Hosp Pharm 1992 ; 49: 1716-1719.	Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Trissel LA, Bready BB.	1992
209	Journal Am J Hosp Pharm 1990 ; 47: 1574-1579.	In vitro evaluation of the stability of raniditine hydrochloride in total parenteral nutrient mixtures. Williams MF, Hak LJ, Dukes G.	1990
221	Journal Am J Hosp Pharm 1992 ; 49: 2149.	Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate. Neels JT.	1992
232	Journal Am J Hosp Pharm 1993 ; 50: 285-288.	Stability of midazolam hydrochloride in parenteral nutrient solutions. Bhatt-Mehta V, Rosen DA, King RS, Marsym CJ.	1993
255	Journal Am J Hosp Pharm 1994 ; 51: 2290,2292.	Visual compatibility of fluconazole with drugs given by continuous infusion. Ishisaka DY.	1994
453	Journal Am J Hosp Pharm 1986 ; 43: 692-694.	Stability and availability of cyclosporine stored in plastic syringes. Ptachcinski RJ, Walker S, Burckart GJ, Venkataramanan R.	1986
479	Journal Am J Hosp Pharm 1992 ; 49: 2964-2966.	Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection. Min DI, Brown T, HWang GC.	1992
69	Journal Am J Hosp Pharm 1986 ; 43: 2810-2812.	Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections. Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA.	1986
70	Journal Am J Hosp Pharm 1991 ; 48: 2641-2643.	Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Silvestri AP, Mitrano FP, Baptista RJ, Williams DA.	1991
73	Journal Am J Hosp Pharm 1990 ; 47: 157-159.	Visual compatibility of foscarnet with other injectable drugs. Lor E, Takagi J.	1990
74	Journal Am J Hosp Pharm 1994 ; 51: 1348-1349.	Stability of ganciclovir sodium in an infusion-pump syringe. Mulye NV, Turco SJ, Speaker TJ.	1994
76	Journal Am J Hosp Pharm 1992 ; 49: 116-118.	Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days. Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA.	1992
91	Journal Am J Hosp Pharm 1993 ; 50: 1208-1210.	Visual compatibility of gallium nitrate with selected drugs during Y-site injection. Lober CA, Dollard PA.	1993
129	Journal Am J Hosp Pharm 1991 ; 48: 125-126.	Visual compatibility of insulin with secondary intravenous drugs in admixtures. Smythe M, Malouf E.	1991
158	Journal Am J Hosp Pharm 1994 ; 51: 2804-2810.	Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets. Trissel LA, Xu QA, Kwan J, Martinez JF.	1994
160	Journal Am J Hosp Pharm 1994 ; 51: 2701-2704.	Effect of sodium chloride concentration and temperature on melphalan stability during storage and use. Pinguet F, Martel P, Rouanet P, Fabbro M, Astre C.	1994
223	Journal Am J Hosp Pharm 1990 ; 47: 1584-1587.	Stability of fentanyl citrate in glass and plastic containers and in a patient-controlled delivery system. Kowalski SR, Gourlay GK.	1990
238	Journal Am J Hosp Pharm 1993 ; 50: 950-952.	Stability of metoprolol tartrate in 5% dextrose injection or 0.9% sodium chloride injection. Belliveau PP, Shea BF, Scavone JM.	1993
244	Journal Am J Hosp Pharm 1994 ; 51: 1907-1913.	Compatibility of filgrastim with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1994
263	Journal Am J Hosp Pharm 1993 ; 50: 698-702.	Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures. Pearson SD, Trissel LA.	1993
276	Journal Am J Hosp Pharm 1994 ; 51: 92-94.	Stability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixtures. Parrish MA, Bailey LC, Medwick T.	1994
291	Journal Am J Hosp Pharm 1993 ; 50: 470-472.	Stability of cyclosporine with magnesium sulfate in 5% dextrose injection. Nieforth KA, Shea BF, Souney PF, Scavone JM.	1993
305	Journal Am J Hosp Pharm 1992 ; 49: 1463-1466.	Stability and sorption of calcitriol in plastic tuberculin syringes. Pecosky DA, Parasrampuria J, Li LC, Stelmach A.	1992
335	Journal Am J Hosp Pharm 1992 ; 49: 402-406.	Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection. Trissel LA, Bready BB, Kwan JW, Santiago NM.	1992
336	Journal Am J Hosp Pharm 1987 ; 44: 1408-1409.	Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection. Forman JK, Lachs JR, Souney PF.	1987
349	Journal Am J Hosp Pharm 1986 ; 43: 384-385.	Stability of phenobarbital sodium diluted in 0.9% sodium chloride injection. Nahata MC, Hipple TF, Strausbaugh SD.	1986
351	Journal Am J Hosp Pharm 1986 ; 43: 2795-2799.	Effect of flow rate and type of IV container on adsorption of diazepam to IV administration systems. Yliruusi JK, Uotila JA, Kristoffersson ER.	1986
352	Journal Am J Hosp Pharm 1986 ; 43: 2789-2794.	Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets. Yliruusi JK, Uotilo JA, Kristoffersson ER.	1986
353	Journal Am J Hosp Pharm 1987 ; 44: 2519-2524.	Reductive destruction of dacarbazine, procarbazine hydrochloride, isoniazid, and iproniazid. Lunn G, Sansone EB.	1987
358	Journal Am J Hosp Pharm 1986 ; 43: 921-925.	Stability of ranitidine admixtures frozen and refrigerated in minibags. Lampasona V, Mullins RE, Parks RB.	1986
360	Journal Am J Hosp Pharm 1992 ; 49: 2769-2772.	Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration. Inagaki K, Gill MA, Okamoto MP, Takagi J.	1992
388	Journal Am J Hosp Pharm 1988 ; 45: 1523-1529.	Stability of nizatidine in commonly used intravenous fluids and containers. Raineri DL, Cwik MJ, Rodvold KA, Deyo KL, Scaros LP, Fischer JH.	1988
389	Journal Am J Hosp Pharm 1991 ; 48: 2161-2166.	Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride. Walker SE, DeAngelis C, Iazzetta J, Eppel JG.	1991
391	Journal Am J Hosp Pharm 1987 ; 44: 1620-1624.	Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures. Johnson CE, Cohen IA, Michelini TJ, McMahon RE.	1987
410	Journal Am J Hosp Pharm 1991 ; 48: 1500-1506.	Characterization of cisplatin degradation as affected by pH and light. Zieske PA, Koberda M, Hines JL, Knight CC, Sriram R, Raghavan NV, Rabinow BE.	1991
411	Journal Am J Hosp Pharm 1991 ; 48: 2158-2160.	Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration. Woloschuk DMM, Wermeling JR, Pruemer JM.	1991
413	Journal Am J Hosp Pharm 1990 ; 47: 1373-1377.	Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection. Stewart CF, Fleming RA.	1990
415	Journal Am J Hosp Pharm 1989 ; 46: 2036-2040.	Stability of fluorouracil administered through four portable infusion pumps. Stiles ML, Allen LV, Tu YH.	1989
417	Journal Am J Hosp Pharm 1989 ; 46: 1400-1404.	Stability of cisplatin and etoposide in intravenous admixtures. Stewart CF, Hampton EM.	1989
418	Journal Am J Hosp Pharm 1985 ; 42: 2211-2214.	Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions. Bosso JA, Townsend RJ.	1985
419	Journal Am J Hosp Pharm 1985 ; 42: 1984-1986.	Stability of intravenous admixtures of aztreonam and clindamycin phosphate. James MJ, Riley CM.	1985
420	Journal Am J Hosp Pharm 1985 ; 42: 1980-1983.	Stability of cefonicid sodium in infusion fluids. Wong WW, Maderich AB, Polli GP, Ravin LJ.	1985
421	Journal Am J Hosp Pharm 1985 ; 42: 839-843.	Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures. Foley PT, Bosso JA, Bair JN, Townsend RJ.	1985
423	Journal Am J Hosp Pharm 1985 ; 42: 332-335.	Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours. Mansur JM, Abramowitz PW, Lerner SA, Smith RB, Townsend RJ.	1985
424	Journal Am J Hosp Pharm 1986 ; 43: 1486-1488.	Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. De NC, Alam AS, Kapoor JN.	1986
426	Journal Am J Hosp Pharm 1986 ; 43: 925-927.	Stability of intravenous admixtures containing aztreonam and cefazolin. Riley CM, James MJ.	1986
427	Journal Am J Hosp Pharm 1986 ; 43: 3027-3030.	Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states. Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB.	1986
428	Journal Am J Hosp Pharm 1987 ; 44: 802-804.	Stability of vancomycin hydrochloride in various concentrations of dextrose injection. Nahata MC, Miller MA, Durrell DE.	1987
430	Journal Am J Hosp Pharm 1986 ; 43: 1729-1731.	Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections. Das Gupta V, Stewart KR, Nohria S.	1986
433	Journal Am J Hosp Pharm 1986 ; 43: 2221-2224.	Interaction of aztreonam with nafcillin in intravenous admixtures. Riley CM, Lipford LC.	1986
435	Journal Am J Hosp Pharm 1991 ; 48: 2430-2433.	Stability of amphotericin B in four concentrations of dextrose injection. Wiest DB, Maish WA, Garner SS, El-Chaar GM.	1991
436	Journal Am J Hosp Pharm 1991 ; 48: 2635-2637.	Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4°C for 35 days. Mitrano FP, Outman WR, Baptista RJ, Palombo JD.	1991
439	Journal Am J Hosp Pharm 1991 ; 48: 283-285.	Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line. Kintzel PE, Kennedy PE.	1991
446	Journal Am J Hosp Pharm 1992 ; 49: 2782-2783.	Stability of undiluted trimethoprim-sulfamethoxazole for injection in plastic syringes. Kaufman MB, Scavone JM, Foley JJ.	1992
2	Journal Am J Hosp Pharm 1994 ; 51: 88-90.	Stability of foscarnet in 0.9% sodium chloride injection. Woods K, Steinmann W, Bruns L, Neels JT.	1994
6	Journal Am J Hosp Pharm 1994 ; 51: 2138-2142.	Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22 and 32°C. Trissel LA, Xu QA, Martinez JF, Fox JL.	1994
8	Journal Am J Hosp Pharm 1988 ; 45: 368-371.	Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration. Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER.	1988
24	Journal Am J Hosp Pharm 1994 ; 51: 514-517.	Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs. Stiles ML, Allen LV Jr, Prince SJ, Holland JS.	1994
25	Journal Am J Hosp Pharm 1993 ; 50: 1410-1414.	Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions. McGuire TR, Narducci WA, Fox JL.	1993
47	Journal Am J Hosp Pharm 1994 ; 51: 1201-1204.	Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration. Burm JP, Jhee SS, Chin A, Moon YSK.	1994
62	Journal Am J Hosp Pharm 1991 ; 48: 123-125.	Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection. Pugh CB, Pabis DJ, Rodriguez C.	1991
65	Journal Am J Hosp Pharm 1990 ; 47: 143-146.	Stability of morphine sulfate in infusion devices and containers for intravenous administration. Duafala ME, Kleinberg ML, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.	1990
77	Journal Am J Hosp Pharm 1990 ; 47: 2073-2074.	Stability of famotidine frozen in polypropylene syringes. Shea BF, Souney PF.	1990
78	Journal Am J Hosp Pharm 1990 ; 47: 2043-2046.	Stability of ranitidine in intravenous admixtures stored frozen, refrigerated, and at room temperature. Stewart JT, Warren FW, Johnson SM, Galante LJ.	1990
79	Journal Am J Hosp Pharm 1991 ; 48: 111-113.	Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection. Lee DKT, Wang DP, Lee A.	1991
80	Journal Am J Hosp Pharm 1993 ; 50: 2559-2561.	Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1993
81	Journal Am J Hosp Pharm 1994 ; 51: 672-678.	Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Trissel LA, Martinez JF.	1994
84	Journal Am J Hosp Pharm 1994 ; 51: 495-499.	Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection. Trissel LA, Martinez JF.	1994
89	Journal Am J Hosp Pharm 1993 ; 50: 2521-2522.	Incompatibility of labetalol hydrochloride and furosemide. Zeisler J, Alagna C.	1993
90	Journal Am J Hosp Pharm 1993 ; 50: 2561-2563.	Stability of nitroglycerin concentrate for injection stored in plastic syringes. Driver PS, Jarvi EJ, Gratzer PL.	1993
92	Journal Am J Hosp Pharm 1990 ; 47: 606-608.	Visual and spectrophotometric determination of compatibility of alteplase and streptokinase with other injectable drugs. Lee CY, Mauro VF, Alexander KS.	1990
96	Journal Am J Hosp Pharm 1994 ; 51: 809-811.	Stability of cefuroxime sodium and aminophylline or theophylline. Stewart JT, Warren FW, Johnson SM.	1994
116	Journal Am J Hosp Pharm 1989 ; 46: 1404-1407.	Stability of morphine sulfate in portable pump reservoirs during storage and simulated administration. Stiles ML, Tu YH, Allen LV Jr.	1989
140	Journal Am J Hosp Pharm 1993 ; 50: 1405-1409.	Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Pearson SD, Trissel LA.	1993
157	Journal Am J Hosp Pharm 1994 ; 51: 3058-3060.	Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32°C. Xu QA, Trissel LA, Martinez JF.	1994
161	Journal Am J Hosp Pharm 1994 ; 51: 2706-2709.	Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers. Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY.	1994
169	Journal Am J Hosp Pharm 1993 ; 50: 2359-2363.	Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1993
175	Journal Am J Hosp Pharm 1994 ; 51: 368-372.	Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags. Trissel LA, Pearson SD.	1994
187	Journal Am J Hosp Pharm 1993 ; 50: 1907-1912.	Stability of flumazenil with selected drugs in 5% dextrose injection. Olsen KM, Gurley BJ, Davis GA, Christensen R, Monaghan MS.	1993
188	Journal Am J Hosp Pharm 1994 ; 51: 2709-2710.	Visual compatibility of neuroleptics with anticholinergics or antihistamines in polyethylene syringes. Gibler B, Kim MS, Raleigh F.	1994
210	Journal Am J Hosp Pharm 1994 ; 51: 1802-1807.	Stability of ranitidine hydrochloride and seven medications. Stewart JT, Warren FW, King AD.	1994
211	Journal Am J Hosp Pharm 1991 ; 48: 1237-1241.	Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection. Strom JG, Miller SW.	1991
212	Journal Am J Hosp Pharm 1994 ; 51: 2157-2159.	Stability of diluted methylprednisolone sodium succinate injection at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1994
216	Journal Am J Hosp Pharm 1994 ; 51: 2963.	Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine. Huang E, Anderson RP.	1994
222	Journal Am J Hosp Pharm 1990 ; 47: 1572-1574.	Stability of fentanyl citrate in 0.9% sodium chloride solution in portable infusion pumps. Allen LV, Stiles ML, Tu YH.	1990
224	Journal Am J Hosp Pharm 1991 ; 48: 515-517.	Stability of methadone hydrochloride in 0.9% sodium chloride injection in single-dose plastic containers. Denson DD, Crews JC, Grummich KW, Stirm EJ, Sue CA.	1991
227	Journal Am J Hosp Pharm 1994 ; 51: 2292.	Compatibility of cyclizine lactate and haloperidol lactate. Fawcett JP, Woods DJ, Munasiri B, Becket G.	1994
228	Journal Am J Hosp Pharm 1994 ; 51: 2964.	Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate. Mendenhall A, Hoyt DB.	1994
229	Journal Am J Hosp Pharm 1994 ; 51: 2962-2963.	Compatibility of haloperidol lactate with benztropine mesylate. Jackson CW, Cunningham K.	1994
230	Journal Am J Hosp Pharm 1994 ; 51: 905-906.	Visual compatibility of haloperidol lactate with injectable solutions. Fraser GL, Riker RR.	1994
231	Journal Am J Hosp Pharm 1993 ; 50: 2379-2381.	Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days. Hagan RL, Jacobs III LF, Pimsler M, Merritt GJ.	1993
235	Journal Am J Hosp Pharm 1994 ; 51: 2273-2276.	Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration. Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA.	1994
242	Journal Am J Hosp Pharm 1986 ; 43: 917-921.	Stability of amiodarone hydrochloride in admixtures with other injectable drugs. Campbell S, Nolan PE, Bliss M, Wood R, Mayersohn M.	1986
248	Journal Am J Hosp Pharm 1993 ; 50: 300-304.	Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection. Trissel LA, Martinez JF.	1993
252	Journal Am J Hosp Pharm 1990 ; 47: 2528-2529.	Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers. Koberda M, Zieske PA, Raghavan NV, Payton RJ.	1990
253	Journal Am J Hosp Pharm 1990 ; 47: 2525-2528.	Visual compatibility of amsacrine with selected drugs during simulated Y-site injection. Trissel LA, Chandler SW, Folstad JT.	1990
256	Journal Am J Hosp Pharm 1993 ; 50: 1206-1208.	Stability of fluconazole in commonly used intravenous antibiotic solutions. Inagaki K, Takagi J, Lor E, Lee KJ, Nii L, Gill MA.	1993
257	Journal Am J Hosp Pharm 1993 ; 50: 1186-1187.	Stability of fluconazole in injectable solutions. Hunt-Fugate AK, Hennessey CK, Kazarian CM.	1993
259	Journal Am J Hosp Pharm 1993 ; 50: 2092-2094.	Stability of ceftriaxone sodium in infusion-pump syringes. Bailey LC, Tang KT, Medwick T.	1993
262	Journal Am J Hosp Pharm 1993 ; 50: 703-706.	Stability and compatibility of fluconazole and aminophylline in intravenous admixtures. Johnson CE, Jacobson PA, Pillen HA, Woycik CL.	1993
279	Journal Am J Hosp Pharm 1994 ; 51: 2159-2161.	Stability of ceftriaxone sodium in injectable solutions stored frozen in syringes. Bailey LC, Cappel KM, Orosz ST.	1994
283	Journal Am J Hosp Pharm 1994 ; 51: 394-396.	Stability of amphotericin B in 5% dextrose injection stored at 4 or 25°C for 120 hours. Lee MD, Hess MM, Boucher BA, Apple AM.	1994
454	Journal Am J Hosp Pharm 1986 ; 43: 94-97.	Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection. Ptachcinski RJ, Logue LW, Burckart GJ, Venkataramanan R.	1986
455	Journal Am J Hosp Pharm 1986 ; 43: 2800-2802.	Leaching of diethylhexyl phtalate from polyvinyl chloride bags into intravenous cyclosporine solution. Venkataramanan R, Burckart GJ, Ptachcinski RJ, Blaha R, Logue LW, Bahnson A, Giam CS, Brady JE.	1986
465	Journal Am J Hosp Pharm 1990 ; 47: 297-298.	More information on the visual compatibility of hetastarch with injectable critical-care drugs. Wohlford JG, Wright JC, Wilson MR.	1990
468	Journal Am J Hosp Pharm 1991 ; 48: 2631-2634.	Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. Tarr BD, Campbell RK, Workman TM.	1991
471	Journal Am J Hosp Pharm 1989 ; 46: 2053-2055.	Stability of cyclosporine in 5% dextrose injection. Shea BF, Ptachcinski RJ, O?Neill S, Cersosimo RJ, Sesin GP, Souney PF.	1989
472	Journal Am J Hosp Pharm 1989 ; 46: 995-996.	Visual compatibility of hetastarch with injectable critical-care drugs. Wohlford JG, Fowler MD.	1989
477	Journal Am J Hosp Pharm 1992 ; 49: 2954-2956.	Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures. Nahata MC, Morosco RS, Fox JL.	1992
478	Journal Am J Hosp Pharm 1992 ; 49: 2962-2963.	Stability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1992
489	Journal Am J Hosp Pharm 1992 ; 49: 1137-1139.	Stability of ifosfamide in 0.9% sodium chloride solution or water for injection in a portable IV pump cassette. Munoz M, Girona V, Pujol M, Duran S, Vicente P, Sol? LA.	1992
491	Journal Am J Hosp Pharm 1991 ; 48: 2181-2184.	Visual compatibility of idarubicin hydrochloride with selected drugs during simulated Y-site injection. Turowski RC, Durthaler JM.	1991
492	Journal Am J Hosp Pharm 1991 ; 48: 2186-2189.	Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection. Trissel LA, Parks NPT, Santiago NM.	1991
494	Journal Am J Hosp Pharm 1992 ; 49: 836,838.	Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate. Thompson DF, Heflin NR.	1992
497	Journal Am J Hosp Pharm 1991 ; 48: 1681.	Stability of amphotericin B in 5% dextrose injection at 25°C. Kintzel PE, Kennedy PE.	1991
605	Journal Am J Hosp Pharm 1982 ; 39: 292-294.	Stability of haloperidol in 5% dextrose injection. Das Gupta V, Stewart KR.	1982
612	Journal Am J Hosp Pharm 1982 ; 39: 622-627.	Stability of cefamandole nafate injection with parenteral solutions and additives. Frable RA, Klink PR, Engel GL, Mundell EE.	1982
616	Journal Am J Hosp Pharm 1982 ; 39: 841-843.	Compatibility of nalbuphine hydrochloride with other preoperative medications. Jump WG, Plaza VM, Poremba A.	1982
617	Journal Am J Hosp Pharm 1982 ; 39: 843-844.	Compatibility of haloperidol lactate and heparin sodium. Solomon DA, Nasinnyk KK.	1982
618	Journal Am J Hosp Pharm 1982 ; 39: 844-846.	Stability of digoxin in common large-volume injections. Shank WA, Coupal JJ.	1982
619	Journal Am J Hosp Pharm 1982 ; 39: 1013-1015.	Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drugs additives. Kirschenbaum HL, Aronoff W, Perentesis GP, Plitz GW, Cutie AJ.	1982
621	Journal Am J Hosp Pharm 1982 ; 39: 1018-1021.	Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers. Yliruusi JK, Sothmann AG, Laine RH, Rajasilta RA, Kristoffersson ER.	1982
626	Journal Am J Hosp Pharm 1982 ; 39: 1495-1498.	Moxalactam disodium compatibility with intramuscular and intravenous diluents. Bornstein M, Lo AY, Thomas PN, Wilham WL.	1982
628	Journal Am J Hosp Pharm 1982 ; 39: 1923-1925.	Stability of dobutamine hydrochloride in selected large-volume parenterals. Kirschenbaum HL, Aronoff W, Perentesis GP, Piltz GW, Goldberg RJ, Cutie AJ.	1982
703	Journal Am J Hosp Pharm 1980 ; 37: 935-941.	Effect of inline filtration on the potency of low-dose drugs. Butler LD, Munson JM, DeLuca PP.	1980
705	Journal Am J Hosp Pharm 1981 ; 38: 183-187.	Bretylium tosylate admixture compatibility. II : Dopamine, lidocaine, procainamide, and nitroglycerin. Lee YC, Malick W, Amann AH, Baaske DM, Shah JJ, Wagenknecht DM, Carter JE.	1981
706	Journal Am J Hosp Pharm 1981 ; 38: 231.	Compatibility of verapamil hydrochloride with other additives. Cutie MR.	1981
707	Journal Am J Hosp Pharm 1980 ; 37: 95-98.	Solubility and stability of phenytoin sodium when mixed with intravenous solutions. Carmichael RR, Mahoney CD, Jeffrey LP.	1980
708	Journal Am J Hosp Pharm 1980 ; 37: 201-205.	Nitroglycerin compatibility with intravenous fluid filters containers, and administration sets. Baaske DM, Amann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG.	1980
709	Journal Am J Hosp Pharm 1980 ; 37: 1614-1615.	Stability of tobramycin sulfate in plastic syringes. Seitz DJ, Archambault JR, Brinck-Johnsen T.	1980
711	Journal Am J Hosp Pharm 1980 ; 37: 492-496.	Avaibility of diazepam from plastic containers. Cloyd JC, Vezeau C, Miller KW.	1980
712	Journal Am J Hosp Pharm 1980 ; 37: 496-500.	Compatibility of diazepam with intravenous fluid containers and administration sets. Parker WA, MacCara ME.	1980
715	Journal Am J Hosp Pharm 1980 ; 37: 677-678.	Stability of carmustine in the presence of sodium bicarbonate. Colvin M, Hartner J, Summerfield M.	1980
729	Journal Am J Hosp Pharm 1977 ; 34: 1071-1074.	Effect of inline filtration on the potency of drugs administered intravenously. Rusmin S, Welton S, DeLuca P, DeLuca PP.	1977
730	Journal Am J Hosp Pharm 1977 ; 34: 939-943.	Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets. Allen LV, Saul Levinson R, Phisutsinthop D.	1977
731	Journal Am J Hosp Pharm 1978 ; 35: 669-672.	Compatibility and stability of diazepam injection following dilution with intravenous fluids. Morris ME.	1978
732	Journal Am J Hosp Pharm 1975 ; 32: 575-578.	Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: Stability with common intravenous fluids. Gardella LA, Zaroslinski JF, Possley LH.	1975
738	Journal Am J Hosp Pharm 1978 ; 35: 581-584.	Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives. Gardella LA, Kesler H, Amann A, Carter JE.	1978
739	Journal Am J Hosp Pharm 1978 ; 35: 402-406.	Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate. Cradock JC, Kleinmann LM, Rahman A.	1978
740	Journal Am J Hosp Pharm 1979 ; 36: 1536-1538.	Stability of refrigerated and frozen solutions of doxorubicin hydrochloride. Hoffman DM, Grossano DD, Damin LA, Woodcock TM.	1979
742	Journal Am J Hosp Pharm 1979 ; 36: 38-43.	Stability of cisplatin in aqueous solution. Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF.	1979
743	Journal Am J Hosp Pharm 1980 ; 37: 803-808.	Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions. Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM.	1980
747	Journal Am J Hosp Pharm 1980 ; 37: 390-392.	Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids. Rosenberg HA, Dougherty JT, Mayron D, Baldinus JG.	1980
789	Journal Am J Hosp Pharm 1990 ; 47: 604-606.	Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system. Garner SS, Wiest DB.	1990
857	Journal Am J Hosp Pharm 1983 ; 40: 1323-1328.	Binding of selected drugs to a “treated” inline filter. Kanke M, Eubanks JL, DeLuca PP.	1983
860	Journal Am J Hosp Pharm 1987 ; 44: 2028.	Visual incompatibility of dacarbazine and heparin. Nelson RW, Young R, Lamnin M.	1987
892	Journal Am J Hosp Pharm 1992 ; 49: 1156-1164.	Practical guidelines for preparing and administering amphotericin B. Kintzel PE, Smith GH.	1992
1020	Journal Am J Hosp Pharm 1987 ; 44: 67.	Compatibility of morphine sulfate injection and prochlorperazine injection. Zuber DEL.	1987
1027	Journal Am J Hosp Pharm 1984 ; 41: 1807-1811.	Stability of nitroglycerin solutions in polyolefin and glass containers. Wagenknecht DM, Baaske DM, Alam AS, Carter JE, Shah J.	1984
1028	Journal Am J Hosp Pharm 1984 ; 41: 1802-1806.	Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures. Cheung YW, Vishnuvajjala BR, Flora KP.	1984
1036	Journal Am J Hosp Pharm 1984 ; 41: 1379-1380.	Visual compatibility of amiodarone hydrochloride injection with other injectable drugs. Hasegawa GR, Eder JF.	1984
1039	Journal Am J Hosp Pharm 1984 ; 41: 1156-1159.	Stability of azacitidine in infusion fluids. Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.	1984
1040	Journal Am J Hosp Pharm 1984 ; 41: 1153-1156.	Stability of fluorouracil in plastic containers used for continuous infusion at home. Quebbeman EJ, Hamid AAR, Hoffman NE, Ausman RK.	1984
1041	Journal Am J Hosp Pharm 1984 ; 41: 949-951.	Visual compatibility of dobutamine hydrochloride with other injectable drugs. Hasegawa GR, Eder JF.	1984
1045	Journal Am J Hosp Pharm 1984 ; 41: 686-689.	Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5 % dextrose injections. Das Gupta V, Stewart KR.	1984
1047	Journal Am J Hosp Pharm 1984 ; 41: 323-324.	Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection. Souney PF, Colucci RD, Mariani G, Campbell D.	1984
1049	Journal Am J Hosp Pharm 1984 ; 41: 303-305.	Stability of nitroglycerin in intravenous admixtures. Klamerus KJ, Ueda CT, Newton DW.	1984
1050	Journal Am J Hosp Pharm 1984 ; 41: 300-302.	Shelf life of unrefrigerated succinylcholine chloride injection. Boehm JJ, Dutton DM, Poust RI.	1984
1057	Journal Am J Hosp Pharm 1983 ; 40: 1205-1207.	Compatibility of verapamil hydrochloride injection with commonly used additives. Cutie MR.	1983
1058	Journal Am J Hosp Pharm 1983 ; 40: 1690-1691.	Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives. Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ.	1983
1079	Journal Am J Hosp Pharm 1985 ; 42: 2651.	Incompatibility of morphine sulfate and prochlorperazine edisylate in syringes. Stevenson JG, Patriarca C.	1985
1080	Journal Am J Hosp Pharm 1985 ; 42: 2652.	Stability of cisplatin admixtures in polyvinyl chloride bags. La Folette JM, Arbus MH, Lauper RD.	1985
1113	Journal Am J Hosp Pharm 1989 ; 46: 2031-2035.	Nitroglycerin delivery through a polyethylene-lined intravenous administration set. Tracy TS, Bowman L, Black CD.	1989
1115	Journal Am J Hosp Pharm 1980 ; 37: 1050-1052.	Stability of procainamide hydrochloride in dextrose solutions. Baaske DM, Malick AW, Carter JE.	1980
1116	Journal Am J Hosp Pharm 1982 ; 39: 471-474.	Stability of thiamine hydrochloride repackaged in disposable syringes. Nolly RJ, Stach PE, Latiolais CJ, Sokoloski TD, Nahata MC.	1982
1120	Journal Am J Hosp Pharm 1974 ; 31: 72-78.	Interactions between drugs and plastic intravenous fluid bags. Part I: Sorption studies on 17 drugs. Moorhatch P, Chiou WL.	1974
1121	Journal Am J Hosp Pharm 1973 ; 30: 236-239.	Stability of prostaglandins. Roseman TJ, Sims B, Stehle RG.	1973
1126	Journal Am J Hosp Pharm 1983 ; 40: 97-101.	Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags. Lackner TE, Baldus D, Butler CD, Amyx C, Kessler G.	1983
1135	Journal Am J Hosp Pharm 1990 ; 47: 2075-2077.	Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Baltz JK, Kennedy P, Minor JR, Gallelli J.	1990
1137	Journal Am J Hosp Pharm 1990 ; 47: 1745-1746.	Incompatibility of iron dextran and a total nutrient admixture. Vaughan LM, Small C, Plunkett V.	1990
1169	Journal Am J Hosp Pharm 1981 ; 38: 358-362.	Phenytoin sodium solubility in three intravenous solutions. Pfeifle CE, Adler DS, Gannaway WL.	1981
1172	Journal Am J Hosp Pharm 1981 ; 38: 377-378.	Compatibility of amphotericin B with certain large-volume parenterals. Jurgens RW, DeLuca PP, Papadimitriou D.	1981
1173	Journal Am J Hosp Pharm 1981 ; 38: 1308-1314.	Interactions between drugs and polyvinyl chloride infusion bags. Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.	1981
1175	Journal Am J Hosp Pharm 1981 ; 38: 995-997.	Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets. Hirsch JI, Wood JH, Thomas RB.	1981
1178	Journal Am J Hosp Pharm 1981 ; 38: 1914-1918.	Stability and compatibility of antitumor agents in glass and plastic containers. Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.	1981
1182	Journal Am J Hosp Pharm 1981 ; 38: 1449-1454.	Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate. Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL.	1981
1183	Journal Am J Hosp Pharm 1981 ; 38: 1001-1004.	Stability of diluted heparin sodium stored in plastic syringes. Tunbridge LJ, Lloyd JV, Penhall RK, Wise AL, Maloney T.	1981
1187	Journal Am J Hosp Pharm 1983 ; 40: 94-97.	Droperidol stability in intravenous admixtures. Ray JB, Newton DW, Nye MT, Leet WA.	1983
1188	Journal Am J Hosp Pharm 1983 ; 40: 428-432.	Stability of aminophylline injection in three parenteral nutrient solutions. Niemiec PW, Venderveen TW, Hohenwarter MW, Gadsden RH.	1983
1189	Journal Am J Hosp Pharm 1983 ; 40: 1692-1693.	Uptake of clonazepam by plastic intravenous infusion bags and administration sets. Nation RL, Hackett LP, Dusci LJ.	1983
1193	Journal Am J Hosp Pharm 1983 ; 40: 1010-1012.	Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives. Perentesis GP, Plitz GW, Kirschenbaum HL, Navalakha P, Aronoff W, Cutie AJ.	1983
1194	Journal Am J Hosp Pharm 1983 ; 40: 1007-1009.	Compatibility and stability of labetolol hydrochloride in commonly used intravenous solutions. Yuen PHC, Taddei CR, Wyka BE, Chaudry IA.	1983
1197	Journal Am J Hosp Pharm 1982 ; 39: 1681-1684.	Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids. Deans KW, Lang JR, Smith DE.	1982
1198	Journal Am J Hosp Pharm 1982 ; 39: 1685-1687.	Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers. Cummings DS, Park MK, Howard B.	1982
1199	Journal Am J Hosp Pharm 1982 ; 1687-1690.	Stability of diazepam injection repackaged in glass unit-dose syringes. Smith FM, Nuessle NO.	1982
1200	Journal Am J Hosp Pharm 1981 ; 38: 1737-1742.	Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Chaudry IA, Bruey KP, Hurlburt LE, Oden EM.	1981
1201	Journal Am J Hosp Pharm 1981 ; 38: 1919-1922.	Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.	1981
1202	Journal Am J Hosp Pharm 1981 ; 38: 1745-1747.	Stability of lidocaine hydrochloride in 5% dextrose injection in plastic bags. Smith FM, Nuessle NO.	1981
1203	Journal Am J Hosp Pharm 1981 ; 38: 1173-1174.	Cimetidine hydrochloride compatibility with preoperative medications. Yuhas EM, Lofton FT, Baldinus JG, Mayron D.	1981
1206	Journal Am J Hosp Pharm 1983 ; 40: 564.	Cefoperazone-aminoglycoside incompatibility. Frear RS.	1983
1221	Journal Am J Hosp Pharm 1980 ; 37: 460,464.	Visual compatibility of dobutamine with seven parenteral drug products. Dahlin PA, Paredes SM.	1980
1223	Journal Am J Hosp Pharm 1980 ; 37: 618.	Plastic IV container for nitroglycerin. Amann AH, Baaske DM, Wagenknecht DM.	1980
1228	Journal Am J Hosp Pharm 1981 ; 38: 380-381.	Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Allen LV, Stiles ML.	1981
1236	Journal Am J Hosp Pharm 1986 ; 43: 1241-1242.	Stability of netilmicin sulfate in admixtures with calcium gluconate and aminophylline. Kuhn RJ, Nahata MC.	1986
1248	Journal Am J Hosp Pharm 1985 ; 42: 590-592.	Stability of ranitidine hydrochloride in total parenteral nutrient solution. Walker SE, Bayliff CD.	1985
1249	Journal Am J Hosp Pharm 1985 ; 42: 595-597.	Stability of dopamine hydrochloride exposed to blue-light phototherapy. Dandurand KR, Stennett DJ.	1985
1258	Journal Am J Hosp Pharm 1981 ; 38: 537-540.	Effect of gentamicin on heparin activity. Tyler LS, Rehder TL, Davis RB.	1981
1259	Journal Am J Hosp Pharm 1981 ; 38: 900-901.	Compatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injection. Jhunjhunwala VP, Bhalla HL.	1981
1260	Journal Am J Hosp Pharm 1981 ; 38: 871-875.	Compatibility of azathioprime sodium with intravenous fluids. Johnson CA, Porter WA.	1981
1338	Journal Am J Hosp Pharm 1985 ; 42: 777-778.	Compatibility of total nutrient admixtures and secondary cardiovascular medications. Baptista RJ, Dumas GJ, Bistrian BR, Condella F, Blackburn GL.	1985
1346	Journal Am J Hosp Pharm 1981 ; 38: 881-883.	Stability and sterility of cimetidine admixtures frozen in minibags. Walker SE, Paton TW, Fabian TM, Liu CC, Coates PE.	1981
1351	Journal Am J Hosp Pharm 1984 ; 41: 2588.	Precipitation of verapamil with nafcillin. Tucker R, Gentle JF.	1984
1352	Journal Am J Hosp Pharm 1984 ; 41: 2588-2589.	Dobutamine-heparin mixture inadvisable. Hasegawa GR, Eder JF.	1984
1353	Journal Am J Hosp Pharm 1984 ; 41: 1835-1837.	Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets. Nix DE, Tharpe WN, Francisco GE.	1984
1354	Journal Am J Hosp Pharm 1984 ; 41: 2405-2406.	Stability of citrated caffeine solutions for injectable and enteral use. Eisenberg MG, Kang N.	1984
1359	Journal Am J Hosp Pharm 1985 ; 42: 2420-2421.	Interaction between vancomycin and ticarcillin. Perest M, Allison J.	1985
1366	Journal Am J Hosp Pharm 1981 ; 38: 462,464.	Nafcillin sodium incompatibility with acidic solutions. Jeglum EL, Winter E, Kotos M.	1981
1371	Journal Am J Hosp Pharm 1985 ; 42: 2436.	Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection. Bornstein M, Templeton RJ.	1985
1380	Journal Am J Hosp Pharm 1984 ; 41: 74.	Identification of labetolol precipitate. Alam AS.	1984
1438	Journal Am J Hosp Pharm 1984 ; 41: 1840-1841.	Visual compatibility of cimetidine hydrochloride wih common preoperative injectable medications. Souney PF, Solomon MA, Stancher D.	1984
1503	Journal Am J Hosp Pharm 1983 ; 40: 1002-1006.	Stability of cimetidine hydrochloride in admixtures after microwave thawing Elliott GT, McKenzie MW, Curry SH, Pieper JA, Quinn SL.	1983
2368	Journal Am J Hosp Pharm 1992 ; 49: 2956 - 2959.	Stability of ciprofloxacin in peritoneal dialysis solution Mawhinney WM, Adair CG, Gorman SP, McClurg B.	1992
2369	Journal Am J Hosp Pharm 1992 ; 49: 1139 - 1142.	Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution Mason NA, Johnson CE, O'Brien MA.	1992
2370	Journal Am J Hosp Pharm 1992 ; 49: 137 - 139.	Stability of vancomycin hydrochloride in peritoneal dialysis solution Mawhinney WM, Adair CG, Gorman SP, McClurg B.	1992
2371	Journal Am J Hosp Pharm 1991 ; 48: 1234 - 1237.	Stability of dobutamine hydrochloride in peritoneal dialysis solutions Gora ML, Seth S, Visconti JA, Shields B, Bay W.	1991
2372	Journal Am J Hosp Pharm 1991 ; 48: 291 - 292.	Stability of cefazolin sodium in peritoneal dialysis solutions Nahata MC, Ahalt PA.	1991
2374	Journal Am J Hosp Pharm 1990 ; 47: 147 - 150.	Stability of cefotaxime in two peritoneal dialysis solutions CM Paap CM, Nahata MC.	1990
2375	Journal Am J Hosp Pharm 1989 ; 46: 1832 - 1833.	Visual compatibility of vancomycin and heparin in peritoneal dialysis solutions Strong DK, Ho W, Nairn JG.	1989
2463	Journal Am J Hosp Pharm 1979 ; 50: 486-488.	Instability of aqueous captopril solutions Anaizi NH, Swenson C.	1979
2466	Journal Am J Hosp Pharm 1981 ; 38: 1750-1753.	Compatibility of lithium citrate syrup with 10 neuroleptic solutions Theesen KA, Wilson JE, Newton DW, Ueda CT.	1981
2469	Journal Am J Hosp Pharm 1981 ; 38: 363-364.	Stability of aqueous suspensions of disulfiram Das Gupta V.	1981
2471	Journal Am J Hosp Pharm 1982 ; 39: 309-310.	Stability of disopyramide phosphate in cherry syrup Mathur LK, Lai PK, Shively CD.	1982
2476	Journal Am J Hosp Pharm 1986 ; 43: 1489-1491.	Formulation and stability of diazepam suspension compounded from tablets Strom JG, Jr, Kalu AU.	1986
2477	Journal Am J Hosp Pharm 1986 ; 43: 1492-1495.	Stability of propranolol hydrochloride suspension compounded from tablets Henry DW, Repta AJ, Smith FM, White SJ.	1986
2478	Journal Am J Hosp Pharm 1993 ; 50: 2353-2355.	Stability of an extemporaneously compounded baclofen oral liquid Johnson CE, Hart SM.	1993
2481	Journal Am J Hosp Pharm 1993 ; 50: 106-108.	Stability of ondansetron hydrochloride injection in extemporaneously prepared oral solutions Graham CL, Dukes GE, Fox JL, Kao CF, Hak LJ.	1993
2482	Journal Am J Hosp Pharm 1992 ; 49: 2784-2785.	Stability of etoposide solution for oral use McLeod HL, Relling MV.	1992
2486	Journal Am J Hosp Pharm 1991 ; 48: 992-993.	Stability of cefadroxil in reconstituted suspension under refrigeration and at room temperature Nahata MC, Jackson DS.	1991
2487	Journal Am J Hosp Pharm 1991 ; 48: 507-509.	Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C McBride HA, Martinez DR, Trang JM, Lander RD, Helms HA.	1991
2488	Journal Am J Hosp Pharm 1990 ; 47: 1799-1801.	Stability of captopril in powder papers under three storage conditions Taketomo CK, Chu SA, Cheng MH, Corpuz RP.	1990
2489	Journal Am J Hosp Pharm 1989 ; 46: 2040-2042.	Stability of extemporaneously compounded spironolactone suspensions Mathur LK, Wickman A	1989
2490	Journal Am J Hosp Pharm 1989 ; 46: 304-307.	Concentration uniformity of extemporaneously prepared ranitidine suspension Karnes HT, Harris SR, Garnett WR, March C.	1989
2491	Journal Am J Hosp Pharm 1989 ; 46: 256.	Stability of cefuroxime axetil in beverages St Claire RL, Caudill WL.	1989
2494	Journal Am J Hosp Pharm 1986 , 43: 2225-2228.	Stability of 1% rifampin suspensions prepared in five syrups Krukenberg CC, Mischler PG, Massad EN, Moore LA, Chandler AD.	1986
2495	Journal Am J Hosp Pharm 1986 ; 43: 380-383.	Long-term stability study of histamine in sterile bronchoprovocation solutions Marwaha RK, Johnson BF.	1986
2496	Journal Am J Hosp Pharm 1986 ; 43: 118-120.	Stability of 5-aminosalicylic acid suspension Montgomery HA, Smith FM, Scott BE, White SJ, Gerald KB.	1986
2499	Journal Am J Hosp Pharm 1992 ; 49: 615-618.	Stability of midazolam hydrochloride in a flavored, dye-free oral solution Steedman SL, Koonce, JR, Wynn JE, Brahen NH.	1992
2500	Journal Am J Hosp Pharm 1990 ; 47: 2716-2719.	Stability of nizatidine in extemporaneous oral liquid preparations Lantz MD, Wozniak TJ.	1990
2501	Journal Am J Hosp Pharm 1992 ; 49: 1720-1724.	Stability of procainamide hydrochloride in an extemporaneously compounded oral liquid Metras JI, Swenson CF, McDermott MP.	1992
2502	Journal Am J Hosp Pharm 1992 ; 49: 122-125.	Stability of an extemporaneously compounded clonidine hydrochloride oral liquid Levinson ML, Johnson CE.	1992
2503	Journal Am J Hosp Pharm 1991 ; 48: 293-295.	Stability of an extemporaneously compounded terbutaline sulfate oral liquid Horner RK, Johnson CE.	1991
2504	Journal Am J Hosp Pharm 1988 ; 45: 530-531.	Stability of propranolol hydrochloride suspension and solution Rooney M, Creurer I.	1988
2505	Journal Am J Hosp Pharm 1987 ; 44: 2287-2290	Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles Ahmed I, Day P.	1987
2508	Journal Am J Hosp Pharm 1988 ; 45: 1092-1099.	Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes Tu YH, Stiles ML, Allen LV, Jr, Olsen KM, Barton CI, Greenwood RB.	1988
2511	Journal Am J Hosp Pharm 1991 ; 48: 1265-1266.	Stability of oxybutynin chloride syrup after repackaging in unit doses Van Gansbeke B.	1991
2513	Journal Am J Hosp Pharm 1987 ; 44: 360-361.	Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets Das Gupta V, Stewart KR.	1987
2516	Journal Am J Hosp Pharm 1993 ; 50: 691-693.	Stability of famotidine in an extemporaneously prepared oral liquid. Quercia RA, Jay GT, Fan C.	1993
2517	Journal Am J Hosp Pharm 1994 ; 51: 806-809.	Stability of ondansetron hydrochloride in syrups compounded from tablets Williams CL, Sanders PL, Laizure SC, Stevens RC, Fox JL, Hak LJ.	1994
2522	Journal Am J Hosp Pharm 1994 ; 51: 1707-1708.	Stability of captopril in liquid containing ascorbic acid or sodium ascorbate Nahata MC, Morosco RS, Hipple TF.	1994
2523	Journal Am J Hosp Pharm 1994 ; 51: 2409-2411.	Stability of isradipine in an extemporaneously compounded oral liquid MacDonald JL, Johnson CE, Jacobson P.	1994
2524	Journal Am J Hosp Pharm 1994 ; 51: 2955-2957.	Stability of mesalamine in rectal suspension diluted with distilled water Henderson LM, Johnson CE, Berardi RR.	1994
2527	Journal Am J Hosp Pharm 1993 ; 50: 2366-2367.	Stability of fluconazole in an extemporaneously prepared oral liquid Yamreudeewong W, Lopez-Anaya A, Rappaport H.	1993
2570	Journal Am J Hosp Pharm 1994 ; 51: 1205-1207.	Degradation of captopril in solutions compounded from tablets and standard powder. Chan DS, Sato AK, Claybaugh JR.	1994
4263	Journal Am J Hosp Pharm 1994 ;51:373-377	Stability of ciprofloxacin injection in peritoneal dialysis solutions. Kane MP, Bailie GR, Moon DG, Siu I.	1994
3168	Journal Am J Hosp Pharm 1993 ; 50: 683-686.	Stability of hydralazine hydrochloride syrup compounded from tablets. Alexander KS, Pudipeddi M, Parker GA.	1993
3694	Journal Am J Hosp Pharm 1989 ; 46: 985-989.	Stability of floxuridine and leucovorin calcium admixtures for intraperitoneal administration. Smith J.A, Morris A, Duafala M.E, Bertino J.R, Markman M, Kleinberg M.	1989
3745	Journal Am J Hosp Pharm 1979 ; 36: 881.	Sodium chloride residue provides potential for drug incompatibiities. Kuenhle C, Moore	1979
4574	Journal Am J Hosp Pharm 2021 ;78,9:825–831	Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions. Ancedy D, Sebti M, Postaire M, Vidal F, Cisternino S.	2021
600	Journal Am J IV Ther Clin Nut 1984 ; 11: 14-15, 18-19.	Stability of piperacillin sodium in dextrose 5% and sodium chloride 0.9% injections. Das Gupta V, Davis DD, Stewart KR.	1984
1903	Journal Am J Obstet Gynecol 2002 ; 186: 496-498.	Oxytocin preparation stability in several common obstetric intravenous solutions. Gard JW, Alexander JM, Bawdon RE, Albrecht JT.	2002
1326	Journal Am J Roentgenol 1986 ; 146: 1300-1301.	Incompatibility of Hexabrix and papaverine. Pilla TJ, Beshany SE, Shields JB.	1986
1646	Journal Anaesthesia 2001 ; 56: 920.	Incompatibility of prochlorperazine and ketoprofen. Kannan S.	2001
1647	Journal Anaesthesia 2001 ; 56: 294.	Physical incompatibility between atracurium and intravenous diclofenac. Ackland G.	2001
794	Journal Anaesthesia 1996 ; 51: 815-818.	The effect of the addition of lignocaine on propofol emulsion stability. Lilley EMM, Isert PR, Carasso ML, Kennedy RA.	1996
2305	Journal Anaesthesia 2008 63, 9: 972-978.	Stability and compatibility of drug mixtures in an implantable infusion system. Bianchi F, Ginggen A, Tardy Y.	2008
2306	Journal Anaesthesia 2004 ; 59, 10: 979-983.	Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine. Priston M.J, Hughes J.M, Santillo M, Christie I.W.	2004
3086	Journal Anaesthesia 2000 ; 55, 9: 853-858.	Chemical stability of bupivacaine, lidocaine and epinephrine in pH-adjusted solutions. Robinson, J, Fernando, R, Sun Wai, W.Y., Reynolds, F.	2000
3374	Journal Anaesthesia 2001 ; 56: 494-495.	Precipitation in Manchester: ketorolac/cyclizine Smith R.P.R, Jones M.	2001
3377	Journal Anaesthesia 1983 ; 38: 601-602.	Precipitation betwen meptazinol and thiopentone. Huddy NC, Durcan JJ.	1983
3485	Journal Anaesthesia 2000 ; 55, 10: 1039-1040.	Vancomycin causes dangerous precipitation when infused with gelatin fluid. Huey-Ping Ng, Kwong-Fah Koh, Lai-San Tham.	2000
4080	Journal Anaesthesia 2017 ;124,3:776-781	Physical Compatibility of Propofol-Sufentanil Mixtures. Zbytovska J, Gallusova J, Vidlarova L, Prochazkova K, Simek J, Stepanek F.	2017
4435	Journal Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.	Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Hanifah S, Nugroho B.H, Chabib L.	2020
4436	Journal Anaesthesiol Intensive Ther 2018 ; 50, 3: 221-225.	Extended compatibility of fentanyl and ketamine in dextrose 5%. Hanifah S, Kennedy R.A; Ball P.A.	2018
2148	Journal Anal Biochem 2002 ; 309: 117-126.	Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum. Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J.	2002
3798	Journal Analytical Letter 1994 . 27: 1159-1164.	Stability indicating HPLC assay of zidovudine in extemporaneously syrup. Radwan M.A.	1994
2575	Journal Anest Prog 1997 ; 44, 1: 17-22.	Stability of parenteral midazolam in an oral formulation. Walker SE, Grad HA, Haas DA, Mayer A.	1997
1644	Journal Anesth Analg 2000 ; 90: 1450-1451.	The stability of remifentanil hydrochloride and propofol mixtures in polypropylene syringes and polyvinylchloride bags at 22-24°C. Stewart JT, Warren FW, Maddox FC, Viswanathan K, Fox JL.	2000
871	Journal Anesth Analg 1998 ; 86: 208-213.	The chemical stability and sterility of sodium thiopental after preparation. Haws JL, Herman N, Clark Y, Bjoraker R, Jones D.	1998
919	Journal Anesth Analg 1998 ; 86: 422-426.	Propofol and thiopental in a 1:1 volume mixture is chemically stable. Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.	1998
2053	Journal Anesth Analg 2003 ; 97: 1646-1651.	Physicochemical compatibility of propofol-lidocaine mixture. Masaki Y, Tanaka M, Nishikawa T.	2003
2071	Journal Anesth Analg 2002 ; 95: 785.	Precipitation of protamine by cefazolin. Ng HP, Koh KF.	2002
1672	Journal Anesthesiology 1998 ; 89: 1609.	Incompatibility of propofol emulsion with anesthesic drugs. Lamontagne C, Brouillette D, Hardy JF.	1998
1091	Journal Anesthesiology 1974 ; 40: 400-404.	Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing. Petty C, Cunningham NL.	1974
1093	Journal Anesthesiology 1984 ; 61: 347-348.	Stability of atracurium administered by infusion. Fisher DM, Canfell, Miller RD.	1984
4605	Journal Ann Allergy 2012 ; 2:28.	Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility. Foinard A, Décaudin B, Barthélémy C, Debaene B, Odou P.	2012
2076	Journal Ann Emerg Med 2003 ; 42: 9-13.	Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning. Dribben WH, Porto SM, Jeffords BK.	2003
2077	Journal Ann Emerg Med 1990 ; 19: 1242-1244.	Stability of epinephrine in alkalinized solutions. Bonhomme L, Benhamou D, Comoy E, Preaux N.	1990
4358	Journal Ann Fr Anesth Réanim 2014 ; 33, 5: 304-309.	Stabilité physico-chimique des solutions injectables de bésilate de cisatracurium dans les conditions cliniques d'utilisation Pignard J, Bourdeaux D, Kauffmann S, Constantin J.M, Sautou V.	2014
1098	Journal Ann Intern Med 1983 ; 98: 672.	Verapamil precipitation. Cutie MR.	1983
1099	Journal Ann Intern Med 1984 ; 101: 880.	Precipitation of verapamil in an intravenous line. Tucker R, Gentile JF.	1984
1100	Journal Ann Intern Med 1982 ; 97: 619.	Precipitation of verapamil. Bar-Or D, Kulig K, Marx JA, Rosen P.	1982
2074	Journal Ann Intern Med 1998 ; 128: 1049.	Dissolving phenytoin precipitate in central venous access device. Tse T, Abdullah R.	1998
4440	Journal Ann Nutr Metab 2018 ; 73: 227-233.	Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion. Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.	2018
1264	Journal Ann Pharm Fr 1997 ; 55: 216-223.	Study of Lavoisier morphine chlorhydrate in different active perfusion systems after reconstitution in different solvents. Truelle-Hugon B, Tourette G, Couineaux B, Gache-Charrette C.	1997
2814	Journal Ann Pharm Fr 2009 ; 67: 272-277.	Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C. Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2009
2904	Journal Ann Pharm Fr 2005 ; 63: 162-166.	Development of an oxybutynin chloride solution: from formulation to quality control. Fratta A, Bordenave J, Boissinot C, Le Grand J, Esquirol C, Radideau E, Benoit G.	2005
4250	Journal Ann Pharm Fr 2019 ;77,3:212-221.	Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units. D'Huart E, Vigneron J, Clarot I, Demoré B.	2019
3001	Journal Ann Pharm Fr 2015 ; 73: 108-113.	Long-term stability of aciclovir in 0.9% NaCl infusion polyolefin bags at 2-8°C after freeze-thaw treatment: A generic product versus the brand name. Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq JD.	2015
3076	Journal Ann Pharm Fr 2009 ; 67: 427-432.	Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags. François JH, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2009
3115	Journal Ann Pharm Fr 2010 ; 68: 157-162.	Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C. Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2010
3255	Journal Ann Pharm Fr 2011 ; 69, 6 : 296-301.	Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.	2011
3300	Journal Ann Pharm Fr 2012 ; 70, 2: 88-93.	Stability study of amiodarone hydrochloride in capsules for paediatric patients using a high-performance liquid chromatography method. Rughoo L, Vigneron J, Zenier H, May I, Demoré B.	2012
3312	Journal Ann Pharm Fr 2012 ; 70, 3: 139-154.	Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration. Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A.	2012
3318	Journal Ann Pharm Fr 2012 ; 70, 3: 155-162.	Stability of ready-to-use temsirolimus infusion solution (100 mg/L) in polypropylene containers under different storage conditions. Poujol S, Bressolle F, Solassol I, Pinguet F.	2012
3331	Journal Ann Pharm Fr 2012 ; 70, 5: 249-255.	Stability of the ready-to-use solutions of eribulin for intravenous infusion. Poujol S, Dell'ova M, Bekhtari K, Bressolle F, Pinguet F.	2012
3448	Journal Ann Pharm Fr 2013 ; 71, 5: 358-363.	Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.	2013
3669	Journal Ann Pharm Fr 2015 ; 73, 1: 31-36.	Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G.	2015
3874	Journal Ann Pharm Fr 2016 ; 74: 283-287.	Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L.	2016
3924	Journal Ann Pharm Fr 2016 ; 75, 1 : 17-29.	One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Vieillard V, Astier A, Sauzay C, Paul M.	2016
3925	Journal Ann Pharm Fr 2016 ; 75, 1 : 30-39.	Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C. Simar J, Godet M, Hecq J.-D, Closset M, Gillet P, Langhendries C, Bihin B, Jamart J, Galanti L.	2016
4016	Journal Ann Pharm Fr 2017 ; 75, 6: 420-435.	Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag. Vieillard V, Paul M, Ibrahim T, Astier A.	2017
4162	Journal Ann Pharm Fr 2018 ;76,6:444-452	Stability of sufentanil and baclofen mixtures for intrathecal analgesia at different concentrations in polypropylene syringes. Sorrieul J, Robert J, Gibory V, Kieffer H, Folliard C, Dupoiron D, Devys C.	2018
1668	Journal Ann Pharmacotherapy 2000 ; 34: 996-1001.	Compatibility and stability of linezolid injection admixed with three quinolone antibiotics. Zhang Y, Xu QA, Trissel LA, Williams KY.	2000
289	Journal Ann Pharmacotherapy 1993 ; 27: 704-707.	Physical and chemical compatibility of intravenous ciprofloxacin with other drugs. Jim LK.	1993
332	Journal Ann Pharmacotherapy 1995 ; 29: 1106-1109.	Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration. Xu QA, Trissel LA, Fox JL.	1995
333	Journal Ann Pharmacotherapy 1992 ; 26: 768-771.	Stability of ondansetron in large-volume parenteral solutions. Graham CL, Dukes GE, Kao CF, Bertch JM, Hak LJ.	1992
513	Journal Ann Pharmacotherapy 1996 ; 30: 756-761.	Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride. Xu QA, Trissel LA, Martinez JF.	1996
514	Journal Ann Pharmacotherapy 1997 ; 31: 297-302.	Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers. Xu QA, Trissel LA, Martinez JF.	1997
532	Journal Ann Pharmacotherapy 1996 ; 30: 343-346.	Lorazepam stability in parenteral solutions for continuous intravenous administration. Hoey LL, Vance-Bryan K, Clarens DM, Wright DH, Konstantinides FN, Guay DRP.	1996
546	Journal Ann Pharmacotherapy 1994 ; 28: 1018-1019.	Stability of diluted dexamethasone sodium phosphate injection at two temperatures. Lugo RA, Nahata MC.	1994
553	Journal Ann Pharmacotherapy 1989 ; 23: 132-135.	Stability of famotidine in minibags refrigerated and/or frozen. Bullock LS, Fitzgerald JF, Glick MR.	1989
215	Journal Ann Pharmacotherapy 1993 ; 27: 422-426.	Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs. Keyi X, Gagnon N, Bisson C, Desmarais M, LeBel M.	1993
660	Journal Ann Pharmacotherapy 1996 ; 30: 228-232.	Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Michaels MR, Stauffer GL, Haas DP.	1996
669	Journal Ann Pharmacotherapy 1994 ; 28: 35-36.	Paclitaxel stability and compatibility in polyolefin containers. Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS.	1994
682	Journal Ann Pharmacotherapy 1991 ; 25: 123-126.	Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection. Raymond GG, Davis RL.	1991
684	Journal Ann Pharmacotherapy 1990 ; 24: 1056-1058.	Chemical stability of suramin in commonly used infusion fluids. Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM.	1990
687	Journal Ann Pharmacotherapy 1990 ; 24: 232-235.	Stability of famotidine in a 3-in-1 total nutrient admixture. Shea BF, Souney PF.	1990
690	Journal Ann Pharmacotherapy 1989 ; 23: 588-590.	Stability of intravenous famotidine stored in polyvinyl chloride syringes. Bullock LS, Fitzgerald JF, Mazur HI.	1989
698	Journal Ann Pharmacotherapy 1989 ; 23: 466-467.	Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions. Nahata MC, Zingarelli JR, Durell DE.	1989
767	Journal Ann Pharmacotherapy 1997 ; 31: 789-790.	Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion. Trinkle R.	1997
780	Journal Ann Pharmacotherapy 1996 ; 30: 1037-1038.	Precipitation of lorazepam infusion. Boullata J, Gelone SP, Mancano MA, Borenstein MR, Zitterman R.	1996
798	Journal Ann Pharmacotherapy 1996 ; 30: 1501-1502.	Epoetin alfa loss with NaCl 0.9% dilution. Widness JA, Schmidt R.	1996
800	Journal Ann Pharmacotherapy 1997 ; 31: 553-559.	Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes. Fischer JH, Cwik MJ, Luer MS, Sibley CB, Deyo KL.	1997
872	Journal Ann Pharmacotherapy 1997 ; 31: 1465-1470.	Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions. Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F.	1997
887	Journal Ann Pharmacotherapy 1997 ; 31: 992-995.	Stability study of epirubicin in NaCl 0.9% injection. Pujol M, Munoz M, Prat J, Giona V, De Bolos J.	1997
900	Journal Ann Pharmacotherapy 1992 ; 26: 1221-1226.	Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion. Pleasants RA, Vaughan LM, Williams DM, Fox JL.	1992
915	Journal Ann Pharmacotherapy 1994 ; 28: 712-714.	Stability of ondansetron stored in polypropylene syringes. Casto DT.	1994
958	Journal Ann Pharmacotherapy 1990 ; 24: 440-442.	Netilmicin sulfate stability in combinaison with metronidazole or ranitidine hydrochloride in NaCl 0.9% infusion. Vervloet E, Lammers J, Tan LSL, Van Mourik CH, Rots M.	1990
982	Journal Ann Pharmacotherapy 1995 ; 29: 1168.	Compatibility of haloperidol and diphenhydramine in a hypodermic syringes. Ukhun IA.	1995
984	Journal Ann Pharmacotherapy 1996 ; 30: 298.	Amphotericin B is incompatible with lipid emulsions. Ericsson O, Hallmen AC, Wikstrom I.	1996
985	Journal Ann Pharmacotherapy 1996 ; 30: 549.	Haloperidol and diphenhydramine compatibility. Raleigh FR, Gibler BS.	1996
990	Journal Ann Pharmacotherapy 1989 ; 23: 1035.	Stability of caffeine injection stored in plastic and glass syringes. Nahata MC, Zingarelli JR, Hipple TF.	1989
992	Journal Ann Pharmacotherapy 1991 ; 25: 869.	Visual compatibility of ondansetron and dexamethasone. Beijnen JH, Koks CHW.	1991
1286	Journal Ann Pharmacotherapy 1998 ; 32: 1013-1016.	Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions. Trissel LA, Xu QA, Gilbert DL.	1998
1290	Journal Ann Pharmacotherapy 1999 ; 33: 906-909.	Stability of cefepime in peritoneal dialysis solution. Williamson JC, Volles DF, Lynch PLM, Rogers PD, Haverstick DM.	1999
1357	Journal Ann Pharmacotherapy 1989 ; 23: 91-92.	Quinolones and penicillins incompatibility. Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM.	1989
1498	Journal Ann Pharmacotherapy 1996 ; 30: 409-412.	Amphotericin B formulated in a lipid emulsion. Cleary JD.	1996
1500	Journal Ann Pharmacotherapy 1996 ; 30: 87.	Ciprofloxacin-ampicillin sulbactam incompatibility. Melonakos TK.	1996
1826	Journal Ann Pharmacotherapy 2001 ; 35: 1360-1363.	Stability of piperacillin and ticarcillin in autodose infusion system bags. Zhang Y, Trissel LA.	2001
1833	Journal Ann Pharmacotherapy 2003 ; 37, 12: 1789-1792.	Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags. Menard C, Bourguignon C, Schlatter J, Vermerie N.	2003
1834	Journal Ann Pharmacotherapy 2003 ; 37, 6: 804-807.	Stability of cefepime hydrochloride in autodose infusion system bags. Trissel LA, Xu QA.	2003
1893	Journal Ann Pharmacotherapy 2004 ; 38: 569-573.	Anti-Xa stability of diluted enoxaparin for use in pediatrics. Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC.	2004
1936	Journal Ann Pharmacotherapy 2004 ; 38: 1608-1611.	Physical and chemical stability of palonosetron HCl in 4 infusion solusions. Trissel LA, Xu QA.	2004
1937	Journal Ann Pharmacotherapy 2004 ; 38: 1612-1616.	Physical and chemical stability of daptomycin with nine medications. Lai JJ, Brodeur SK.	2004
1938	Journal Ann Pharmacotherapy 2004 ; 38: 1836-1839.	Stability of sufentanil citrate with levobupivacaine hydrochloride in NaCl 0.9% after microwave freeze-thaw treatment. Boitquin LP, Hecq JD, Vanbeckbergen DF, Jamart J, Galanti LM.	2004
1945	Journal Ann Pharmacotherapy 2004 ; 38: 2041-2044.	Stability of cefepime in icodextrin peritoneal dialysis solution. Elwell RJ, Volino LR, Frye RF.	2004
1955	Journal Ann Pharmacotherapy 2005 ; 39: 280-283.	Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Trissel LA, Zhang Y.	2005
2008	Journal Ann Pharmacotherapy 2005 ; 39: 1244-1248.	Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C. Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.	2005
2010	Journal Ann Pharmacotherapy 2005 ; 39: 1462-1466.	Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial. André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE.	2005
2015	Journal Ann Pharmacotherapy 2005 39: 1654-1658.	Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine. Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.	2005
2036	Journal Ann Pharmacotherapy 2005 ; 39, 12: 2026-2028.	Physical and chemical stability of pemetrexed solutions in plastic syringes. Zhang Y, Trissel LA.	2005
2114	Journal Ann Pharmacotherapy 2006 ; 40, 6: 1082-1085.	Physical and chemical stability of pemetrexed in infusion solutions. Zhang Y, Trissel LA.	2006
2117	Journal Ann Pharmacotherapy 2006 ; 40, 7: 1289-1292.	Physical instability of frozen pemetrexed solutions in PVC bags. Zhang Y, Trissel LA.	2006
2147	Journal Ann Pharmacotherapy 2006 ; 40, 11: 1950-1954.	Stability of vancomycin in icodextrin peritoneal dialysis solution. Nornoo AO, Elwell RJ.	2006
2268	Journal Ann Pharmacotherapy 2008 ; 42, 4: 511-515.	AntiXa stability of diluted dalteparin for pediatric use. Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J.	2008
2270	Journal Ann Pharmacotherapy 2008 ; 42, 9: 1247-1251.	Physical and chemical stability of esomeprazole sodium solutions. Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J.	2008
2321	Journal Ann Pharmacotherapy 2009 ; 43,2: 390-391.	Stability of Oxaliplatin Solution. Junker A, Roy S, Desroches M.C, Moussay C, Berhoune M, Bellanger A, Fernandez C,Farinotti R.	2009
2381	Journal Ann Pharmacotherapy 2010 ;44:462-465.	Stability of Extemporaneously Prepared Rufinamide Oral Suspensions . Hutchinson DJ, Liou Y, Best R, Zhao F.	2010
2534	Journal Ann Pharmacotherapy 1993 ;27:1198-1199.	Stability of spironolactone in an extemporaneously prepared suspension at two temperatures Nahata MC, Morosco RS, Hipple TF.	1993
2538	Journal Ann Pharmacotherapy 1995 ;29:987-990.	Stability of hydrocortisone oral suspensions prepared from tablets and powder. Fawcett JP, Boulton DW, Jiang R, Woods DJ.	1995
2541	Journal Ann Pharmacotherapy 1997 ;31:851-852.	Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature. Nahata MC.	1997
2542	Journal Ann Pharmacotherapy 1997 ;31:1291-1295.	Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone. Fawcett JP, Morgan NC, Woods DJ.	1997
2543	Journal Ann Pharmacotherapy 1998 ;32:755-757.	Stability of mycophenolate mofetil as an extemporaneous suspension. Venkataramanan R, McCombs, JR, Zuckerman S, McGhee B, Pisupati J, Dice JE.	1998
2545	Journal Ann Pharmacotherapy 2000 ;34:848-850.	Stability of dapsone in two oral liquid dosage forms. Nahata MC, Morosco RC, Trowbridge JM.	2000
2546	Journal Ann Pharmacotherapy 2000 ;34:600-605.	Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes. DiGiacinto JL, Olsen KM, BergmanKL, Hoie EB.	2000
2547	Journal Ann Pharmacotherapy 2001 ;35:1293-1294.	Stability of extemporaneously prepared gentamicin ophthalmic solutions. Ho PC, Soh H, Lim SM, Yow KL.	2001
2548	Journal Ann Pharmacotherapy 2003 ;37:506-509.	Stability of Sotalol in Two Liquid Formulations at Two Temperatures Nahata MC, Morosco RS.	2003
2549	Journal Ann Pharmacotherapy 2004 ;38:396-399.	Stability of Lisinopril in Two Liquid Dosage Forms Nahata MC, Morosco RS.	2004
2774	Journal Ann Pharmacotherapy 2004 ; 38: 967-972.	Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions. McKenzie J.E, Mario Cruz-Rivera M.	2004
2980	Journal Ann Pharmacotherapy 2007 ; 41: 1954-1961.	Stability of partial doses of omeprazole-sodium bicarbonate oral suspension. Johnson CE, Cober MP, Ludwig JL.	2007
3096	Journal Ann Pharmacotherapy 2010 ;44:295-301.	Stability of Cyclophosphamide in Extemporaneous Oral Suspensions. Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF.	2010
3174	Journal Ann Pharmacotherapy 2011 ; 45: 130-131.	Stability of Ondansetron and Dexamethasone Infusion upon Refrigeration. Rolin C, Hecq JD, Vanbeckbergen DF, Jamart J, Galanti LM.	2011
3204	Journal Ann Pharmacotherapy 2011 ;45, 4:546.	Stability of Azacitidine Suspensions. Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M.	2011
3380	Journal Ann Pharmacotherapy 2013 ;47:426-427.	Incompatibility of Piritramide with Cephalosporins. Eckle V-S, Heim E, Hahn M, Grasshoff C.	2013
3449	Journal Ann Pharmacotherapy 2013 ; 47: 1237-1238.	Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles. Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J.	2013
3490	Journal Ann Pharmacotherapy 2002 ; 36: 423-426.	Stability of furosemide in human albumin solution. Elwell R.J, Spencer A.P, Barnes J.F, Wynn J.E, Jones C.E.	2002
3498	Journal Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.	Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M	2008
3832	Journal Ann Pharmacotherapy 2016 ; 50: 155-156.	Stability Studies of Extemporaneously Compounded Clobazam Oral Suspension. Ei Mon Phyo Lwin, Ellis D, SonY, Turner S, Garg S.	2016
3844	Journal Ann Pharmacotherapy 2016 ; 50: 243-244.	Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates. Sauberan J.B, Phuong P, Ilog N.D, Rossi S.S.	2016
3845	Journal Ann Pharmacotherapy 2016 ; 50: 245-246	Stability of Pentobarbital in Water and Oral Pediatric Suspensions. Schlatter J, Kabiche S, Balde I-S, Majoul E, Cisternino S, Fontan J.E.	2016
3895	Journal Ann Pharmacotherapy 2016 ; 50: 790-792.	Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients Lim Tze-Peng, Kim-Hor Hee D, Lee W, Qi-Min Teo J, Cai Y,Yu-Hng Chia S, Yee-Kiat Leaw J, Jing-Yi Lee S, Soon-U Lee L, Kwa A.L.	2016
4105	Journal Ann Pharmacotherapy 2008 ;42:962-966	Stability of Sunitinib in Oral Suspensions. Navid F, Christensen R, Minkin P, Stewart C, Furman W, Baker S.	2008
4572	Journal Antibiotics 2021 ; 10, 217.	Toward Safe Pharmacotherapy: The Interplay between Meropenem and Parenteral Nutrition Admixtures. Gostynska A, Piwowarczyk L, Nadolna M, Jelinska A, Dettlaff K, Ogrodowczyk M, Popielarz-Brzezinska M, Stawny M.	2021
4592	Journal Antibiotics 2021 ; 10: 715.	The Role of Non-Enzymatic Degradation of Meropenem—Insights from the Bottle to the Body. Liebchen U, Rakete S, Vogeser M, Arend F.M, Kinast C, Scharf C, Zoller M, Schönermarck U, Paal M.	2021
4634	Journal Antibiotics 2022 ;11,4: 458	Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.	2022
156	Journal Anticancer Drugs 1995 ; 6: 163-164.	Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions. Barberi-Hayob M, Merlin JL, Vigneron M, Conroy T.	1995
1759	Journal Antimicrob Agents Chemother 2001 ; 45: 2643-2647.	Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Servais H, Tulkens PM.	2001
1167	Journal Antimicrob Agents Chemother 1987 ; 31: 610-611.	Instability of vancomycin in infusaid drug pump model 100. Grennberg RN, Saeed AM, Kennedy DJ, McMillian R.	1987
1168	Journal Antimicrob Agents Chemother 1983 ; 23: 653-657.	Tobramycin inactivation by carbenicillin, ticarcillin and piperacillin. Konishi H, Goto M, Nakamoto Y, Yamamoto I, Yamashina H.	1983
2042	Journal Antimicrob Agents Chemother 2002 ; 46: 2327-2332.	Comparative stability studies of antipseudomonal ß-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Viaene E, Chanteux H, Servais H, Mingeot-Leclerq MP, Tulkens PM.	2002
2043	Journal Antimicrob Agents Chemother 1998 ; 42: 762-766.	Amphotericin B in lipid emulsion : stability, compatibility, and in vitro antifungal activity. Walker S, Tailor SAA, Lee M, Louie L, Louie M, Simor AE.	1998
2046	Journal Antimicrob Agents Chemother 2003 ; 47: 1991-1994.	Stability and antibacterial activity of cefepime during continuous infusion. Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA.	2003
2285	Journal Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.	Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.	2008
2810	Journal Antimicrob Agents Chemother 2009 ; 53, 2: 798-799.	Preparation and stability of voriconazole eye drop solution. Dupuis A, Tournier N, Le Moal G, Venisse N.	2009
3308	Journal Antimicrob Agents Chemother 2012 ; 56: 3435-3437;	Stability of Extemporaneously Prepared 0.5-Percent Caspofungin Eye Drops: a Potential Cost-Savings Exercise. Neoh C.F, Jacob J, Leung L, Li J, Stathopoulos A, Stewart K, Kong D.C.M.	2012
3360	Journal Antimicrob Agents Chemother 2012 ; 56:6432-6433.	Stability of Colistimethate Sodium in Aqueous Solution. Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J.	2012
3757	Journal Antimicrob Agents Chemother 2014 ; 58 : 2849-2855.	How To Minimize Toxic Exposure to Pyridine during Continuous Infusion of Ceftazidime in Patients with Cystic Fibrosis? Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus J.C, Jouani B.-L., Merlette C, Nov?-Josserand R, Pages J, Panzo R	2014
3723	Journal Archives de Pédiatrie 1998 ; 5, 10: 1170-1171.	Stabilité des préparations extemporanées de doxapram (Doprams®) à usage néonatal. Barb? F, Legagneur H, Boisseau D, Badonnel Y, Boutroy M.J.	1998
4538	Journal Archives of Disease in Childhood 2020 ; 105: 395-397.	Compatibility of pentoxifylline and parenteral medications. Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K.	2020
4543	Journal Archives of Disease in Childhood 2018 ;104:292–295.	Physical compatibility of pentoxifylline and intravenous medications. Senarathna G, Strunk T, Petrovski M, Batty K.	2018
1842	Journal Arzneimittel Forschung 1995 ; 45: 93-98.	Compatibility of morphin, baclofen, floxuridine and fluorouracil in an implantable infusion pump. Sadjack A, Wintersteiger R.	1995
2205	Journal Arzneimittel Forschung 2006 ; 56, 10: 714-720.	Compatibility and stability of furosemide and dexamethasone combined in infusion solutions. Negro S, Rendon AL, Azuara ML, S?nchez Y, Fern?ndez-Carballido A, Barcia E.	2006
3956	Journal ASAIO Journal 2005 ; 51,6:761-763.	Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique. Bastani B; Amin K; Herr A.	2005
2841	Journal Atencion Pharmaceutica 2009 ; 11, 3: 161-166.	Estudio de estabilidad de la mezcla ondansetron-dexametasona en cloruro sodico 0,9%. Gonzalves Navaro M, Carril Aviles M, Borras Almenar C, Romero Crespo I, Jimenez Torres NV.	2009
1649	Journal Aust J Hosp Pharm 1997 ; 27: 470.	Ticarcillin-potassium clavulanate and vancomycin incompatibility. Gilbar P, McAllan Z.	1997
246	Journal Aust J Hosp Pharm 1996 ; 26: 560-561.	The stability of foscarnet in the presence of potassium. McDonald C, Boddy M, Garas G.	1996
519	Journal Aust J Hosp Pharm 1991 ; 21: 316.	Compatibility of morphine tartrate admixtures in polypropylene syringes. Poggi GL.	1991
399	Journal Aust J Hosp Pharm 1993 ; 23: 260-262.	Stability of midazolam in sodium chloride infusion packs. Bleasel MD, Peterson GM, Jestrimski KW.	1993
401	Journal Aust J Hosp Pharm 1991 ; 21: 115-118.	A preliminary study of the stability of midazolam in polypropylene syringes. Peterson GM, Khoo BHC, Galloway JG, Paterson J.	1991
920	Journal Aust J Hosp Pharm 1997 ; 27: 452-454.	Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes. Targett PL, Keefe PA, Merridew CG.	1997
939	Journal Aust J Hosp Pharm 1994 ; 24: 167-170.	Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection. Gilbar PJ, Groves CF.	1994
980	Journal Aust J Hosp Pharm 1995 ; 25: 352.	Compatibility of morphine and ketamine for subcutaneous infusion. Ambados F.	1995
1349	Journal Aust J Hosp Pharm 1987 ; 17: 31-34.	Effects of freezing, long term storage and microwave thawing on the stability of three antibiotics reconstituted in minibags. Sanburg AL, LyndonRC, Sunderland B.	1987
1379	Journal Aust J Hosp Pharm 1986 ; 16: 55-56.	Stability and light sensitivity of sodium nitroprusside infusions. Saunders A.	1986
2550	Journal Aust J Hosp Pharm 1993 ; 23: 35-37.	Compatibility of nebulizer solutions Roberts GW, Rossi S.O.P.	1993
2556	Journal Aust J Hosp Pharm 1989 ; 19,: 344-346.	Stability of extemporaneously prepared mixtures of metoprolol and spironolactone. Peterson GM, Meaney MF, Reid CA.	1989
2557	Journal Aust J Hosp Pharm 1991 ; 21: 239-241.	Prednisolone stability in a hydroalcoholic prednisolone mixture. Sullivan JA.	1991
2558	Journal Aust J Hosp Pharm 1993 ; 23: 18-21.	The stability of acetylcysteine eyedrops. Fawcett JP, Woods DJ, Hayes P.	1993
2559	Journal Aust J Hosp Pharm 1993 ; 23: 83.	The formulation of spironolactone solution for paediatric use. Mc Knight DL.	1993
2560	Journal Aust J Hosp Pharm 1994 ; 24: 312-316.	A short-term stability study of an oral solution of dexamethasone. Accordino A, Chambers R, Thomson B.	1994
2561	Journal Aust J Hosp Pharm 1994 ; 24: 151-156.	The stability of an enalapril maleate oral solution prepared from tablets. Boulton DW, Woods DJ, Fawcett JP.	1994
4194	Journal Bio Drugs 2018 32;619-625	In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion. Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y.	2018
4279	Journal Bio Drugs 2019 ; 33: 193–205.	Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N.	2019
3937	Journal Biomat Res 2015 ; 19, 2	Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Park K.H, Chung D.J.	2015
4298	Journal Biomed Chromatogr 2019 ; 33, 4:e4471	Stability and degradation products of imipenem applying High-Resolution Mass Spectrometry: an analytical study focused on solutions for infusion. Fabio de Souza Barbosa F, Capra Pezzi L, Tsao M, Franco de Oliveira T, Dias Macedo S.M, Schapoval E.E.S, Mendez A.S.L.	2019
4299	Journal Biomed Chromatogr 2019 ; 33, 7: e4529.	Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the EQUASHIELD® closed-system transfer device. Ezquer-Garin C, Ferriols-Lisart R, Alos-Alminana M.	2019
4664	Journal Biomed Chromatogr 2022 ;e5340.	Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care. Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M.	2022
3087	Journal BJID 2008 ; 12, 5: 400-404.	Treatment of invasive fungal infections: Stability of voriconazole infusion solutions in PVC bags. Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M.	2008
4501	Journal BMC Anesthesiology 2020 ;20:283.	The effect of concentration, reconstitution solution and pH on the stability of a remifentanil hydrochloride and propofol admixture for simultaneous co-infusion. Henkel E, Vella R, Behan K, Austin D, Kruger P, Fenning A.	2020
2224	Journal Bolletino SIFO 2007 ; 53: 178-180.	Dexrazoxane: Stabilià in soluzione. Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P.	2007
2225	Journal Bolletino SIFO 2006 ; 77:81	Studio di stabilità chimico-fisica di una formulazione per la terapia antalgica a base di levobupivacaina e fentanyl. Sacco R, Sacchetto G, Francalanci M, Boselli C.	2006
2789	Journal Bone Marrow Transplantation 2006 ; 37, 8: 781-784.	Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels. Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL.	2006
2586	Journal Br Assoc Dermatol 1998 ; 139 (suppl 52): 8-1.	Chemical stability of adepalene and tretinoin when combined with benzoyl peroxyde in presence and in absence of visible light and ultraviolet radiation. Martin B, Meunier C, Montels D.	1998
507	Journal Br J Anaesth 1992 ; 68: 414-417.	Stability of fentanyl, bupivacaine and adrenaline solutions for extradural infusion. Dawson PJ, Bjorksten AR, Duncan IP, Barnes RK, Beemer GH.	1992
2051	Journal Br J Anaesth 2003 ; 90: 179-182.	Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability. Sanchez del Aguila MJ, Jones MF, Vohra A.	2003
558	Journal Br J Parent Ther 1986 ; july/august : 86-92.	Stability of reconstituted mustine injection BP during storage. Kirk B.	1986
1329	Journal Br J Parent Ther 1986 ; march/april: 42-44.	Freeze-thaw stability of antibiotics used in an IV additive service. Brown AF, Harvey DA, Hoddinott DJ, Britton.	1986
1229	Journal Br J Pharm Pract 1990 ; 12: 53-54, 60.	Chemical stability of cytarabine and vinblastine injections. Weir PJ, Ireland DS.	1990
1230	Journal Br J Pharm Pract 1986 ; 8: 218-220.	Anti-emetic / diamorphine mixture compatibility in infusion pumps. Regnard C, Pashley S, Westrope F.	1986
1232	Journal Br J Pharm Pract 1987 ; 9: 223-226, 236.	A physical compatibility study of furosemide & flucloxacillin injections. Beatson C, Taylor A.	1987
1233	Journal Br J Pharm Pract 1990 ; 12: 328, 330, 334.	The stability of reconstituted aztreonam. McLaughlin JP, Simpson C.	1990
1234	Journal Br J Pharm Pract 1989 ; 11: 34-36.	Stability of low-dosage heparin in pre-filled syringes. Parkinson R, Wilson JV, Ross M, Denyer SP.	1989
1235	Journal Br J Pharm Pract 1988 ; 10: 22-23.	Pentamidine infusion stability. Leigh PH, Buddle GC.	1988
1877	Journal Br Ophtalmol 2000 ; 84: 117.	Vancomycin and ceftazidime incompatibility upon vitreal injection. Lifshitz T, Lapid-Gortzak R, Finkelman Y, Klemperer I.	2000
3796	Journal Br Ophtalmol 1995 ; 79: 753-755.	High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study. Morlet N, Young S, Naidoo D et al.	1995
3227	Journal Braz J Pharm Sci 2014 ; 50, 3 : 521-527.	Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Simon B, Hancu G, Gy?resi A.	2014
3696	Journal Braz J Pharm Sci 2012 ; 48, 4: 691-698.	Biological and physicochemical stability of ceftazidime and aminophylline on glucose parenteral solution. Santos C.A.D, Oliveira-Nascimento L, Knirsch M.C, Stephano M.A, Pessoa J?nior A, Penna T.C.V.	2012
3700	Journal Braz J Pharm Sci 2010 ; 46, 1 : 109-114.	Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp. Salgado A.C.G.B; Silva A.M.N.N; Machado M.C.J.C; Duarte MA.S.C; Ribeiro, Helena M.O.M.	2010
4366	Journal Braz J Pharm Sci 2019 ;55:e17351	Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures. Estan-Cerezo G, Rodriguez-Lucena F.J, Matoses Chirivella C, Jiminez-Pulido I, Garcia-Monsalve A, Navarro-Ruiz A.	2019
4637	Journal Braz J Pharm Sci 2021 ;57: e18896.	Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. Gobetti C, da Silva Bitencourt, A, Vinícius Ayres M, Peixoto de Freitas A.L, Loureiro Mendez A.S, Garcia C.V.	2021
4689	Journal Braz J Pharm Sci 2022 ;58: e19175	Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo. Dysarz L.P, Tavares M, Viçosa A.L, Ribeiro M.F, Teixeira R.G.S, Elias S.C, Márcio R. M.	2022
2130	Journal Bull Cancer 1999 ; 86, 11: 946-954.	Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.	1999
2181	Journal Bull Cancer 1995 ; 82: 189-195.	Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Milano G, Renée N.	1995
2073	Journal Can J Anesth 1998 ; 45: 347-351.	Precipitate formed by thiopentone and vecuronium causes pulmonary embolism. Taniguchi T, Yamamoto K, Kobayashi T.	1998
2079	Journal Can J Anesth 1987 ; 34: 87-89.	The effect of pancuronium on the solubility of aqueous thiopentone. Morton WD, Lerman J.	1987
1613	Journal Can J Hosp Pharm 2000 ; 53: 338-345.	Stability and compatibility of etoposide in normal saline. Lepage R, Walker SE, Godin J.	2000
1633	Journal Can J Hosp Pharm 2002 ; 55: 27-38.	Stability and compatibility of granisetron alone and in combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions. Walker SE, Law S.	2002
1634	Journal Can J Hosp Pharm 2000 ; 53: 263-269.	Stability of ketorolac tromethamine in IV solutions and waste reduction. Shi A, Walker SE, Law S.	2000
1637	Journal Can J Hosp Pharm 2000 ; 53: 24-31.	Concentration-dependant compatibility and stability of dexamethasone and midazolam. Wong AH, Law S, Walker SE, Bowles SK.	2000
1669	Journal Can J Hosp Pharm 1994 ; 47: 9-14.	The pharmaceutical stability of deferoxamine mesylate. Hayes DM, Reilly RM, Lee MMC.	1994
1724	Journal Can J Hosp Pharm 2001 ; 54: 102-105.	Visual compatibility of various injectable neuroleptic agents with benztropine and lorazepam in polypropylene syringes. Elbe D, Condé C.	2001
1725	Journal Can J Hosp Pharm 2001 ; 54: 112-113.	Compatibility of oxytocin, zidovudine, and penicillin G. Oliver C, Law S.	2001
1726	Journal Can J Hosp Pharm 2002 ; 55: 272-277.	Stability of oxycodone hydrochloride for injection in dextrose and saline solutions. Turnbull K, Bielech M, Walker SE, Law S.	2002
1758	Journal Can J Hosp Pharm 1999 ; 52: 90.	Ampicillin and ciprofloxacin incompatibility. Lewis GM, Donelly RF.	1999
345	Journal Can J Hosp Pharm 1996 ; 49: 290-298.	Stability and compatibility of reconstituted sterile hydromorphone with midazolam. Walker SE, Meinders A, Tailor H.	1996
522	Journal Can J Hosp Pharm 1989 ; 42: 97-103.	Famotidine stability in total parenteral nutrient solutions. Walker SE, Iazetta J, Lau DWC, Madorin PL.	1989
567	Journal Can J Hosp Pharm 1989 ; 42: 109-112.	Stability of clindamycin phophate in dextrose and saline solutions. Das Gupta V, Parasrampuria J, Bethea C, Wright W.	1989
591	Journal Can J Hosp Pharm 1993 ; 46: 13-16.	Stability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chloride. Knoppert DC, Freeman D, Webb D.	1993
120	Journal Can J Hosp Pharm 1988 ; 41: 177-182.	Hydromorphone and morphine stability in portable infusion pump cassettes and minibags. Walker SE, Coons C, Matte D, DeAngelis C, Iazzetta J, Kolos C, Birkhans B.	1988
226	Journal Can J Hosp Pharm 1991 ; 44: 289-295.	Stability and compatibility of combinations of hydromorphone and a second drug. Walker SE, DeAngelis C, Iazzetta J.	1991
9	Journal Can J Hosp Pharm 1992 ; 45: 187-192.	Compatibility and stability of hyaluronidase and hydromorphone. Walker SE, Lau DWC.	1992
58	Journal Can J Hosp Pharm 1985 ; 38: 160-161.	Physical compatibility of ranitidine HCl with preoperative injectable medications. Parker WA.	1985
66	Journal Can J Hosp Pharm 1996 ; 49: 140-145.	Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin. Avelar MA, Walker SE.	1996
117	Journal Can J Hosp Pharm 1988 ; 41: 5-9.	The stability of morphine intravenous infusion solutions. Vecchio M, Walker SE, Iazzetta J, Hardy BG.	1988
121	Journal Can J Hosp Pharm 1989 ; 42: 195-200.	Stability of sulfite free high potency morphine sulfate solutions in portable infusion pump cassettes. Walker SE, Iazzetta J, Lau DWC.	1989
640	Journal Can J Hosp Pharm 1987 ; 40: 161-166.	Stability of reconstituted ceftriaxone in dextrose and saline solutions. Walker SE, Dranitsaris G.	1987
659	Journal Can J Hosp Pharm 1996 ; 49: 62-65.	Epinephrine stability in plastic syringes and glass vials. Donnely RF, Yen M.	1996
674	Journal Can J Hosp Pharm 1992 ; 45: 237-242.	Cephalotin stability in normal saline, five percent dextrose in water, and Dianeal* solutions. Walker SE, Paton TW, Oreopoulos DG.	1992
677	Journal Can J Hosp Pharm 2015 ; 68, 4 : 346-348.	Stability of Extemporaneously Compounded Levetiracetam in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, D?carie D.	2015
681	Journal Can J Hosp Pharm 1991 ; 44: 71-78.	Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination. Walker S, Lau D, DeAngelis C, Iazetta J, Coons C.	1991
683	Journal Can J Hosp Pharm 1990 ; 43: 265-272.	Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.	1990
689	Journal Can J Hosp Pharm 1988 ; 41: 105-108.	Stability of ranitidine hydrochloride admixtures refrigerated in polyvinyl chloride minibags. Walker SE, Kirby K.	1988
694	Journal Can J Hosp Pharm 1988 ; 41: 233-238, 242.	Stability of intravenous vancomycin. Walker SE, Birkhans B.	1988
697	Journal Can J Hosp Pharm 1988 ; 41: 65-71.	Ceftazidime stability in normal saline and dextrose in water. Walker SE, Dratnitsaris G.	1988
840	Journal Can J Hosp Pharm 1986 ; 39: 60-66.	Stability of 5-fluorouracil and flucytosine in parenteral solutions. Biondi L, Nairn JG.	1986
925	Journal Can J Hosp Pharm 1998 ; 51: 55-57.	Compatibility and stability of propafenone hydrochloride with five critical-care medications. Dupuis LL, Trope A, Giesbrecht E, Wong B.	1998
960	Journal Can J Hosp Pharm 1990 ; 43: 57-60.	Stability of aqueous solutions of deferoxamine. Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N.	1990
978	Journal Can J Hosp Pharm 1994 ; 47: 147.	Methotrexate and cytarabine for intrathecal administration. Dick DM, Woloschuk DMM.	1994
1055	Journal Can J Hosp Pharm 1983 ; 36: 43-52.	Compatibility of antibiotics and other drugs in total parenteral nutrition solutions. Faragos S.	1983
1241	Journal Can J Hosp Pharm 1985 ; 38: 162-163.	The stability of penicillin G sodium in 5% dextrose in water minibags after freezing. Rayani S, Jamali F.	1985
1243	Journal Can J Hosp Pharm 1989 ; 42: 143-146.	The use of stability-indicating assays to determine the in vitro compatibility and stability of metronidazole / gentamicin admixtures. Rovers JP, Meneilly G, Souny PF, Rekhi GS, Drum D.	1989
1275	Journal Can J Hosp Pharm 1998 ; 51: 156-168.	Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride. Walker SE, Varrin S, Yannicelli D, Law S.	1998
1276	Journal Can J Hosp Pharm 1998 ; 51: 110-116.	Stability and compatibility of morphine with bupivacaine. Shiffman E, Walker SE, Yoon T, Yeung M.	1998
1277	Journal Can J Hosp Pharm 1999 ; 52: 150-155.	Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes. Donnelly RF.	1999
1278	Journal Can J Hosp Pharm 1998 ; 51: 13-19.	Concentration and solution dependent stability of cloxacillin intravenous solutions. Walker SE, Dufour A, Iazetta J.	1998
1391	Journal Can J Hosp Pharm 1998 ; 51: 271-272.	Is heparin always compatible with TPN and fat emulsion admixtures? Vanstone GL.	1998
1392	Journal Can J Hosp Pharm 1999 ; 52: 90.	Ampicillin and ciprofloxacin incompatibility. Lewis GM, Donnelly RF.	1999
1492	Journal Can J Hosp Pharm 1995 ; 48: 155-160.	Compatibility of morphine and midazolam or haloperidol in parenteral admixtures. LeBelle MJ, Savard C, Gagnon A.	1995
1497	Journal Can J Hosp Pharm 1993 ; 46: 61-65.	Stability and compatibility of combinations of hydromorphone and dimenhydrinate lorazepam or prochlorperazine. Walker SE, Iazetta J, DeAngelis C, Lau DWC.	1993
1806	Journal Can J Hosp Pharm 2002 ; 55, 5: 307-312.	Chemical stability of dimenhydrinate in minibags and polypropylene syringes. Donnely RF.	2002
1807	Journal Can J Hosp Pharm 2003 ; 56, 2: 87-92.	Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water. Chan J, Walker SE, Law S.	2003
1902	Journal Can J Hosp Pharm 2004 ; 57, 2: 90-96.	Physical compatibility of pantoprazole with selected medications during simulated Y-site administration. Walker SE, Wyllie A, Law S.	2004
1931	Journal Can J Hosp Pharm 2004 ; 4: 230-235.	Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes. Donnely RF.	2004
1946	Journal Can J Hosp Pharm 2004 ; 57, 5: 276-282.	Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion. Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L.	2004
2020	Journal Can J Hosp Pharm 2005 ; 58: 65-70.	Effect of freezing on stability of a fortified 5 mg/ml ticarcillin ophtalmic solution. Blondeel S, Pelloquin A, Pointereau-Bellanger A, Thuillier A, Fernandez C.	2005
2027	Journal Can J Hosp Pharm 2005 ; 58: 212-222.	Simulation of Y-site compatibility of irinotecan and leucovorin at room temperature in 5% dextrose in water in 3 different containers. Walker SE, Shirley L, Puodziunas A.	2005
2210	Journal Can J Hosp Pharm 2007 ; 60, 4: 231-237.	Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags. Walker S.E, Charbonneau F, Law S.	2007
2232	Journal Can J Hosp Pharm 2008 ; 61, 1: 14-20.	Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C) Walker SE, Milliken D, Law S.	2008
2294	Journal Can J Hosp Pharm 2008 ; 61, 5: 356-357.	Stability of magnesium sulfate 20% in Viaflex bags. Newby B.D, Benes C, Palmer L, Cleve R.	2008
2261	Journal Can J Hosp Pharm 2008 ; 61, 3: 191-195.	Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution. Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R.	2008
2322	Journal Can J Hosp Pharm 2009 ; 62, 1	Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes. Donnelly R.F.	2009
2323	Journal Can J Hosp Pharm 2009 ; 62, 1	Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and Refrigeration Galanti L, Lebitasy M.P, Hecq J.D, Cadrobbi J, Vanbeckbergen D, Jamart J.	2009
2329	Journal Can J Hosp Pharm 2008 ; 61, 6: 426-430.	Stability of Ketamine-Propofol mixtures for procedural sedation and analgesia in the emergency department. Donnely R.F, Willman E, Andolfatto G.	2008
2336	Journal Can J Hosp Pharm 2009 ; 62, 2: 112-118.	Stability of Hydromorphone–Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use Ensom M.H.H, Decarie D, Leung K, MontgomeryC	2009
2337	Journal Can J Hosp Pharm 2009 ; 62, 2: 135-141.	Extended Stability of Pantoprazole for Injection in 0.9% Sodium Chloride or 5% Dextrose at 4°C and 23°C Walker S.E, Iazzetta J, Law S.	2009
2339	Journal Can J Hosp Pharm 2002 ; 55, 3: 207-211.	Stability of Trimethoprim in Admixtures of Trimethoprim–Sulfamethoxazole Prepared in Polyvinylchloride Bags and Glass Bottles Curtis J.M, Edwards D.J.	2002
2340	Journal Can J Hosp Pharm 2005 ; 58, 4: 212-222.	Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers Walker S.E, Law S, Puodziunas A.	2005
2345	Journal Can J Hosp Pharm 2009 ; 62, 3: 226-231.	Stability of aseptically prepared Tazocin solutions in polyvinyl chloride bags. Donnelly R.F.	2009
2591	Journal Can J Hosp Pharm 1988 ; 41: 121-123.	Stability of a sotalol hydrochloride oral liquid formulation. Dupuis LL, James G, Bacola G.	1988
2592	Journal Can J Hosp Pharm 2005 ; 58, 5: 279-284.	Stability of clozapine stored in oral suspension vehicles at room temperature. Walker SE, Baker D, Law S.	2005
2593	Journal Can J Hosp Pharm 2006 ; 59, 4: 194-200.	Stability of sulfasalazine oral suspension. Linger-Walsh K, Walker SE, Law S, Abesamis M, Sales P.	2006
2594	Journal Can J Hosp Pharm 2007 ; 60, 3: 184-191.	Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. Ensom MHH, Decarie D, Sheppard I.	2007
2840	Journal Can J Hosp Pharm 2010 ; 63, 1 : 25-30.	Stability of Diclofenac Sodium Oral suspensions Packaged in Amber Polyvinyl Chloride Bottles. Donnell RF, Pascuet E, Ma C, Vaillancourt R.	2010
2857	Journal Can J Hosp Pharm 2002 ; 55, 1: 63-65.	Stability of Mycophenolate Mofetil in a 1:1 Mixture of Ora-Sweet and Ora-Plus. Ensom MHH, Decarle D.	2002
2875	Journal Can J Hosp Pharm 2004 ; 57, 5: 283.287.	Chemical Stability of 4-Aminopyridine Capsules. Donnelly RF.	2004
2878	Journal Can J Hosp Pharm 2009 ; 62, 5: 375-380.	Buffered Lidocaine Hydrochloride Solution With and Without Epinephrine: Stability in Polypropylene Syringes. Pascuet E, Donnelly RF, Garceau D, Vaillancourt R.	2009
2961	Journal Can J Hosp Pharm 2001 ; 54: 96-101.	Stability of dexamethasone in extemporaneously prepared oral suspensions. Wen-Lin Chow J, Decarie D, Dumont RJ.	2001
3078	Journal Can J Hosp Pharm 2009 ; 62, 6: 464-468.	Stability of celecoxib oral suspensions. Donnelly RF, Pascuet E, Ma C, Vaillancourt R.	2009
3111	Journal Can J Hosp Pharm 2010 ; 63, 2: 113-118.	Stability of Norepinephrine Solutions in Normal Saline and 5% Dextrose in Water. Walker SE, Law S, Garland J, Fung E, Iazzetta J.	2010
3131	Journal Can J Hosp Pharm 2010 ; 63, 2: 154-155.	Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl. Donnely RF, Wong K, Spencer J.	2010
3141	Journal Can J Hosp Pharm 2010 ; 63, 4: 304-311.	Stability of Trisodium Citrate and Gentamicin Solution for Catheter Locks after Storage in Plastic Syringes at Room Temperature. Cote D, Lok CE, Battistella M, Vercaigne L.	2010
3153	Journal Can J Hosp Pharm 2010 ; 63, 5: 366-372.	Stability of Vancomycin 25 mg/mL in Ora-Sweet and Water in Unit-Dose Cups and Plastic Bottles at 4°C and 25°C. Ensom M.H.H, Decarie D, Lakhani A.	2010
3166	Journal Can J Hosp Pharm 2011 ; 63, 6: 437-443.	Stability of Levothyroxine in Sodium Chloride for IV Administration. Strong DK, Decarie D, Ensom MHH.	2011
3220	Journal Can J Hosp Pharm 2011 , 64, 32: 192-198.	Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes. Donnelly RF.	2011
3221	Journal Can J Hosp Pharm 2011 ; 64, 3: 207-211.	Stability of Levetiracetam in Extemporaneously Compounded Suspensions. Ensom MHH, Decarie D, Rudolph S.	2011
3230	Journal Can J Hosp Pharm 2011 ; 64, 4: 241-245.	Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags Donnelly RF.	2011
3231	Journal Can J Hosp Pharm 2011 ; 64, 4 : 252-256.	Stability of Ciprofloxacin in Polyvinylchloride Minibags. Donnelly RF.	2011
3263	Journal Can J Hosp Pharm 2011 ; 64, 4: 289-290.	Stability of buffered lidocaine in glass vials. Donnelly R.F.	2011
3351	Journal Can J Hosp Pharm 2012 ; 65, 5: 352-359	Stability of Azacitidine in Sterile Water for Injection. Walker S.E, Charbonneau L.F, Law S, Earle C.	2012
3410	Journal Can J Hosp Pharm 2013 ; 66, 2: 118-124.	Stability of Propranolol in Extemporaneously Compounded Suspensions Ensom M.H, Kendrick J, Rudolph S, Decarie D.	2013
3431	Journal Can J Hosp Pharm 2001 ; 54, 3: 214-215.	Stability of preservative-free tobramycin in half-normal saline. Law S.	2001
3434	Journal Can J Hosp Pharm 2013 ; 66, 3 : 167-170.	Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection. Kistner C, Ensom M.H.H, Decarie D, Lauder G, Carr R.R.	2013
3435	Journal Can J Hosp Pharm 2013 ; 66, 3 : 198.	Stability of Diluted Ketamine Packaged in Glass Vials. Donnelly R.F.	2013
3557	Journal Can J Hosp Pharm 2013 ; 66, 5: 310-312	Physical Incompatibility between Parenteral Cloxacillin and Vancomycin. Chan A, Tawfik G, Cheng W.	2013
3558	Journal Can J Hosp Pharm 2013 ; 66, 5: 332.	Physical Compatibility of Ranitidine and Metoclopramide in 50-mL Minibags of Normal Saline. Rowe H, Riley J, Newby B.	2013
3688	Journal Can J Hosp Pharm 2014 ; 67, 2: 102-107	Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C). Walker S.E, Charbonneau L.F, Law S.	2014
3704	Journal Can J Hosp Pharm 2014 ; 67, 3:179-202.	Stability of Epinephrine at Standard Concentrations Carr R.R, Decarie D, Ensom M.H.H	2014
3713	Journal Can J Hosp Pharm 2014 ; 67, 4 : 274-278	Stability of Extemporaneously Compounded Dexamethasone in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, Décarie D.	2014
3714	Journal Can J Hosp Pharm 2014 ; 67, 4: 274-280.	Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, Décarie D.	2014
3763	Journal Can J Hosp Pharm 2014 ; 67, 5:	Stability of Extemporaneously Compounded Pyridoxine in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, Décarie D.	2014
3794	Journal Can J Hosp Pharm 2017 ; 70,3 :247-249	Vancomycin 50 mg/mL Suspension in Oral Syrup: Stability in Plastic Bottles and Syringes at 2 Temperatures. Smith A.D, Rempel G, Szeitz A, Klassen T.L, Ensom M.H.H.	2017
3826	Journal Can J Hosp Pharm 2015 ; 68, 6: 489-491.	Stability of Extemporaneously Compounded Naproxen 25 mg/mL Suspension in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, D?carie D, Lingertat-Walsh K.	2015
3851	Journal Can J Hosp Pharm 2016 ; 69, 1: 49-51.	Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, D?carie D.	2016
3854	Journal Can J Hosp Pharm 2016 ; 69, 2: 171-173.	Stability of extemporaneously compounded trimethioprim in glass and plastic bottles and plastic syringes. Ensom M.H.H, Decarie D.	2016
3891	Journal Can J Hosp Pharm 2015 ; 68, 2: 121-126.	Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C Walker S.E, Law S, Perks W, Iazzetta J.	2015
3892	Journal Can J Hosp Pharm 2016 ; 69, 4 : 329-333.	Stability of Hydrocortisone, Nifedipine, and Nitroglycerine Compounded Preparations for the Treatment of Anorectal Conditions Friciu M, Chefson A, Leclair G.	2016
3893	Journal Can J Hosp Pharm 2016 ; 69, 4: 327-329.	Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions Friciu M, Zaraa S, Leclair G.	2016
3921	Journal Can J Hosp Pharm 2016 ; 69, 6: 505-507.	Stability of extemporaneously prepared enalapril maleate suspensions in glass bottles and plastic syringes. Friciu M, Zaraa S, Leclair G.	2016
3945	Journal Can J Hosp Pharm 2017 ; 70,1 : 7-12.	Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags. Perks W, Iazzetta J, Chan P.C, Brouzas A, Law S,Walker S.E.	2017
3946	Journal Can J Hosp Pharm 2017 ; 70,1 :51-53.	Stability of Extemporaneously Compounded Tacrolimus in Glass Bottles and Plastic Syringes Friciu M, Zaraa S, Leclair G.	2017
4085	Journal Can J Hosp Pharm 2005 ; 58: 26-30.	Stability of Thiamine in Extemporaneously Compounded Suspensions. Ensom M, Decarie D	2005
4106	Journal Can J Hosp Pharm 2018 ;71,2/152-154	Stability of Dapsone in Extemporaneously Compounded Oral Suspensions. Alarie H, Friciu M, Leclair G.	2018
4142	Journal Can J Hosp Pharm 2018 ;71,3:165-172	Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastinc and Glass Bottles and Plastic Syringes. Lingertat-Walsh K, Law S, Walker S.E.	2018
4607	Journal Can J Hosp Pharm 2021 ;74(3):227-34	Stability of Compounded Clozapine 25 mg/mL and 50 mg/mL Suspensions in Plastic Bottles. Walker SE, Sachedina H, Bichar K.	2021
4348	Journal Can J Hosp Pharm 2019 ;72(5):360-8	Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes. D'Huart E, Vigneron J, Charmillon A, Clarot I, Demoré B.	2019
4406	Journal Can J Hosp Pharm 2020 2020;73(2):141-4	Stability of Methadone Hydrochloride for Injection in Saline Solution Friciu M, Alarie H, Beauchemin M, Forest JM, Leclair G.	2020
4485	Journal Can J Hosp Pharm 2021 ;74;1:57-69	Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C) Law S, Charbonneau L, Iazetta J, Perks W, Ma N, Walker S.E.	2021
4638	Journal Can J Hosp Pharm 2021 2021;74(4):327-33	Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes. St-Jean I, Friciu M, Monfort A, MacMahon J, Forest J-M, Walker S, Leclair G.	2021
4639	Journal Can J Hosp Pharm 2021 2021;74(4):344-9	Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions. Friciu M, Monfort A, Dubé P-A, Leclair G.	2021
855	Journal Cancer Chemother Pharmacol 1992 ; 29: 252-255.	Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump. Hrubisko M, Mc Gown AT, Prendiville JA, Radford JA, Thatcher N, Fox BW.	1992
2167	Journal Cancer Chemother Pharmacol 1995 ; 37, 1: 117-124.	Stability of the iv and oral formulations of etoposide in solution. Joel SP, Clark PI, Slevin ML.	1995
2168	Journal Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.	Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Ozdemir FA, Anilanmert B, Pekin M.	2005
3459	Journal Cancer Chemother Pharmacol 2013 ; 72: 509-513.	Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids. Sun S, Schaller J, Placek J, Duersch B.	2013
643	Journal Cancer Treat Rep 1987 ; 71: 1189-1192.	In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide. Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR.	1987
763	Journal Cancer Treat Rep 1985 ; 69: 1325-1326.	Drug precipitation within IV tubing : A potential hazard of chemotherapy administration. Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.	1985
3486	Journal Cardiovasc Intervent Radiol 2013 ; 36: 237-238.	Incompatibility of contrast medium and trisodium citrate. Delcour C, Brunnix G.	2013
2215	Journal Chem Pharm Bull 1984 ; 32, 3: 1113-1119.	Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5. Boehm J.J, Poust R.I.	1984
3316	Journal Chem Pharm Bull 2012 ; 60, 1: 86-93.	A 5% Glucose Infusion Fluid Provokes Significant Precipitation of Phenytoin Sodium Injection via Interruption of the Cosolvent Effect of Propylene Glycol. Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K.	2012
4445	Journal Chemotherapy 1979 ; 25: 336-345.	Antibiotic compatibility and stability in a parenteral nutrition solution. Reed M.D, Perry E.B, Fennell S.J, Brissie E.O, Ball W.D.	1979
1951	Journal Chin Pharm J 2001 ; 53: 185-189.	Stability of sodium cefazolin and tenoxicam in 5% dextrose. Wang DP, Lee D, Wang CN.	2001
2239	Journal Chinese J New Drugs 2005 ; 14, 2: 189-191.	Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry. Wang C, Zhang X, Liu HY.	2005
3297	Journal Chromatographia 2008 ; 68, 9-10: 767-772.	Development of an LC–DAD Method for Analysis of Dexketoprofen, Tramadol, and Haloperidol. Study of the Stability of Mixtures Used for Patient-Controlled Analgesia. Salmeron-Garcia A, Lopez-Lopez E, Roma E, Cabeza J, Navas N, Capitan-Vallvey L.F.	2008
1879	Journal Clin J Pain 2001 : 17: 239-244.	Stability, compatibility, and safety of intrathecal bupivacaine administered via an implantable delivery system. Hildebrand KR, Elsberry DE, Deer TR.	2001
1014	Journal Clin Pharmacol Ther 1988 ; 43: 183.	Lack of photodegradation but significant adsorption of nifedipine in administration systems. Larsen JS, Uden DL, Zaske DE.	1988
146	Journal Clin Ther 1992 ; 14: 821-824.	Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine. Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M.	1992
285	Journal Clin Ther 1996 ; 18: 246-255.	Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs. Elmore RL, Contois ME, Kelly J, Noe A, Poirier A.	1996
4247	Journal Clin Ther 2018 ;40,4:664-667	Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices. Patel R, Jacob J, Sedeeq M, Ming L.C, Wanandy T, Zaidi S.T.R, Peterson G.M.	2018
1873	Journal Clin Ther 2003 ; 25: 1219-1224.	Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study. Laposata M, Johnson SM.	2003
1978	Journal Clin Ther 1992 ; 14, 2: 192-195.	Comparative sorption of clomipramine, viloxazine and maprotiline hydrochlorides in polyvinylchloride bags and glass vials. Airaudo C, Bianchi C, Verdier M, Gayte-Sorbier A.	1992
2316	Journal Clin Ther 2008 ; 30, 11: 2075-2087.	Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas P.A, Kuzmission A, Ikeda K, Yasuo S.	2008
4433	Journal Clin Ther 2020 ; 42, 3: 475-485.	Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.	2020
4434	Journal Clin Ther 2019 ; 41, 10: 2162-2170.	Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.	2019
4548	Journal Clin Ther 2020 ; 42, 8: 1580-1586.	Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. O'Donnell J.N, Xu A, Lodise T.P.	2020
1949	Journal Clinical Cancer Research 2001 ; 7: 1569-1576.	Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.	2001
4444	Journal Clinical Nutrition 1999 ; 19, 3: 159-165.	Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics. Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P.	1999
380	Journal Crit Care Med 1995 ; 23: 1061-1066.	Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system. Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B.	1995
1108	Journal Crit Care Med 1983 ; 11: 50-52.	Loss of nitroglycerin to cardiopulmonay bypass apparatus. Dasta JF, Jacobi J, Wu LS, Sokoloski T, Beckley P, Reilley TE, Howie MB.	1983
1109	Journal Crit Care Med 1990 ; 18: 858-861.	Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible. Horrow JC, Digregorio J, Barbieri EJ, Rupp E.	1990
4383	Journal Crit Care Resusc 2020 ;22(1):83-85.	Stability of bicarbonate in normal saline: a technical report. Naorungroj T, Neto AS, Fujii T, Jude B, Udy A, Bellomo R.	2020
4550	Journal Crit Care Resusc 2013 ;15, 1: 63–66.	The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration. Semark, A.J, Venkatesh, K, McWhinney B.C, Pretorius, C, Roberts, J.A, Cohen J, Venkatesh B.	2013
4470	Journal Critical care 2005 ; 9(Suppl 1) P37	Continuous versus intermittent infusion of temocillin in intensive care unit patient. Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.	2005
3019	Journal Curr Med Res Opin 2007 ; 23: 2477-2483.	Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Bonasia P, Cook C, Cheng Y et al.	2007
3456	Journal Curr Med Res Opin 2011 ; 27, 12: 2241-2243.	Short-term stability of a new generic sodium ferric gluconate in complex with sucrose. Baribeault D.	2011
3849	Journal Curr Pharm Biotech 2013 ; 14, 2: 220-225.	Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions. Pabari R.M, Ryan B, Ahmad W, Ramtoola Z.	2013
561	Journal Current Ther Res 1976 ; 20: 359-368.	Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions. Part II. Nunning BC, Granatek AP.	1976
2050	Journal Current Ther Res 2000 ; 61: 1-6	Stability of reconstituted urokinase solutions. Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA.	2000
3835	Journal Current Ther Res 2015 ; 77: 99-104.	Chemical Stability of Telavancin in Elastomeric Pumps. Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C.	2015
3839	Journal Current Ther Res 2015 ; 77: 105-110.	Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T.	2015
803	Journal Diabetes Care 1997 ; 20: 1061-1065.	Stability of insulin lispro in insulin infusion systems. Lougheed WD, Weymouth AB, Zinman B, Bernstein EA, Strack TR, Korbas AM, Janis LJ, Frank BH.	1997
3149	Journal Diabetes Tech and Ther 2006 ; 8, 3: 358-368.	In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion. DeFelippis MR, Bell MA, Heyob JA, Storms SM.	2006
4115	Journal Drug Design Dev Ther 2016 ;10:3873-3878	Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use. Fang B, Wang L, Gu J, Chen F, Shi X.	2016
4116	Journal Drug Design Dev Ther 2016 ;10:1869-1875	Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems. Chen F, Zhu J, Li B, Yuan F, Wang K.	2016
4117	Journal Drug Design Dev Ther 2017 ;11:2087-2097	Evaluation of the stability of linezolid in aqueous solution and commonly used intravnous fluids. Taylor R, Sunderland B, Luna G, Czarniak P.	2017
4118	Journal Drug Design Dev Ther 2016 ;10:1029-1034	Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids. Czarniak P, Boddy M, Sunderland B, Hughes J.	2016
4559	Journal Drug Design Dev Ther 2020 ;14, 4179-4187.	Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration. Chen P, Chen F, Lei J, Zhou B.	2020
4693	Journal Drug Design Dev Ther 2022 ;16:1433-1440.	Compatibility and Stability of Ten Commonly Used Clinical Drugs in Pediatric Electrolyte Supplements Injection. Shen H, Fu Y, Chen Y, Xia W, Jia Z, Yu Q, Zhang L, Han L.	2022
1972	Journal Drug Dev Ind Pharm 2016 ; 42, 1: 166-174.	Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC–UV stability-indicating method. Feutry, F., Simon, N., Genay, S., Lannoy, D., Barthelemy, C., Decaudin, B., Labalette, P., Odou, P.	2016
2291	Journal Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.	Degradation kinetics of neostigmine in solution. Yeh MK.	2000
2991	Journal Drug Dev Ind Pharm 1997 ; 23: 285-291.	Evaluation of oil/water-type cyclosporine gel ointment with commercially available oral solution. Tamura T, Takayama K, Satoh H et al.	1997
3347	Journal Drug Discov Ther 2012 ; 6, 1 : 49-54.	Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags. Kaushal, G., Sayre, B.E., Prettyman, T.	2012
539	Journal Drug Intell Clin Pharm 1988 ; 22: 592-593.	Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection. Baptista RJ, Mitrano FP.	1988
565	Journal Drug Intell Clin Pharm 1986 ; 20: 960-963.	Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions. Marble DA, Bosso JA, Townsend RJ.	1986
573	Journal Drug Intell Clin Pharm 1977 ; 11: 542-548.	Stability of antibiotic admixtures frozen in minibags. Dinel BA, Ayotte DL, Behme RJ, Black BL, Whitby JL.	1977
576	Journal Drug Intell Clin Pharm 1980 ; 14: 353-357.	Activity of antibiotic admixtures subjected to different freeze-thaw treatments. Holmes CJ, Ausman RK, Walter CW, Kundsin RB.	1980
639	Journal Drug Intell Clin Pharm 1987 ; 21: 806-810.	Compatibility and stability of clindamycin phosphate - aminoglycoside combinations within polypropylene syringes. Zbrozek AS, Marble DA, Bosso JA, Bair JN, Townsend RJ.	1987
644	Journal Drug Intell Clin Pharm 1988 ; 22: 54-57.	Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles. Marble DA, Bosso JA, Townsend RJ.	1988
695	Journal Drug Intell Clin Pharm 1988 ; 22: 873-875.	Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutions. Zbrozek AS, Marble DA, Bosso JA.	1988
827	Journal Drug Intell Clin Pharm 1988 ; 22: 634-636.	Stability of vinblastine sulfate when exposed to light. Black J, Buechter DD, Thurston DE.	1988
850	Journal Drug Intell Clin Pharm 1982 ; 16: 765-767.	Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes. Munson J, Kubiak EJ, Cohon MS.	1982
1022	Journal Drug Intell Clin Pharm 1986 ; 20: 886.	Heparin and aminoglycosides instability. Hutchinson SMW.	1986
1302	Journal Drug Intell Clin Pharm 1988 ; 22: 173-174.	Cyclosporine binding to components in medication administration sets. Parr MD, Barton SD, Haver VM, Porter WH.	1988
3793	Journal Drug Intell Clin Pharm 1991 ; 25: 465-469.	Stability of labetalol hydrochloride in distilled water, simple syrup, and three fruit juices. Nahata M.C.	1991
1920	Journal Drug Stability 1996 ; 1: 118-122.	Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution. Akimoto K, Kaway A, Ohya K et al.	1996
1921	Journal Drug Stability 1996 ; 1; 141-146.	Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution. Akimoto K, Kawai A, Ohya K.	1996
3977	Journal Drugs R D 2015 ;15:253-259.	Stability of Melphalan in 0,9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous Injection. Desmaris R.P, Mercier L, Paci A.	2015
4282	Journal Drugs R D 2017	Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration. Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M.	2017
4292	Journal Drugs R D 2019 19: 127–140.	Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. Vimpolsek M, Gottar-Guillier M, Rossy E.	2019
4304	Journal Drugs R D 2014 ; 14:13?23.	Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices. Klasen K, Kessari R, Mercier L, Valade C, Grill J, Desmaris R, Paci A.	2014
4484	Journal Drugs R D 2022 ;22, 95–104	In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered. Bokser A D, Holmes Adegbenle Y, Stoisavljevic V, Norton J C.	2022
4708	Journal Drugs R D 2022 ; 22,3: 225–234	Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage. Borišek R, Mischo A, Šmid I.	2022
3725	Journal Dysphagia 2014	An investigation into the stability and sterility of citric acid solutions used for cough reflex testing. Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D.	2014
1645	Journal EJHP 2010 ; 16: 42-47.	Evaluation of a diltiazem hydrochloride gel for the treatment of anal fissure. Pinto JF, Salgado AC, Alves ML, Alves S, Neves C, Falcao F.	2010
1663	Journal EJHP 2002 ; 1: 23-25.	The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. Ponton JL, Munoz C, Rey M, Val M.	2002
1722	Journal EJHP 2002 ; 2: 33-40.	Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions. Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J.	2002
1746	Journal EJHP 2010 ; 16, 30-37.	Stability studies of amoxicillin/clavulanic acid combinaison in polyolefin infusion bags. Kambia N, Merite N, Dine T, Dupin-Spriet T, Gressier B, Luyckx M, Watinne C, Brunet C.	2010
761	Journal EJHP 2015 ;22:89-93	Physicochemical and microbiological stability studies of a melatonin oral suspension in a commercially available vehicle for paediatric use. Zerbit J, Bordenave J, Benoit G.	2015
917	Journal EJHP 1994 ; 4: 12-13.	Stability of refrigerated and frozen solutions of ondansetron hydrochloride. Blaise N, Vigneron J, Perrin A, Noirez V, Hoffman MA, Hoffman M.	1994
918	Journal EJHP 1994 ; 4: 17-19.	Stability of ornidazole in PVC bags under various storage conditions. Rodriguez-Sasiain JM, Prieto M, Errecalde F, Jaio N, Martinez-Bengoechea MJ.	1994
1067	Journal EJHP 1999 ; 5: 106-110.	Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers. Zeidler C, Dettmering D, Schrammel W, Spieteller M.	1999
1506	Journal EJHP 2015 ;22:107-112.	Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units. Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D.	2015
1508	Journal EJHP 2015 ;22:123-124.	Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.	2015
1809	Journal EJHP 2003 ; 3: 34-42.	Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study. Arrault XL, Rieutord A, Hassan M, Brion F.	2003
1810	Journal EJHP 2003 ; 1:1-3.	Stability of morphine sulphate in P.C.A.s. Lee G, Sabra K, Doyle N, Malley GO.	2003
1845	Journal EJHP 2003 ; 6: 106-111.	The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container). Müller HJ, Haker I.	2003
1897	Journal EJHP 2001 ; 7, 3: 108-115.	Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.	2001
1927	Journal EJHP 2004 ; 4: 60-63.	Stability of ranitidine hydrochloride in different aqueous solutions. Ferreira MO, Bahia MF, Costa P.	2004
2292	Journal EJHP 2016 ;23:22-27	Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability Philipp E, Braitsch M, Bichsel T, Mühlebach S.	2016
2815	Journal EJHP 2009 ; 15, 4: 30-32.	Assessment of stability in extemporaneously prepared venlafaxine solutions. Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE.	2009
2900	Journal EJHP 2009 ; 15, 5: 32-38.	Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration. Hines S, Pleasance S.	2009
3163	Journal EJHP 2010 ; 16, 5: 26-28.	Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage. Acott SR, Hart M.	2010
3195	Journal EJHP 2011 ; 17, 2: 39-43.	Physical and chemical stability of docetaxel infusions. MacLeod S, Sewell G.	2011
3256	Journal EJHP 2011 ; 17, 5: 49-56.	Stability of Hospira filgrastim following changes to thermal and photic storage conditions. Burnett B, Radic I.	2011
3293	Journal EJHP 2012 ; 19: 52-56.	Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service Patel N, Taki M, Tunstell P, Forsey P, Forbes B.	2012
3294	Journal EJHP 2012 ; 19: 57-64.	In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs Humbert-Delaloye V, Berger M, Voirol P, Pannatier A.	2012
3309	Journal EJHP 2012 ;19:378-380	Stability of diluted epinephrine in prefilled syringes for use in neonatology. Zenoni D, Priori G, Bellan C, Invernizzi R.W.	2012
3334	Journal EJHP 2013 ;20:36-41	Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate. Krämer I, Walz-Jung H, Stanko C, Kamin W.	2013
3336	Journal EJHP 2013 ;20:46-49	Stability of an oral ranitidine suspension (15 mg/ml). Petit-Jean E, Perello L, Hernandez C, Gairard Dory A.C, Gourieux B, Ubeaud-Sequier G.	2013
3337	Journal EJHP 2012 ; 19: 428-431.	Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature. Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z	2012
3381	Journal EJHP 2013 ; 20:110-116.	In vitro compatibility of various cardioactive drugs during simulated Y-site administration. Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Gattlen L, Pannatier A.	2013
3569	Journal EJHP 2014 ;21:34-38	Development of ready-to-use cefuroxime syringes for use in ophthalmology. Fleury-Souverain S, Sadeghipour F, Bonnabry P.	2014
3682	Journal EJHP 2016 ;23:33-37	Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study. Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P.	2016
3685	Journal EJHP 2017 ; 24:4 : 235-241	A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements. Pfeifer C, Noll S, Gerecke H, Fassauer G, Jira T, Remane Y , Vogel J, Frontini R, Reinhardt R.	2017
3705	Journal EJHP 2014 ;21:161-166	Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine. Knudsen L, Eisend S, Haake N, Kunze T.	2014
3780	Journal EJHP 2015 ;22:7-11	Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride Chen F, Peng L, Zhou B, Fang B, Yang Y.	2015
3781	Journal EJHP 2015 ;22:1 56-58	Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide. Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Testa B, Pannatier A	2015
3804	Journal EJHP 2014 ;22:150-155	Physicochemical stability of cabazitaxel and docetaxel solutions. Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.	2014
3875	Journal EJHP 2016 ; 23: 4: 213-218.	Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus. Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S.	2016
3898	Journal EJHP 2016 ;23:288-293	Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients Bonacucina G, Logrippo S, Cespi M, Ganzetti R, Casettari L, Sestili M, Perinelli D.R, Ricciutelli M, Marziali A, Polidori C, Pa	2016
3910	Journal EJHP 2016 ; 23: 352-358.	Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions. Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O.	2016
3911	Journal EJHP 2017 ; 24: 230-234.	Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes? Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L.	2017
3913	Journal EJHP 2018 ;25,3:150-156.	Compatibility of proton pump inhibitors in a preservative-free suspending vehicle. Polonini H.C, Silva S.L, Loures S, Almy R, Balland A, Brandao M.A.F, Ferreira A.O.	2018
3981	Journal EJHP 2017 ;24:162?166	Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D.	2017
3983	Journal EJHP 2016 ; 24: 157-161.	Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder. Zaid A.N, Assali M, Zalmout S, Basheer A.	2016
4003	Journal EJHP 2017 ; 25, 3: 157-164.	Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). Kim J, Chung J, Park S, Jung S, Kang D.	2017
4011	Journal EJHP 2016 2016;0:1-11	Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit. Gersonde F, Eisend S, Haake N, Kunze T.	2016
4012	Journal EJHP 2018 ; 25, e2	Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions. Khaleel I, Tabish R Zaidi S, Shastri M, Suji Eapen M, Chiau Ming L, Wanandy T, P Patel R.	2018
4013	Journal EJHP 2018 ; 25, e2	Stability of warfarin sodium flavoured preservative-free oral liquid formulations. Schlatter J, Cisternino S.	2018
4035	Journal EJHP 2017 ;0:1-5	Physicochemical stability of voriconazole in elastomeric devices. Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P.	2017
4036	Journal EJHP 2017 ;25,4: 200-203.	Stability and compatibility of ondansetron with haloperidol in parenteral admixtures. Estan-Cerezo G, Matoses-Chirivella C, Soriano-Iriga L, Murcia-Lopez A.C, Rodrguez-Lucena F.J, Navarro-Ruiz A.	2017
4059	Journal EJHP 2017 ; 25, e2	Physical and chemical stability of ceftaroline in an elastomeric infusion device. Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.	2017
4060	Journal EJHP 2018 ;25,3:144-149	Furosemide ethanol-free oral solutions for paediatric use : formulation, HPLC method and stability study. Zahalka L, Klovrzova S, Matysova L, Sklubalova Z, Solich P.	2018
4069	Journal EJHP 2018 ; 25, e2	Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns. Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F.	2018
4074	Journal EJHP 2018 ; 25: 107-110.	Stability of daptomycin reconstituted vials and infusion solutions. Ferrandez J, Sanchez R, Diaz D, Diaz M, Estevan M, Garcia T.	2018
4082	Journal EJHP 2018 ; 25, e2	Stability of mixtures of ondansetron and haloperidol stored in infusors at different temperatures. Espinosa-Bosch M, Sanchez-Rojas F, Bosche-Ojeda C.	2018
4125	Journal EJHP 2020 ; 27, 1: 43-48.	Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags. D'Huart E, Vigneron J, Lider P, Demoré B.	2020
4143	Journal EJHP 2016 ; 25, 4	Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use. Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R.	2016
4144	Journal EJHP 2018 ;75,14:1010-1012	Physical compatibility of milrinone with levofloxacin and ceftriaxone injection. Ross A, Boddu S, Mauro V, Churchwell M.	2018
4178	Journal EJHP 2017 ; 25, e2	Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration. Post T.E, Kamerling I van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E.	2017
4199	Journal EJHP 2018	Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas. Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M.	2018
4200	Journal EJHP 2018	Stability study of hydromorphone and bupivacaine mixture by HPLC-UV. Macorigh C, Guibbert V, Casanova M, Haenni C.	2018
4218	Journal EJHP 2020 ; 27, 2: 90-94.	Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements. Allwood M.C,Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C,	2020
4267	Journal EJHP 2019	Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units. D'Huart E, Vigneron J, Clarot I, Demoré B.	2019
4344	Journal EJHP 2018	Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments. Yay? HS, Faucheron A, Dupont L, El Kouari F, Fekkar A, Bellanger A, Tilleul P.	2018
4350	Journal EJHP 2019 ;0:1-5	Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia. Beiler B, Barraud D, Vigneron J, Demor? B.	2019
4362	Journal EJHP 2018 Eur J Hosp Pharm 2018;0:1	Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use. Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M.	2018
4370	Journal EJHP 2018 2018;0:1-7	Physical stability of an all-in one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs Staven V, Wang S, Gronlie I, Tho I.	2018
4373	Journal EJHP 2020	Evaluation of the stability of vancomycin solutions at concentrations used in clinical services. Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P.	2020
4512	Journal EJHP 2020 2020;0:1-5.	Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements Jamieson C,Ozolina L,Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS.	2020
4517	Journal EJHP 2020	Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. Cordero-Ramos J, Merino-Bohórquez V, Delgado-Valverde , Barros-Tornay R, Cameán-Fenández M, Calleja-Hernández M.A.	2020
4518	Journal EJHP 2020	In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion. Mohr A, Krämer I.	2020
4546	Journal EJHP 2021	Stability of pemetrexed diarginine concentrates for solution in vials and diluted in 0.9% sodium chloride and dextrose 5% polyolefin infusion bags. Vidal F, Cotteret C, Negbane A, Sebti M, Hinterlang M, Cisternino S, Schlatter J.	2021
4547	Journal EJHP 2021	Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia. Lin Y-S, Lin S-C, Hsieh Y-T,Liu L-Y,Lin C-H, Shen L-J, Huang C-F.	2021
4584	Journal EJHP 2021	Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials. Gilliot S, Henry H, Carta N, Genay S, Barthélémy C, Décaudin B, Odou P.	2021
4643	Journal EJHP 2021	Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L.	2021
4653	Journal EJHP 2021 ; 28: 331-335.	Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers. Jansen MMPM, van Waas VPH, Verzijl JM, Burger D.	2021
1958	Journal EJHP Science 2005 ; 11: 23-25.	Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags. Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L.	2005
2003	Journal EJHP Science 2005 ; 2: 31-36.	Stability of prostaglandin E1 (PGE1) in aqueous solutions. Paul M, Razzouq N, Tixier G, Astier A.	2005
2028	Journal EJHP Science 2005 ; 11, 4: 88-90.	Sodium nitroprusside stability at 1 µg/ml in aqueous solutions. Kaisserlian CE, Razzouq N, Astier A, Paul M.	2005
2034	Journal EJHP Science 2005 ; 11, 5: 111-113.	Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions. Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2005
2035	Journal EJHP Science 2005 ; 11: 107-110.	The stability of ready-to-use (RTU) ephedrine hydrochloride in polypropylene syringes for use in maternal hypotension. Griffiths W, Ing H, Fleury-SouverainS, Kern C, Sadeghipour F, Bonnabry P.	2005
2094	Journal EJHP Science 2006 ; 12, 1: 10-12.	Stability of intravenous admixtures of doxorubicin and vincristine confirmed by LC-MS. Trittler R.	2006
2095	Journal EJHP Science 2006 ; 12, 2: 32-34.	Stability of cefuroxime infusion: the brand-name drug versus a generic product. Rodenbach, MP, Hecq JD, Vanbeckbergen D, jamart J, Galanti L.	2006
2110	Journal EJHP Science 2006 ; 12, 3: 52-56.	Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C. Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM.	2006
2111	Journal EJHP Science 2006 ; 12, 3: 57-59.	Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C. Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L.	2006
2122	Journal EJHP Science 2006 ; 12, 4: 81-84.	Stability and compatibility of paracetamol injection admixed with ketoprofen. Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C.	2006
2123	Journal EJHP Science 2006 ; 12, 4: 76-80.	Stability of morphine sulphate in ANAPA Plus ambulatory infusion device and PEGA infusion sets. Lee G, Sabra K.	2006
2124	Journal EJHP Science 2006 ; 12, 4: 72-75.	Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C. Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L.	2006
2139	Journal EJHP Science 2006 ; 12,5: 96-99.	Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.	2006
2140	Journal EJHP Science 2006 ; 12, 5: 91-95.	Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion. Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.	2006
2173	Journal EJHP Science 2006 ; 12, 6: 135-139.	Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care. Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P.	2006
2174	Journal EJHP Science 2006 ; 12, 6: 129-134.	Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions. Kattige A.	2006
2183	Journal EJHP Science 2007 ; 13, 1: 14-16.	Stability of pemetrexed 25 mg/ml in a glass vial and 5 mg/ml stored in a PVC container after storage for one month at 2-8°C. Rondelot G, Serrurier C, Vigneron J, Zenier H, May I, Demoré B.	2007
2188	Journal EJHP Science 2007 ; 13, 2: 40-47	Chemical and physical stability of diluted busulfan infusion solutions. Karstens A, Krämer I.	2007
2201	Journal EJHP Science 2007 ; 13, 3: 55-59.	Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B.	2007
2287	Journal EJHP Science 2008 ; 14, 1: 14-18.	Development of ready-to-use ketamine hydrochloride syringes for safe use in post-operative pain. Stucki MC, Leury-Souverain S, Sautter AM, Sadeghipour F, Bonnabry P.	2008
2310	Journal EJHP Science 2008 ; 14, 6: 36-38.	Stability of diluted nadroparin for the treatment of paediatric thrombosis. Hunfeld N, Ypma P, Westerman E, Leebeck F, Touw D.	2008
2317	Journal EJHP Science 2009 ; 15, 1: 3-5.	Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia. Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G.	2009
2319	Journal EJHP Science 2009 ; 15, 1: 11-14.	Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump. Janssen K, Wisselo R, Geerlings C, Schouten J.P.	2009
2320	Journal EJHP Science 2009 ; 15, 1: 15-19.	Effect of freezing, long-term storage and microwave thawing on the stability of sodium folinate. Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.	2009
3075	Journal EJHP Science 2009 ; 15, 4: 78-82.	Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J.	2009
2928	Journal EJHP Science 2005 ; 11: 68-73.	Stability of spironolactone in an extemporaneously prepared aqueous suspension: the importance of microbiological quality of compounded paediatric formulations. Salgado AC, Rosa ML, Duarte MA et al.	2005
2984	Journal EJHP Science 2007 ; 13-67-72.	The development of a stable oral solution of captopril for paediatric patients. Berger-Gryllaki M, Podilsky G, Widmer N, Gloor S, Testa B, Pannatier A.	2007
3124	Journal EJHP Science 2010 ; 16, 1: 17-22.	Physicochemical stability of a 1mg/ml dexamethasone acetate oral suspension. Tiphine T, Armand A, Navas D, Dailly E, Menanteau M, Thomare P.	2010
3224	Journal EJHP Science 2011 ; 1: 3-6.	The stability of soluble insulin in plastic syringes Fleury-Souverain S, Sigrist T, Griffiths W, Ing H, Matthey B; Sadeghipour F, Bonnabry P.	2011
3225	Journal EJHP Science 2011 ; 17, 1: 7-12.	Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags. Kaiser J, Krämer I.	2011
3183	Journal EJOP 2010 ; 4, 3: 11-13.	Physical and chemical stability of cisplatin infusions in PVC containers. Sewell G	2010
3214	Journal EJOP 2011 ; 5,1: 10-14.	Stability of vincristine (TEVA) in original vials after re-use in dilute infusions in polyolefin bags and in polypropylene syringes. Trittler R, Sewell G.	2011
3215	Journal EJOP 2011 ; 5,1: 24-27.	Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution. Hart MC, Ahmed W.	2011
3306	Journal EJOP 2012 ; 6, 1: 1-2.	New stability studies for fludarabine according to the European Pharmacopoeia 7.0 Trittler R.	2012
3670	Journal EJOP 2014 ; 8, 3: 26-30.	Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. Sewell G, Massimini M.	2014
4526	Journal EJOP 2021 4: 1.	Stability of mitomycin in polypropylene syringes for use in glaucoma surgery. Nisse, Y.E, Vigneron J, Zenier H, D'Huart E, Demoré B.	2021
4600	Journal EJOP 2021 ; 4: 3.	Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose. Loeuille G, Vigneron J, D’Huart E, Demoré B.	2021
4702	Journal EJOP 2022 ; 5: 2.	Physicochemical stability of pemetrexed diarginine at 25 mg/mL in partially-used vials and at 3 and 12 mg/mL diluted in dextrose 5% or in sodium chloride 0.9% in polyolefin bags. Nisse Y-E, Sobalak N, Vigneron J, Demoré B.	2022
3464	Journal Enferm Clin 2011 21:25-29.	Compatibilidad física de la amiodarona en perfusión continua Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau.	2011
3134	Journal Enferm Intensiva 2010 ; 21: 96-103.	Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM.	2010
3212	Journal Enferm Intensiva 2011 ;22:78-82.	Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.	2011
3465	Journal Enferm Intensiva 2010 ;21:96-103.	Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. E. P?rez Juan, M. Maqueda Palau, M. Ar?valo Rubert, B. Ribas Nicolau, S.M. Amor?s Cerd?.	2010
3466	Journal Enferm Intensiva 2011 ;22:78-82.	Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.	2011
1604	Journal Eur Hosp Pharm 2001 ; 7: 11-14.	Stability of citalopram hydrochloride in polyvinyl chloride bag for I.V. solutions and compatibility in the presence of dipotassium clorazepate. Gury C, Dolizy I, Aymard N, Sellali Y, Rochet S.	2001
1638	Journal Eur Hosp Pharm 1996 ; 2: 47-48.	Stability of reconstituted ceftriaxone solution in polypropylene syringes. O'Connell C, Sabra K, Scott K.	1996
1639	Journal Eur Hosp Pharm 1997 ; 3: 168-171.	Stability of meropenem in elastomeric portable infusion devices. Krämer I.	1997
1452	Journal Eur Hosp Pharm 2000 ; 6: 17-23.	Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*. Muller HJ, Howe K, Frank C, Haker I.	2000
1491	Journal Eur Hosp Pharm 1995 ; 1: 12-14.	Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs. Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP.	1995
1505	Journal Eur Hosp Pharm 1997 3,4: 154-6	Stability of cladribine in either polyethylene containers or polyvinylchloride bags. Daouphars M, Vigneron J, Perrin A, Hoffman MA, Hoffman M.	1997
3017	Journal Eur Hosp Pharm 1996 ; 2: 176-180.	Formulation of a stable calcium gluconate gel for topical treatment of hydrofluoric acid burns. Rotheli-Simmen B, Martinelli E, Muhlebach S.	1996
3069	Journal Eur Hosp Pharm 1997 ; 3: 59-60.	Stability of amphotericin B in water solution for inhalation. Juarez JC, ,Lopez RM, Hucto M et al.	1997
2119	Journal Eur J Anaesthesiol 2003 ; 20: 124-126.	Adsorption of sufentanil to epidural filters and catheters. Westphal M, Hohage H, Buerckle H, Van Aken H, Ermert T, Brodner G.	2003
2138	Journal Eur J Anaesthesiol 2002 ; 19: 295-297.	Stability of a sufentanil-ropivacaine mixture in a glass and a PVC reservoir. Brodner G, Ermert T, Van Aken H et al.	2002
3850	Journal Eur J Cancer 2016 ; 58: 8-16.	Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues. Bardo-Brouard P, Vieillard V, Shekarian T, Marabelle A, Astier A, Paul M.	2016
4505	Journal Eur J Cancer 2020 ; 135: 192-202.	Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion. Le Guyader G, Vieillard V, Mouraud S, Do B, Marabelle A, Paul M.	2020
4458	Journal Eur J Clin Microbiol Infec Dis 2017 36:2237–2242.	Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G.	2017
1102	Journal Eur J Clin Pharmacol 1981 ; 19: 181-185.	Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems. Cossum PA, Roberts MS.	1981
4491	Journal Eur J Pedia 2020	Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.	2020
4651	Journal Eur J Pedia 2021 ;180,1169–1176.	Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.	2021
2621	Journal Eur J Pharm Biopharm 2003 ; 55: 209-213.	Stability of fludrocortisone acetate solutions prepared from tablets and powder. Cisternino S, Schlatter J, Saulnier JL.	2003
1835	Journal Eur J Pharm Sci 2003 ; 19, 1: 31-36.	Stability of sufentanil and levobupivacain solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes. Jäppinen A, Turpeinen M, Kokki H, ,Rasi A, Ojanen T, Pelkonen O, Naaranlahti T.	2003
3886	Journal Eur J Pharm Sci 2016 ; 92 : 220-223.	Design and stability study of an oral solution of amlodipine besylate for pediatric patients. van der Vossen A.C, van der Velde I, Smeets O.S.N.M,. Postma D.J, Vermes A,. Koch B.C.P, Vulto A.G,.Hanff L.M.	2016
3919	Journal Eur J Pharm Sci 2017 ; 96: 449-455.	Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice. Aeberhard C, Steuer C, Saxer C, Huber A, Stanga Z, Mühlebach S.	2017
3974	Journal Eur J Pharm Sci 2020	Stability of frozen 1% voriconazole eye drops in glass and in innovative containers. Roche M, Lannoy D, Bourdon F, Dhorne C, Berneron C, Danel C, G.Fernandez, M.J,Simon N, Odou P.	2020
4283	Journal Eur J Pharm Sci 2019	Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate. Lopalco A, Curci A, Lopedota A, Cutrignelli A, Laquintana V, Franco M, Denora N.	2019
4563	Journal Eur J Pharm Sci 2021 ; 160: 105738.	Stability study of a compounded oral solution of nicardipine for the treatment of hypertension in children. Fuss D, Gondé H, Lamoureux F, Pereira T, Colnot M, Buchbinder N, Coquard A, Varin R, Hervouët C.	2021
4641	Journal Eur J Pharm Sci 2021 ;167: 106039.	Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies. Zanon D, Selmin F, Centin G, Maximova N, Casiraghi A, Minghetti P.	2021
3033	Journal Eur Respir J 1998 ; 11: 946-948.	Stability of metacholine chloride solutions under different storage conditions over a 9 months period. Haynes RD, Beach JR, Rutherford DM et al.	1998
2661	Journal Eye 2015 ; 29, 6: 820-827.	Storage stability of bevacizumab in polycarbonate and polypropylene syringes Khalili H, Sharma G, Froome A, Khaw P.T, Brocchini S.	2015
2100	Journal Farm Hosp 1995 ; 19: 38-40.	Estabilidad fisica y quimica del sulfato magnesico combinado con heparina sodica en solucion salina al 0,9 por 100. Gervas S, Gosalbez F.	1995
2103	Journal Farm Hosp 1999 ; 23: 103-108.	Estabilidad y compatibilidad del metamizol en jeringa y en mezclas intravenosas. Noguera Rodriguez A, Sancho Chust V, Medina Hernandez C, Medina Hernandez MJ, Jimenez Torrez NV.	1999
2104	Journal Farm Hosp 2000 ; 24: 145-150	Estudio de la estabilidad de mezclas ciclofosfamida/mesna e ifosfamida/mesna en soluciones intravenosas de gran volumen. Iriarte Izura MA, Gozalo garcia MJ, Marcotegui Ros F, Nagore Indurain C, Urdaniz Baztan AO.	2000
2105	Journal Farm Hosp 1999 ; 23: 357-360.	Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.	1999
2906	Journal Farm Hosp 2005 ; 29: 30-36.	Stability study of an aqueous formulation of captopril at 1 mg/ml. Escribano Garcia MJ, Torrado Duran S, Torrado Duran JJ.	2005
3167	Journal Farm Hosp 2010 ;34:293-7.	Carvedilol stability in paediatric oral liquid formulations. Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA.	2010
3198	Journal Farm Hosp 2008 ; 32, 6 : 344-348.	Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas. Nebot Martinez J, Alos Alminana M, Diez Sales O.	2008
3383	Journal Farm Hosp 2013 ;37,1:4-9	Evaluación de la estabilidad de un jarabe de hidrato de cloral al 7% en envases mono y multidosis bajo condiciones ambiente y de refrigeración. Bustos-Fierro C, Olivera M. E, Manzo P.G, Jimenez-Kairuz A.K.	2013
3384	Journal Farm Hosp 2013 ;37,1:10-14	Estudio de estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua. Otero F.M	2013
3407	Journal Farm Hosp 2013 ; 37, 21: 103-110.	Suspensiones extratemporáneas de clobazam para uso pediátrico preparadas a partir de tabletas disponibles comercialmente y fármaco puro. Buontempo F, Moretton M.A, E. Quiroga y D. A. Chiappetta.	2013
3488	Journal Farm Hosp 1995 ; 19, 1: 41-44.	Jarabe de midazolam: Estudio de estabilidad de una solucion oral para uso hospitaliaro. Caldes R, Ciges S.M, Borras E, Calvelo R, Lisart F.	1995
3489	Journal Farm Hosp 1998 ; 22, 5: 249-251.	Estabilidad de las soluciones orales de clohidrato de metadona al 0,1% y 0,5% en suero fisiologico. Soy D, Roca M, Deulofeu R, Montes E, Codina C, Ribas J.	1998
3706	Journal Farm Hosp 2014 ;38, 3:154-161	Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia. Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B.	2014
4191	Journal GaBI Journal 2018	Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures. Vieillard V, Astier A, Paul M.	2018
4396	Journal GaBI Journal 2020 ; 9, 1:	Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions. Lueras A, Polozova A, Asbury D, Hippenmeyer J, Litowski J, Goss M, Breslin P, Crampton S.	2020
4477	Journal GaBI Journal 2020 ; 9, 1: 5-13.	Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentration and stress conditions. Crampton S, Polozoxa A, Asbury D, Lueras A, Breslin P, Hippenmeyer J, Litkowski J,,Goss M.	2020
4516	Journal GaBI Journal 2020 ; 9, 4	Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags. Seckute J, Castellanos I, Bane S.	2020
4649	Journal GaBI Journal 2021 ; 10, 4	Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J.	2021
3951	Journal Hemodial Int 2009 ; 13, 3: 322-328.	Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C Battistella M, Walker S, law S, Lok C.	2009
3952	Journal Hemodial Int 2010 ; 14, 3 : 322-326.	Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C. Battistella M,. Vercaigne L.M, Cote D,. Lok C.E.	2010
3953	Journal Hemodial Int 2011 ; 15, 2 : 364-272.	In vitro stability and compatibility of tenecteplase in central venous access devices. Lentz Y.K, Joyce M, Lam X.	2011
1601	Journal Hosp Pharm 2001 ; 36: 950-954.	Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration. Godwin DA, Kim NH, Zuniga R.	2001
1602	Journal Hosp Pharm 2001 ; 36: 740-745.	The stablity of diluted vincristine sulfate used as a deterrent to inadvertent intrathecal injection. Trissel LA, Zhang Y, Cohen MR.	2001
1605	Journal Hosp Pharm 2000 ; 35: 1057-1064.	Stability of cefepime hydrochloride injection and metronidazole in polyvinyl chloride bags at 4°C and 22-24°C. Stewart JT, Maddox FC, Warren FW.	2000
1607	Journal Hosp Pharm 2000 ; 35: 1192-1196.	Incompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injection. Trissel LA, Zhang Y, Xu QA.	2000
1614	Journal Hosp Pharm 2001 ; 36: 1170-1173.	Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags. Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS.	2001
1643	Journal Hosp Pharm 1994 ; 29: 76.	Haldol-benztropine incompatibility. Raleigh F, Gibler B.	1994
1674	Journal Hosp Pharm 1998 ; 33: 1515-1522.	Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1998
288	Journal Hosp Pharm 1992 ; 27: 957-958,961-962.	Visual compatibility of injectable ciprofloxacin lactate with selected injectable drugs during simulated Y-site administration. Cervenka P, Dejong DJ, Butler BL, Monzingo MD.	1992
499	Journal Hosp Pharm 1991 ; 26: 634-635.	Intramuscular antibiotic preparation and administration using a 1% lidocaine diluent: policies for the pediatric patient. Rockwell K, Burch K.	1991
31	Journal Hosp Pharm 1996 ; 31: 965-970.	Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solution. Zhang Y, Xu QA, Trissel LA, Gilbert DL.	1996
141	Journal Hosp Pharm 1989 ; 24: 929-934.	Stability of gallium nitrate and mitoguazone dihydrochloride in commonly used intravenous fluids. Kleinberg ML, Oberdier J, Muller RJ, Duafala M, Boylan JC.	1989
642	Journal Hosp Pharm 1988 ; 23: 44,49, 59.	Norepinephrine stability in saline solutions. Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.	1988
805	Journal Hosp Pharm 1997 ; 32: 1013-1020.	An automated process for determining the physical compatibility of drugs. Oskroba DM, Leissing NC, Trissel LA.	1997
891	Journal Hosp Pharm 1992 ; 27: 200, 202, 209.	Visual compatibility of sargramostim (GM-CSF) during simulated Y-site administration with selected agents. Matsuura G.	1992
905	Journal Hosp Pharm 1994 ; 29: 1010-1017.	Screening teniposide for Y-site physical incompatibilities. Trissel LA, Martinez JF.	1994
921	Journal Hosp Pharm 1998 ; 33: 284-292.	Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1998
1407	Journal Hosp Pharm 1998 ; 33: 1203-1207.	Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture. Xu QA, Trissel LA, Gilbert DL.	1998
1486	Journal Hosp Pharm 1987 ; 22: 1131-1132.	Stability of gentamicin diluted in 0.9% sodium chloride injection in glass syringes. Nahata MC, Hipple TF, Strausbaugh SD.	1987
1496	Journal Hosp Pharm 1996 ; 31: 1425-1428.	Screening cladribine for Y-site physical compatibility with selected drugs. Trissel LA, Martinez JF, Gilbert DL.	1996
1811	Journal Hosp Pharm 2003 ; 38: 130-134.	Stability of imipenem-cilastatin sodium in autodose infusion system bags. Trissel LA, Xu QA.	2003
1907	Journal Hosp Pharm 2004 ; 39: 554-557.	Sustaining treatment of coccidioidal meningitidis by extending the stability of amphotericin B. Burger DE, Caldwell JW.	2004
1959	Journal Hosp Pharm 2005 ; 40, 2: 154-155.	Precipitate formation after subconjonctival administration of ceftazidime and vancomycin. Mac Lellan C, Papadopoulos A.	2005
2006	Journal Hosp Pharm 2015 ; 50, 7: 609-614.	Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags. Gu Z, Wong A, Raquinio E, Nguyen A.	2015
4248	Journal Hosp Pharm 2019 ; 55, 3: 199-193.	Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers. Colsoul M.L, Breuer A, Goderniaux N, Hecq J.D, Soumoy L, Bihin B, Jamart J, Galanti L.	2019
2475	Journal Hosp Pharm 2015 ; 50: 376-379.	Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam Wade J, Cooper M, Ragan R.	2015
2630	Journal Hosp Pharm 1981 ; 16: 486-487.	Incompatibilities with orally administered liquid neuroleptic medication combinations. Raleigh F.	1981
2634	Journal Hosp Pharm 1997 ; 32: 691-693.	Stability of metolazone in a liquid dosage form. Nahata MC, Morosco RS, Hipple TF.	1997
2635	Journal Hosp Pharm 2008 ; 43, 4: 303-306.	Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution. Yamreudeewoh W, Teixeira G, Mayer GE.	2008
2793	Journal Hosp Pharm 2015 ; 50, 4 : 296-303.	In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem. Tomasello C, Leggieri A, Cavalli R, Di Perri G, D?Avolio A.	2015
2931	Journal Hosp Pharm 2006 ; 41: 254-259.	Stability of two extemporaneously prepared oral metoprolol and carvedilol liquids. Yamreudeewong W, Dolence EK, Pahl D.	2006
3012	Journal Hosp Pharm 2015 ; 50, 3: 214-220.	Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Sullivan T, Forrest J.M, Leclair G.	2015
3301	Journal Hosp Pharm 2012 ; 47, 4: 289-292.	Extended Stability of Magnesium Sulfate Infusions Prepared in Polyolefin Bags. Sayre B.E, Prettyman T, Kaushal G.	2012
3307	Journal Hosp Pharm 2012 ; 47, 1: 27-30.	Managing the intravenous calcium shortage: Evaluation of calcium chloride stability in 0.9% sodium chloride and dextrose 5% water polyvinyl chloride bags. Kiser T.H, Barber G.R, Robinson A.	2012
3310	Journal Hosp Pharm 2012 ; 47, 5: 367-370.	Stability of Regular Human Insulin Extemporaneously Prepared in 0.9% Sodium Chloride in a Polyvinyl Chloride Bag. Greenwood B.C, Chesnick M.A, Szumita P.M, Caryn Belisle C, Cotugno M.	2012
3329	Journal Hosp Pharm 2012 ; 47, 7: 538-543.	Extended Stability of Sodium Bicarbonate Infusions Prepared in Polyolefin Bags. Sayre B.E, Prettyman T, Kaushal G.	2012
3365	Journal Hosp Pharm 2013 ; 1: 44-47	Y-Site Compatibility of Vancomycin and Piperacillin/Tazobactam at Commonly Utilized Pediatric Concentrations. Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A.	2013
3422	Journal Hosp Pharm 2013 ; 48, 6: 484-488.	Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags. Almagambetova E, Hutchinson D, Blais D.M, Zhao F.	2013
3428	Journal Hosp Pharm 2013 ; 48, 1: 44-47.	Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations. Nichols K.R, DeMarco M.W, Vertin M.D, Knoderer C.A.	2013
3571	Journal Hosp Pharm 2014 ; 49, 1: 42-47.	Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration. Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.	2014
3813	Journal Hosp Pharm 2015 ; 50, 8: 710-713.	Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery. Teibel H.M, Knoderer C.A, Nichols K.R.	2015
3862	Journal Hosp Pharm 2016 ; 51, 3: 246-251.	Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions. Cutshall B.T, Gorman G.S, Freeman M.K ,. Kyle J.A.	2016
3872	Journal Hosp Pharm 2016 ; 51: 389-395.	Stability of an Extemporaneously Compounded Oral Suspension of Bosentan. Malik A, Gorman G, Coward L ,. Arnold J.J.	2016
3926	Journal Hosp Pharm 2016 ; 51 ; 11 : 915-921.	Stability of Levodopa/Carbidopa Rectal Suspensions. Donnelly R.F.	2016
3960	Journal Hosp Pharm 2017 ;52,2:132-137.	Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story? Kufel W.D, Miller C.D, Johnson P.R, Reid K., Zahra J.J, Seabury R.W.	2017
3984	Journal Hosp Pharm 2017 ,52;3 : 221-228	Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water. Meyer K, Santarossa M, Danziger L.H, Wenzler E.	2017
4020	Journal Hosp Pharm 2010 ;45,10:779?784	Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous Admixture. T. Schulz L, J. Elder E, Jones K, Vijayan A, D. Johnson B, E. Medow J, Vermeulen L.	2010
4023	Journal Hosp Pharm 2017 ; 52,7 : 478-482.	Compounded Apixaban Suspensions for Enteral Feeding Tubes. Carabello M, Donmez S, Nathan K, Zhao F.	2017
4026	Journal Hosp Pharm 2017 ; 52, 8 : 570-573	Extended Stability of Epinephrine Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light-Blocking Bags. Van Matre E.T, Ho K.C., Lyda C, Fullmer B.A, Oldlan A.R, Kiser T.H.	2017
4027	Journal Hosp Pharm 2017 ;52,10:685-690	Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution. Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M.	2017
4028	Journal Hosp Pharm 2017 ;52,10 :704-708	Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags. Donnelly R.	2017
4048	Journal Hosp Pharm 2017 ;52,11:752-760	In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes. Reindel K, Zhao F, Hughes S, Dave V.	2017
4057	Journal Hosp Pharm 2018 ; 53, 2: 125-127.	Physical Compatibility of Micafungin With Sodium Bicarbonate Hydratation Fluids Commonly Used With High-Dose Methotrexate Chemotherapy. Joiner L, Ynes C, Arnold J, Miller R, Gorman G.	2018
4070	Journal Hosp Pharm 2018 ;53, 2: 73-74.	Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags. DeAngelis M, Ferrara A, Gregory K, Zammit K, Zhao F.	2018
4122	Journal Hosp Pharm 2018 ;54,3:190?196	Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion. Fawaz S, Barton S, Whitney L, Swinden J, Nabhani-Gebara S.	2018
4131	Journal Hosp Pharm 2019 ;54,1:32-36.	Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine. Fleming K, Donnelly R.	2019
4185	Journal Hosp Pharm 2019 ; 54, 5: 330-334.	Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures : A New Look at an Old Drug. Sabins D, Diep T, McCartan P, Patel S, Zhao F	2019
4319	Journal Hosp Pharm 2020 ; 55, 5: 332-337.	Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.	2020
4360	Journal Hosp Pharm 2019	Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients. Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli.	2019
4569	Journal Hosp Pharm 2021 ; 56, 4: 282-286.	Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications. Lee T.M , Villareal C.L, Meyer L.M.	2021
4602	Journal Hosp Pharm 2021 ; 56, 4: 215-220.	Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting. Buga I, Uzoma J.I, Reindel K, Rashid K, Diep T, McCartan P, Zhao F.	2021
4603	Journal Hosp Pharm 2021 ; 56, 4: 228-234.	Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.	2021
4640	Journal Hosp Pharm 2021 ; 56, 5: 507–512.	Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Huskey M, Lewis P, Brown S.D.	2021
4681	Journal Hosp Pharm 2022 ; 57, 1: 69-75.	An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding. Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F.	2022
4690	Journal Hosp Pharm 2022 ; 57, 2: 294-299.	Stability of Compounded Digoxin Solution 0.05mg/mL for Injection. Friciu M, Marcelin R.B, Bédard P, Forest J.M, Leclair G.	2022
1300	Journal Hosp Pharm Pract 1992 ; 2: 285-289.	The stability of drugs in pre-filled syringes: flucloxacillin, ampicillin, cefuroxime, cefotaxime and ceftazidime. Ahmed ST, Parkinson R.	1992
1301	Journal Hosp Pharm Pract 1992 ; 2: 59-62.	The stability of reconstituted diethanolamine fusidate in a 5% dextrose infusion. McLaughlin JP, Simpson C.	1992
1494	Journal Hosp Pharm Pract 1993 ; 3: 553-556.	When is flucloxacillin stable ? McLaughlin JP, Simpson C.	1993
1968	Journal Hosp Pharm Pract 1992 ; 2, 9: 597-600.	Stability of morphine and droperidol separately and combined, for use as an infusion. Williams OA, Middleton M, Henderson P, Reilly CS.	1992
2125	Journal Hospital Pharmacist 2003 ; 10: 354-361.	Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration. Gardiner PR.	2003
2331	Journal Hospital Pharmacy Europe 2009 ; 42 : 30-31.	Stability of 5-fluorouracil and sodium folinate admixture. Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.	2009
1859	Journal Il Farmaco 2002 ; 57: 925-930.	Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G.	2002
2263	Journal Il Farmaco 2005 ; 60: 599-603.	Stability of aztreonam in AZACTAM. Zajac M, Jelinska A, Cielecka-Piontek J, Osqczapowicz I.	2005
4492	Journal Int J Antimicrob Agents 2020	Preparation and physicochemical stability of 50 mg/ml hydroxychloroquine oral suspension in Syrspend pH4 dry. Binson G, Venisse N , Sauvaget A , Bacle A , Lazaro P , Dupuis A.	2020
4671	Journal Int J Antimicrob Agents 2020 ; 56: 106083.	Voriconazole topical cream formulation: evidence for stability and antifungal activity. Bouchand C, Nguyen D, Secretan P-H, Vidal F, Guery R, Auvity S, Cohen J.F, Lanternier	2020
2790	Journal Int J COPD 2007 ; 1, 4: 599-607.	Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Kamin W, Schwabe A, Krämer I.	2007
2308	Journal Int J Obstet Anesth 2005 ; 14, 4: 284-287.	Stability of premixed syringes of diamorphine and hyperbaric bupivacaine. Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M.	2005
1667	Journal Int J Pharm 1996 ; 138: 125-128.	Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion. Vali?re C, Arnaud P, Caroff E, Dauphin JF, Cl?ment G, Brion F.	1996
1671	Journal Int J Pharm 1996 ; 139: 243-247.	Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay. Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC.	1996
1673	Journal Int J Pharm 1997 ; 154: 185-190.	Stability study of cefepime in different infusion solutions. Rabouan-Guyon M, Guet AF, Courtois PY, Barthes DMC.	1997
1676	Journal Int J Pharm 1997 ; 154: 95-102.	Compatibility of granisetron towards glass and plastics and its stability under various storage conditions. Hourcade F, Sautou-Miranda V, Normand B, Laugier M, Picq F, Chopineau J.	1997
1678	Journal Int J Pharm 1997 ; 153: 13-24.	Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine. Sitaram BR, Tsui M, Rawicki HB, Lam S, Sitaram M.	1997
1679	Journal Int J Pharm 2001 ; 212: 93-99.	Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes. Micard S, Rieutord A, Prognon P, Hassan M, Brion F.	2001
110	Journal Int J Pharm 1989 ; 54: 181-189.	Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers. Vincke BJ, Verstraeten AE, El Eini DID, Mc Carthy TM.	1989
167	Journal Int J Pharm 1994 ; 103: 87-92.	Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters. Francomb MM, Ford JL, Lee MG.	1994
525	Journal Int J Pharm 1990 ; 65: 49-56.	A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. De Vroe C, De Muynck C, Remon JP, Samsom M.	1990
162	Journal Int J Pharm 1994 ; 105: 83-87.	Compatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixtures. Benaji B, Dine T, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Gressier B, Cazin M, Cazin JC.	1994
165	Journal Int J Pharm 1994 ; 105: 89-93.	Leaching of diethylhexyl phthlate from PVC bags into intravenous teniposide solution. Faouzi MA, Dine T, Luyckx M, Gressier B, Goudaliez F, Mallevais ML, Brunet C, Cazin M, Cazin JC.	1994
22	Journal Int J Pharm 1991 ; 72: 57-63.	The chemical and physical stability of three intravenous infusions subjected to frozen storage and microwave thawing. Sewell GJ, Palmer AJ.	1991
38	Journal Int J Pharm 1996 ; 127: 65-71.	The extraction of diethylhexylphtalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection. Allwood MC, Martin HJ.	1996
144	Journal Int J Pharm 1991 ; 77: 279-285.	Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags. Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.	1991
166	Journal Int J Pharm 1994 ; 101: 257-262.	Stability and compatibility study of carboplatin with three portable infusion pump reservoirs. Rochard E, Barthes D, Courtois P.	1994
829	Journal Int J Pharm 1988 ; 42: 41-46.	Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets. Cartwright-Shamoon JM, McElnay JC, D'Arcy PF.	1988
835	Journal Int J Pharm 1979 ; 4: 21-26.	Determination of the stability of mitomycin C by high performance liquid chromatography. Edwards D, Selkirk AB, Taylor RB.	1979
1062	Journal Int J Pharm 1997 ; 146: 213-223.	The stability of morphine and the stability of concentrated morphine solutions in glass, polypropylene syringes and PVC containers. Vermeire A, Remon JP.	1997
1153	Journal Int J Pharm 1992 ; 80: R7-R9.	The influence of buffering on the stability of erythromycin injection in small-volume infusions. Allwood MC.	1992
1154	Journal Int J Pharm 1990 ; 62: R1-R3.	The stability of erythromycin injection in small-volume infusions. Allwood MC.	1990
1155	Journal Int J Pharm 1988 ; 45: 237-244.	Stability of methotrexate injection in prefilled plastic disposable syringes. Wright MP, Newton JM.	1988
1157	Journal Int J Pharm 1988 ; 43: 131-138.	Degradation kinetics of vinblastine sulphate in aqueous solutions. Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM.	1988
1158	Journal Int J Pharm 1988 ; 47: 239-247.	Stability of methotrexate and vinblastine in burette administration sets. McElnay JC, Elliott DS, Cartwright-Shamoon J, D?Arcy PF.	1988
1160	Journal Int J Pharm 1986 ; 32: 123-131.	Aspects of the degradation kinetics of doxorubicin in aqueous solution. Beijnen JH, van der Houwen OAGJ, Underberg WJM.	1986
1161	Journal Int J Pharm 1987 ; 39: 183-188.	Sorption of parenteral nitrates during administration with a syringe pump and extension set. Allwood MC.	1987
1165	Journal Int J Pharm 1980 ; 4: 263-265.	Compatibility of the cephalosporin, cefamandole nafate with injections. Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.	1980
1166	Journal Int J Pharm 1980 ; 6: 63-76.	Rapid adsorptive loss of nitroglycerin from aqueous solution to plastic. Sokoloski TD, Wu CC, Burkman AM.	1980
1467	Journal Int J Pharm 1995 ; 118: 181-189.	Stability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pump. Sitaram BR, Tsui M, Rawicki HB, Lam S, Courage P, Sitaram M, Chapman CB.	1995
1468	Journal Int J Pharm 1994 ; 107: 111-119.	Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin. Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F.	1994
1469	Journal Int J Pharm 1996 ; 128: 283-286.	Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days. Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F.	1996
1472	Journal Int J Pharm 1994 ; 110: 197-201.	Sorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags). Salomies HEM, Heinonen RM, Toppila MAI.	1994
1501	Journal Int J Pharm 1999 ; 185: 113-121.	Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.	1999
1860	Journal Int J Pharm 1996 ; 130: 251-255.	Compatibility of propofol diluted in 5% glucose with glass and plastics (polypropylene, molyvinylchloride) containers. Sautou-Miranda V, Levadoux E, Groueix MT, Chopineau J.	1996
1861	Journal Int J Pharm 1996 ; 127: 255-259.	Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture. Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J.	1996
1865	Journal Int J Pharm 1999 ; 178: 77-82.	Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions. Sautou-Miranda V, Brigas F, Vanheerswinghels S, Chopineau J.	1999
1866	Journal Int J Pharm 1998 ; 174: 157-177.	Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone. Vermeire A, Remon JP.	1998
1871	Journal Int J Pharm 2002 ; 234: 205-212.	Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions. Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.	2002
1887	Journal Int J Pharm 1995 ; 123: 229-235.	Photochemical decomposition of midazolam. IV . Study of pH dependant stability by high-performance liquid chromatography. Andersin R, Tammilehto S.	1995
1889	Journal Int J Pharm 2015 ; 492 : 137?140.	Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes. Briota Th, Vrignaud S, Lagarce F.	2015
1961	Journal Int J Pharm 2005 ; 293: 303-310.	Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles. Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC.	2005
2055	Journal Int J Pharm 2006 ; 307: 278-284.	Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients. Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E.	2006
2151	Journal Int J Pharm 1995 ; 115: 113-117.	Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F.	1995
2242	Journal Int J Pharm 1998 ; 167, 1-2: 223-228.	A note on the solution chemistry of carboplatin in aqueous solutions. Lederer M, Leipzig-Pagani E.	1998
2243	Journal Int J Pharm 1997 ; 146: 263-269.	Degradation pathway of carboplatin in aqueous solution. Pujol M, Girona V, Prat J, Munoz M, De Bolos J.	1997
2245	Journal Int J Pharm 1996 ; 129: 275-277.	Stability of carboplatin in 5% glucose solution exposed to light. Torres F, Girona V, Puiol M, Prat J, de Bolos J.	1996
2275	Journal Int J Pharm 1998 ; 173: 221-232.	Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers. Craig Dyar S, Notari RE.	1998
2304	Journal Int J Pharm 2005 304; 1-2: 135-144.	The development and stability assessment of extemporaneous pediatric formulations of Accupril. Freed A.L, Silbering S.B, Kolodsick K.J, Rossi D, Mahjour M, Kingsmill C.A.	2005
2324	Journal Int J Pharm 2009 ; 369, 1-2 : 30-37	Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application Treleano A, Wolz G, Brandsch R, Welle F.	2009
2642	Journal Int J Pharm 1982 ; 11, 4: 329-336.	Factors affecting captopril stability in aqueous solution Timmins P, Jackson IM, Yu-chang John Wang.	1982
2647	Journal Int J Pharm 1998 ; 51, 2: 157-160.	Stability of loperamide hydrochloride in aqueous solutions as determined by high performance liquid chromatography Tu YH, Allen LV, Wang DP.	1998
2648	Journal Int J Pharm 1999 ; 190, 1: 103-107.	Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone Rieutord A, Arnaud P, Dauphin JF, Brion F.	1999
2649	Journal Int J Pharm 2002 ; 234, 1-2: 205-212.	Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions. Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.	2002
2654	Journal Int J Pharm 2007 ; 344, 1-2: 150-153.	Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F.	2007
2655	Journal Int J Pharm 2008 ; 353, 1-2: 1-7.	Invitro release and stability of an artesunate rectal gel suitable for pediatric use. Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AML, Dubost JP, Millet P, Fawaz F.	2008
2783	Journal Int J Pharm 2015 ; 486; 1-2: 367-369.	Stability of colistimethate sodium in a disposable elastomeric infusion device. Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P.	2015
2791	Journal Int J Pharm 2015 ; 479 : 23-27.	Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy. Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J.	2015
2865	Journal Int J Pharm 2001 ; 223: 49-54.	Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel Gebauer MG, McClure AF, Vlahakis TL.	2001
2884	Journal Int J Pharm 2015 ; 487 : 270-273.	Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F.	2015
3074	Journal Int J Pharm 2008 ; 362: 67-73.	Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use. Ritschel WA, Ye W, Buhse L, Reepmeyer JC.	2008
3319	Journal Int J Pharm 2012 ; 433, 1-2 : 119-120.	Development and validation of a paediatric oral formulation of clonidine hydrochloride de Goede A.L, Boedhram R.R, Eckhardt M, Hanff L.M, Koch B.C.P, Vermaat C.H, Vermes A.	2012
3323	Journal Int J Pharm 2012 ; 436, 1-2: 282-290.	Long-term stability of diluted solutions of the monoclonal antibody rituximab. Paul M, Vieillard V, Jaccoulet E, Astier A.	2012
3361	Journal Int J Pharm 2012 ; 423: 360-364.	Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide. Santovena A, Hernandez-Paiz Z, Farina J.B.	2012
3386	Journal Int J Pharm 2013 ; 448: 101-104.	Long-term physico-chemical stability of diluted trastuzumab. Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A.	2013
3390	Journal Int J Pharm 1993 ; 99: 73-78.	Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution. Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M.	1993
3473	Journal Int J Pharm 2015 ; 495, 2: 956-962.	Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.	2015
3743	Journal Int J Pharm 1991 ; 69: 197-210.	The degradation of carboplatin in aqueous solutions containing chloride or other selected nucleophiles. Allsopp M.A, Sewell G.J, Rowland C.G, Riley C.M, Schowen R.L.	1991
3782	Journal Int J Pharm 2014 , 477, 1-2 : 32-38.	Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a	2014
3885	Journal Int J Pharm 2016 ; 506 : 414-419.	Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method. Su-Eon Jin, Siwon You, Seungho Jeon, Sung-Joo Hwang.	2016
3992	Journal Int J Pharm 2016 ; 509 : 279:284.	Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas. Bougueon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S.	2016
3349	Journal Int J Pharm Bio Sci 2012 ; 2, 3: 344-350.	Chemical stability of bortezomib solutions in original manufacturer vials. Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M.	2012
3418	Journal Int J Pharm Bio Sci 2013 ; 3, 1: 449-458.	Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C. Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C	2013
1315	Journal Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 294-297.	Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection. Halpern NA, Colucci RD, Alicea M, Greenstein R.	1989
1490	Journal Int J Pharm Clin Pharmacol Ther Tox 1989 ; 27: 250-254.	The compatibility of nicardipine hydrochloride injection with various ICU medications during simulated Y-site injection. Halpern NA, Colucci RD, Alicea M, Greenstein R.	1989
1608	Journal Int J Pharm Compound 2001 ; 5: 397-400.	Assessment of the stability of teicoplanin in intravenous infusions. Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.	2001
1625	Journal Int J Pharm Compound 2001 ; 5: 314-321.	Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Trissel LA, Saenz C, Williams YW, Ingram D.	2001
1626	Journal Int J Pharm Compound 2001 ; 5: 151-152.	Stability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Ling J, Das Gupta V.	2001
1627	Journal Int J Pharm Compound 2001 ; 5: 148-150.	Chemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes. Das Gupta V.	2001
1628	Journal Int J Pharm Compound 2001 ; 5: 482-484.	Stability of pentobarbital sodium after reconstitution in 0.9% sodium chloride injection and repackaging in glass and polypropylene syringes. Das Gupta V.	2001
1631	Journal Int J Pharm Compound 2008 ; 12, 4: 372-374.	Chemical stability of perphenazine in two commercially available vehicles for oral liquid dosage forms Gupta VD.	2008
1648	Journal Int J Pharm Compound 2002 ; 6: 391-394.	Effect of freezing, long-term storage, and microwave thawing on the stability of cefepime in 5% dextrose infusion polyvinyl chloride bags. Schlesser V, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti LM.	2002
1675	Journal Int J Pharm Compound 2002 ; 6, 2: 155-157.	Stability of 4-Aminopyridine and 3,4-Diaminopyridine oral capsules Trissel LA, Zhang Y, Xu QA.	2002
1680	Journal Int J Pharm Compound 2002 ; 6: 468-470.	Chemical stability of furosemide in minibags and polypropylene syringes. Donnelly RF.	2002
1682	Journal Int J Pharm Compound 2002 ; 6: 475-477.	Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes. Storms M, Stewart JT, Warren FW.	2002
1701	Journal Int J Pharm Compound 2002 ; 6: 395-397.	Chemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes. Gupta VD.	2002
1704	Journal Int J Pharm Compound 2002 ; 6: 152-154.	Stability of gentamicin sulfate and tobramycin sulfate in autodose infusion system bags. Xu QA, Trissel LA, Saenz A.	2002
1705	Journal Int J Pharm Compound 2002 ; 6: 226-229.	Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags. Zhang Y, Trissel LA.	2002
1706	Journal Int J Pharm Compound 2002 ; 6: 74-76.	Physical and chemical stability of hydromorphone hydrochloride 1.5 and 80 mg/ml packaged in plastic syringes. Trissel LA, Xu QA.	2002
1707	Journal Int J Pharm Compound 2002 ; 6: 70-73.	Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes. Trissel LA, Xu QA, Pham L.	2002
1708	Journal Int J Pharm Compound 2002 ; 6: 66-69.	Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes. Xu QA, Trissel LA, Pham L.	2002
1709	Journal Int J Pharm Compound 2002 ; 6: 62-65.	Physical and chemical stability of morphine sulfate 5 mg/ml and 50 mg/ml packaged in plastic syringes. Trissel LA, Xu QA.	2002
1711	Journal Int J Pharm Compound 2002 ; 6: 234-236.	Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Das Gupta V.	2002
1712	Journal Int J Pharm Compound 2002 ; 6: 230-233.	Compatibility screening of Precedex during simulated Y-site administration with other drugs. Trissel LA, Saenz CA.	2002
1713	Journal Int J Pharm Compound 2002 ; 6: 311-315.	Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Trissel LA, Saenz CA.	2002
1714	Journal Int J Pharm Compound 2002 ; 6: 316-317.	Stability of ketamine hydrochloride injection after reconstitution in water for injection and storage in 1-ml tuberculin polypropylene syringes for pediatric use. Gupta VD.	2002
1715	Journal Int J Pharm Compound 2002 ; 6: 388-390.	Stability of lidocaine hydrochloride injection at ambient temperature and 4°C in polypropylene syringes. Storms ML, Stewart JT, Warren FW.	2002
1716	Journal Int J Pharm Compound 2001 ; 5: 73-75.	Stability of ethacrynate sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Ling J, Das Gupta V.	2001
1717	Journal Int J Pharm Compound 2001 ; 5: 75-77.	Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Ling J, Das Gupta V.	2001
1718	Journal Int J Pharm Compound 2001 ; 5: 230-231.	Stability of piperacillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Das Gupta V, Ling J.	2001
1720	Journal Int J Pharm Compound 2001 ; 5: 394-396.	Stability of ephedrine sulfate at ambient temperature and 4°C in polypropylene syringes. Storms ML, Stewart JT, Warren FW.	2001
1721	Journal Int J Pharm Compound 2001 ; 5: 69-72.	Compatibility screening of Hextend during simulated Y-site administration with other drugs. Trissel LA, Williams KY, Baker MB.	2001
1740	Journal Int J Pharm Compound 1998 ; 2, 4: 314-317.	Stability of ciprofloxacin in an extemporaneous oral liquid dosage form. Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V.	1998
1748	Journal Int J Pharm Compound 1997 ; 1: 354-355.	Compatibility of vancomycin hydrochloride and famotidine in 5% dextrose injection. Wang DP, Wang MT, Wong CY, Lee DKT.	1997
1750	Journal Int J Pharm Compound 1998 ; 2: 463-465.	Chemical stability of meperidine hydrochloride in polypropylene syringes. Donelly RF, Bushfield TL.	1998
1752	Journal Int J Pharm Compound 1998 ; 2: 466-468.	Stability of sufentanil in a syringe pump under simulated epidural infusion. Jäppinen AL, Hokki H, Rasi AS, Naaranlathi TJ.	1998
1753	Journal Int J Pharm Compound 1999 ; 3: 412-414.	Stability of dobutamine hydrochloride 4 mg/ml in 5% dextrose injection at 5 and 23°C. Webster AA, English BA, McGuire JM, Riggs RM, Lander V, Buckle T.	1999
1754	Journal Int J Pharm Compound 1999 ; 3: 241-244.	Compatibility of docetaxel with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Wolkin AC.	1999
1755	Journal Int J Pharm Compound 2003 ; 7: 68-70.	Stability of succinylcholine chloride injection at ambient temperature and 4°C in polypropylene syringes. Storms ML, Stewart JT, Warren FW.	2003
1756	Journal Int J Pharm Compound 2003 ; 7: 65-67.	Stability of glycopyrrolate injection at ambient temperature and 4°C in polypropylene syringes. Storms ML, Stewart JT, Flynn WW.	2003
451	Journal Int J Pharm Compound 1997 ; 1: 206-207.	Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections. Das Gupta V, Maswoswe J, Bailey RE.	1997
549	Journal Int J Pharm Compound 1997 ; 1: 121-122.	Compatibility of common respiratory therapy drug combinations. Owsley HD, Rusho WJ.	1997
550	Journal Int J Pharm Compound 1997 ; 1: 132-134.	Stability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection. Zhang YP, Trissel LA.	1997
552	Journal Int J Pharm Compound 1997 ; 1: 356-358.	Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions. Martinez JF, Trissel LA, Gilbert DL.	1997
647	Journal Int J Pharm Compound 1997 ; 1: 347-348.	Chemical stability of amiodarone hydrochloride in intravenous fluids. Pramar YV.	1997
648	Journal Int J Pharm Compound 1997 ; 1: 282-283.	Stability of mitomycin aqueous solution when stored in tuberculin syringes. Das Gupta V.	1997
649	Journal Int J Pharm Compound 1997 ; 1: 280-281.	Stability of ceftriaxone sodium when mixed with metronidazole injection. Das Gupta V.	1997
650	Journal Int J Pharm Compound 1997 ; 1: 274-277.	Development of clonidine hydrochloride injections for epidural and intrathecal administration. Trissel LA, Hassenbusch SJ.	1997
652	Journal Int J Pharm Compound 1997 ; 1: 208-209.	Stability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injection. Das Gupta V, Maswoswe J, Bailey R.E, County H.	1997
653	Journal Int J Pharm Compound 1997 ; 1: 125-127.	Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture. Das Gupta V.	1997
654	Journal Int J Pharm Compound 1997 ; 1: 123-124.	Stability of vancomycin hydrochloride in Medication Cassette* reservoirs. Allen LV.	1997
665	Journal Int J Pharm Compound 2005 ; 9, 4: 323-326.	Stability of Nebulizer Admixtures. Blondino, FE, Baker M.	2005
865	Journal Int J Pharm Compound 1998 ; 2: 79-81.	Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion. Bhatt-Mehta V, Hirata S.	1998
873	Journal Int J Pharm Compound 1997 ; 1: 435-436.	Stability of cefepime hydrochloride dextrose in 5% dextrose injection and 0.9% sodium chloride injection. Das Gupta V, Maswoswe J, Bailey RE.	1997
874	Journal Int J Pharm Compound 1997 ; 1: 433-434.	Stability of two concentrations of heparin sodium prefilled in CADD-Micro pump syringes. Stiles ML, Allen LV, Mc Laury HJ.	1997
922	Journal Int J Pharm Compound 1998 ; 2: 168-169.	Stability of milrinone lactate 200 microg /mL in 5% dextrose injection and 0.9% sodium chloride injection. Wong F, Gill MA.	1998
923	Journal Int J Pharm Compound 1998 ; 2: 170-171.	Stability of indomethacin in 0.9% sodium chloride injection. Das Gupta V, Maswoswe J.	1998
928	Journal Int J Pharm Compound 1998 ; 2: 246-248.	Stability of milrinone lactate in 5% dextrose injection and 0.9% sodium chloride injection at concentrations of 400, 600 and 800 microg/mL. Nguyen D, Gill MA, Wong F.	1998
934	Journal Int J Pharm Compound 1998 ; 2: 318-321.	Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration. Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M.	1998
935	Journal Int J Pharm Compound 1998 ; 2: 322-324.	Stability of lorazepam in 5% dextrose injection. Das Gupta V, Pramar Y.	1998
1372	Journal Int J Pharm Compound 2007 ; 11, 1: 79-81.	Chemical Stability of Desonide in Ear Drops. Gupta,VD.	2007
1412	Journal Int J Pharm Compound 1999 ; 3: 64-66.	Y-site stability of fosphenytoin and sodium phenobarbital. Brett A, Riggs RM, Webster AA, Benner KW.	1999
1413	Journal Int J Pharm Compound 1999 ; 3: 67-68.	Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature. Lieu CL, Chin A, Gill MA.	1999
1419	Journal Int J Pharm Compound 1999 ; 3: 235-238.	Fosphenytoin Y-site stability studies with lorazepam and midazolam hydrochloride. Riggs RM, English BA, Webster AA, McGuire JM, Riordan JM.	1999
1812	Journal Int J Pharm Compound 2000 ; 4, 4: 320-323.	Stability of 5-fluorouracil in an extemporaneously compounded ophtalmic solution. Fuhrman LC, Godwin DA, Davis RA.	2000
1813	Journal Int J Pharm Compound 2003 ; 7, 4: 310-312.	Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Gupta VD.	2003
1814	Journal Int J Pharm Compound 2003 ; 7, 2: 152-154.	Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene suyringes for padiatric use. Gupta VD.	2003
1815	Journal Int J Pharm Compound 2003 ; 7, 2: 149-151.	Stability of clindamycin phosphate in autodose infusion system bags. Xu QA, Trissel LA.	2003
1816	Journal Int J Pharm Compound 2003 ; 7, 3: 230-232.	Stability of amikacin sulfate in autodose infusion system bags. Zhang Y, Trissel LA.	2003
1878	Journal Int J Pharm Compound 2004 ; 8, 1: 73-76.	Stability of zidovudine and dobutamine hydrochloride injections in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23±2°C) and 4°C in 50 ml polyvinyl chloride bags up to 24 hours. Musami P, Stewart JT, Will Taylor E.	2004
1891	Journal Int J Pharm Compound 2004 ; 8, 2: 153-155.	Chemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusion. Gupta VD.	2004
1892	Journal Int J Pharm Compound 2004 ; 8, 2: 156-159.	Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags. Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM.	2004
1898	Journal Int J Pharm Compound 2004 ; 8, 3: 228-230.	Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirs. Xu QA, Trissel LA, Pham L.	2004
1899	Journal Int J Pharm Compound 2004 ; 8, 3: 231-235.	Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Trissel LA, Zhang Y.	2004
1900	Journal Int J Pharm Compound 2004 ; 8, 3: 236-239.	Stability of zidovudine and ranitidine in 0.9% sodium chloride and 5% dextrose injections stored at ambient temperature (23°C±2°C) and 4°C in 50 ml polyvinylchloride bags up to 24 hours. Musami P, Stewart JT, Taylor EW.	2004
1932	Journal Int J Pharm Compound 2004 ; 8,5: 398-403.	Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate. Trissel LA, Zhang Y.	2004
1933	Journal Int J Pharm Compound 2004 ; 8, 5: 404-406.	Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags. Gupta VD.	2004
1957	Journal Int J Pharm Compound 2005 ; 9, 1: 72-74.	Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature. Gupta VD.	2005
1975	Journal Int J Pharm Compound 2005 ; 9, 3: 235-237.	Physical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration. Trissel LA, Xu QA.	2005
1976	Journal Int J Pharm Compound 2005 ; 9, 3: 238-241.	Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration. Trissel LA, Xu QA.	2005
2009	Journal Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.	Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Trissel LA, Zhang Y.	2005
2031	Journal Int J Pharm Compound 2005 ; 9: 482-483.	Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags. Donnelly RF.	2005
4251	Journal Int J Pharm Compound 2019 ;23,2:157-162	Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base, SuspendIt. Pramar YV, Mandal TK, Bostanian LA, Nguyen ATQ, Morris TC, Graves RA.	2019
2054	Journal Int J Pharm Compound 2015 ; 19, 4 : 337-339.	Stability of Prednisone in Oral Mix Suspending Vehicle. Friciu M, Plourde K, Leclair G, Danapoulos P, Savji T.	2015
2064	Journal Int J Pharm Compound 2006 ; 10: 69-73.	Stability of morphine sulfate in polypropylene infusion bags for use in patient-controlled analgesia pumps for postoperative pain management. Nguyen-Xuan Tho, Griffiths W, Kern C, Van Gessel E, Bonnabry P.	2006
4252	Journal Int J Pharm Compound 2019 ;23,2:163-166	Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit. Lardinois B, Dimitriou A, Delcave C, Jamart J, Bihin B, Soumoy L, Hecq JD, Galanti LM.	2019
2097	Journal Int J Pharm Compound 2006 ; 10: 156-158.	Extended stability of oxytocin in common infusion solutions. Trissel LA, Zhang Y, Douglass K, Kastango E.	2006
2107	Journal Int J Pharm Compound 2006 ; 10: 234-236.	Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration. Trissel LA, Zhang Y, Xu QA.	2006
2108	Journal Int J Pharm Compound 2006 ; 10: 230-232.	Compatibility of micafungin injection with other drugs during simulated Y-site co-administration. Trusley C, Kupiec TC, Trissel LA.	2006
2132	Journal Int J Pharm Compound 2015 ; 19, 4 : 344-347.	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes. Anderson Collin R, Halford Zachery, MacKay Mark.	2015
2179	Journal Int J Pharm Compound 2007 ; 11, 1: 82-85.	Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration. Trusley C, Ben M, Kupiec TC, Trissel LA.	2007
2214	Journal Int J Pharm Compound 2007 ; 11, 6: 520-524.	Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration. Ben M, Trusley C,Kupiec T.C, Trissel L.A.	2007
2227	Journal Int J Pharm Compound 2008 ; 12, 2: 156-160.	Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration. Trusley C, Ben M, Kupiec TC, Trissel LA.	2008
2228	Journal Int J Pharm Compound 2008 ; 12,2: 170-173.	Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration. Kupiec T, Ben M, Trusley C, Trissel LA.	2008
2247	Journal Int J Pharm Compound 2008 ; 12, 3: 276-278.	Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Chan P, Heatherly K, Kupiec T.C, Trissel L.A.	2008
2250	Journal Int J Pharm Compound 2008 ; 12, 6: 558-564.	Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System. Vu N.T, Aloumanis V, Ben MJ, Kupiec T.C, Patterson E K, Radke J, Erickson M A III, Schneider G.	2008
2280	Journal Int J Pharm Compound 2008 ; 12, 5: 463-466.	Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration. Shields DE, Aclan J, Szatkowski A.	2008
2281	Journal Int J Pharm Compound 2008 ; 12, 5: 460-462.	Compatibility and stability of palonosetron hydrochloride with lactated Ringer's, Hetastarch in lactated electrolyte, an mannitol injections during simulated Y-site administration. Ben M, Kupiec T, Trusley C, Trisel LA.	2008
2286	Journal Int J Pharm Compound 2008 ; 12, 4: 368-371.	Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Ben M, Trusley C, Kupiec TC, Trissel LA.	2008
2297	Journal Int J Pharm Compound 2008 ; 11, 6: 550-552	Physical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/ml) for use as an antidote in nerve agent casualties. Donnelly R.F, Corman C.	2008
2298	Journal Int J Pharm Compound 2008 ; 12, 6: 553-557.	Chemical stability of admixtures containing ziconotide 25 mcg/ml and morphine sulfate 10 mg/ml or 20 mg/ml during simulated intrathecal administration. Shields D.E, Aclan J, Szatkowski A.	2008
2312	Journal Int J Pharm Compound 2009 ; 13, 1: 78-80.	Compatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administration. Trissel L.A, Trusley C, Kupiec T.C, Ben M.	2009
2350	Journal Int J Pharm Compound 2000 ; 4, 3: 225-228.	Stability of morphine-ketamine in 0.9% sodium chloride injection packaged in syringes, plastic bags and MEDICATION CASSETTE Reservoirs. Roy J.J, Hildgen P.	2000
2352	Journal Int J Pharm Compound 2000 ; 4, 6: 480-481.	Stability of nafcillin sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Ling J, Das Gupta V.	2000
2353	Journal Int J Pharm Compound 2000 ; 4, 6: 476-479.	Compatibility and stability of linezolid injection admixted with gentamicin sulfate and tobramycin sulfate. Xu Q.A, Trissel L.A, Zhang Y, Williams K.Y.	2000
2354	Journal Int J Pharm Compound 2000 ; 4, 5: 396-397.	Stability of hydrocortisone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Das Gupta V, Ling J.	2000
2355	Journal Int J Pharm Compound 2000 ; 4, 2: 150-153.	Stability of ranitidine hydrochloride with cefazolin sodium, cefbuperazone sodium, cefoxitin sodium nd cephalotin sodium during simulated Y-site administration. Inagaki K, Miyamoto Y, Kurata N, Nakane S, Gill M.A, Nishida M.	2000
2356	Journal Int J Pharm Compound 1998 ; 2, 5: 385-388.	Stability of magnesium sulfate in 0.9% sodium chloride and lactated Ringers solutions. Sarver J.G, Pryka R, Alexander K.S, Weinstein L, Erhardt P.W.	1998
2358	Journal Int J Pharm Compound 2000 ; 4, 6: 482-483.	Stability of levothyroxine sodium injection in polypropylene syringes. Das Gupta V.	2000
2360	Journal Int J Pharm Compound 2008 ; 12, 1: 83-85.	Room temperature stability of injectable succinylcholine dichloride. Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.	2008
2367	Journal Int J Pharm Compound 2005 ; 9, 5: 399-401.	Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion. Gupta V.D.	2005
2530	Journal Int J Pharm Compound 2022 ;26,4:330-335	Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes. Bartoll A, Bellés Medall M, Peñarrocha J, Escrig L, Clemente R, Azuara J.	2022
2657	Journal Int J Pharm Compound 1997 : 60-63.	Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets. Alexander KS, Kothapalli MR, Dollimor D.	1997
2659	Journal Int J Pharm Compound 2010 ; 14, 2: 160-164.	Chemical stability of hydromorphone hydrochloride in patient-controlled analgesia injector. Khondkar D, Chopra P, McArter JP, Rosen JA, Li SK.	2010
2663	Journal Int J Pharm Compound 1997 ; 1: 200-205.	The formulation development and stability of metronidazole suspension. Alexander KS, Vangala SSKS, Dollimore D.	1997
2665	Journal Int J Pharm Compound 1997 ; 1: 352-353.	The stability of lisinopril as an extemporaneous syrup. Webster AA, English BA, Rose DJ.	1997
2668	Journal Int J Pharm Compound 1998 ; 2: 89-91.	Stability of mechlorethamine hydrochloride 0.01% ointment in Aquafor Base. Zhang Y, Trissel LA, Johansen JF, Kimball CL.	1998
2670	Journal Int J Pharm Compound 1998 ; 2: 394-396.	Stability of albuterol in continuous nebulization. Hunter DA, Yoo SD, Fox JL.	1998
2676	Journal Int J Pharm Compound 1998 ; 2: 314-317.	Stability of ciprofloxacin in an extemporaneous oral liquid dosage form. Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V.	1998
2678	Journal Int J Pharm Compound 2000 ; 4: 69-71.	Naratriptan hydrochloride in extemporaneously compounded oral suspensions. Zhang YP, Trissel LA, Fox JL.	2000
2680	Journal Int J Pharm Compound 2000 : 398-399.	Stability of lisinopril syrup (2 mg/ml) extemporaneously compounded from tablets. Rose DJ, Webster AA, English BA.	2000
2695	Journal Int J Pharm Compound 2015 ; 19, 3: 248-251.	Stability of Metronidazole Suspensions. Donnelly Ronald F, Ying James.	2015
2808	Journal Int J Pharm Compound 2015 ; 19, 3: 268-270.	Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles. Dewulf J, Hecq J.D, Huvelle S, Godet M, Gillet P, Jamart J, Galanti L.M.	2015
2825	Journal Int J Pharm Compound 2015 ; 19, 3: 261-267.	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials. Mueller C, Dietel E, Heynen S, Nalenz H, Goldbach P, Mahler H, Schmidt J, Grauschopf U, Schoenhammer K.	2015
2833	Journal Int J Pharm Compound 2001 ; 5, 6: 480-481.	Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets Das Gupta V.	2001
2834	Journal Int J Pharm Compound 2003 ; 7, 5: 386-388.	Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared With the Use of Powder Das Gupta V.	2003
2835	Journal Int J Pharm Compound 2007 ; 11, 3: 259-261.	Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Das Gupta V.	2007
2836	Journal Int J Pharm Compound 2003 ; 7, 4: 313-319.	Stability of Hydralazine Hydrochloride in Both Flavored and Nonflavored Extemporaneous Preparations Okoka CC, Modwick T, Naira G, Khuspo S, Grady LT.	2003
2837	Journal Int J Pharm Compound 2005 ; 9, 2: 165-166.	Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Das Gupta V, Sood A.	2005
2842	Journal Int J Pharm Compound 2006 ; 10, 4: 316-317.	Stability of Memantine in an Extemporaneously Prepared Oral Liquid Yamreudeewong W, Teixeira MJ, Mayer GE.	2006
2843	Journal Int J Pharm Compound 2004 ; 8, 6: 489-491.	Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Donnelly R.	2004
2849	Journal Int J Pharm Compound 2005 ; 9, 6: 484-486.	Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Das Gupta V.	2005
2851	Journal Int J Pharm Compound 2005 ; 9, 1: 82-86.	Stability of An Extemporaneously Compounded Propylthiouracil Suspension Alexander KS, Mitra P.	2005
2852	Journal Int J Pharm Compound 2004 ; 8, 6: 486-488.	Stability of Extemporaneous Oral Ribavirin Liquid Preparation Chan JP, Tong HHY, Chow AHL.	2004
2854	Journal Int J Pharm Compound 1997 ; 1, 3: 195-199.	The Formulation Development and Stability of Spironolactone Suspension Alexander KS, Sundar S, White DB, Dollimore D.	1997
2855	Journal Int J Pharm Compound 2006 ; 10, 5: 396-399.	Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Trissel LA, Zhang Y, Koontz SE.	2006
2858	Journal Int J Pharm Compound 2003 ; 7, 6: 485-489.	Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension. Haase MR, Khan MA, Bonilla J.	2003
2867	Journal Int J Pharm Compound 1999 ; 3, 4: 316-320.	Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution. Peyron F, Elias R, Ibrahim E, Amirat-Combralier V, Bu?s-Charbit M, Balansard G.	1999
2868	Journal Int J Pharm Compound 2000 ; 4, 2: 146-149.	Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution. Kommanaboyina B, Lindauer RF, Rhodes CT, Grady LT.	2000
2872	Journal Int J Pharm Compound 2009 ; 13, 2: 170-174.	Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule. Haywood A, Burrell A, van Breda K, Testa C, Norris R.	2009
2876	Journal Int J Pharm Compound 2009 ; 13, 5: 438-439.	Chemical Stability of Scopolamine Hydrobromide Nasal Solution. Das Gupta V.	2009
2877	Journal Int J Pharm Compound 2009 ; 13, 5: 445-446.	Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms. Das Gupta V.	2009
2886	Journal Int J Pharm Compound 2009 ; 13, 3: 250-253.	Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding. Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S.	2009
3090	Journal Int J Pharm Compound 2010 ; 14, 1: 82-85.	Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution). Voudrie MA, Brett Allen D.	2010
3125	Journal Int J Pharm Compound 2010 ; 14, 4: 346-349.	Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin. Baker D S, Waldrop Bruce, Arnold John.	2010
3140	Journal Int J Pharm Compound 2010 ; 14, 5 : 436-439.	Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device. Tsiouris M, Ulmer M, Yurcho J F, Hooper K L, Gui M.	2010
3180	Journal Int J Pharm Compound 2011 ; 15, 1: 78-80.	Chemical stability of brompheniramine maleate in an oral liquid dosage form. Gupta VD, Gupta VS.	2011
3181	Journal Int J Pharm Compound 2011 ; 15, 1: 81-84.	Stability of venlafaxine immediate-release suspension. Donnelly RF, Wong K, Goddard R	2011
3206	Journal Int J Pharm Compound 2011 ; 15, 2: 166-169.	Nifedpine in Compounded Oral and Topical Preparations. McCluskey Susan V, Brunn Gregory J.	2011
3207	Journal Int J Pharm Compound 2011 ; 15, 2: 170-173.	Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes. McCluskey Susan V, Lovely Jenna K .	2011
3208	Journal Int J Pharm Compound 2011 ; 15, 3: 252-254.	Stability of Ertapenem in an Elastomeric Infusion Device. Phipps Stephen D, Peacock Gina F, Smith Douglas L .	2011
3209	Journal Int J Pharm Compound 2011 ; 15, 3: 255-258.	Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles. Voudrie Mark A, Alexander Bridget, Allen D Brett.	2011
3210	Journal Int J Pharm Compound 2011 ; 15, 3: 259-261.	Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations. Jasti Bhaskara R, Saraf Poonam.	2011
3277	Journal Int J Pharm Compound 2012 ; 16, 1 : 82-85.	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration. Yang Z, Cameron S, Paul H.	2012
3258	Journal Int J Pharm Compound 2011 ; 15, 6 : 515-520.	Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags. Kaiser J, Krämer I.	2011
3278	Journal Int J Pharm Compound 2012 ; 16, 1: 80-81.	Chemical Stability of Pentoxifylline in a Topical Cream. Gupta Vishnu D	2012
3302	Journal Int J Pharm Compound 2012 ; 16, 2 : 164-166.	Stability of Omeprazole in SyrSpend SF Alka (Reconstituted). Whaley P A, Voudrie M A, Sorenson B.	2012
3303	Journal Int J Pharm Compound 2012 ; 16, 2: 167-169.	Stability of Vancomycin in SyrSpend SF. Whaley P A, Voudrie M.	2012
3321	Journal Int J Pharm Compound 2012 ; 16, 4: 342-346.	Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets. Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa.	2012
3322	Journal Int J Pharm Compound 2012 ; 16, 4 : 347-349.	Stability of Gabapentin in SyrSpend SF. Sorenson B, Voudrie M, Gehrig D.	2012
3345	Journal Int J Pharm Compound 2012 ; 16, 5: 428-430.	Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date. Peacock G.F, Sauvageot J.	2012
3356	Journal Int J Pharm Compound 2012 ; 16, 6 : 513-515.	Stability of Propranolol Hydrochloride in SyrSpend SF. Geiger C M, Voudrie M A, Sorenson B.	2012
3403	Journal Int J Pharm Compound 2013 ; 17 ; 2 : 165-167.	Stability of Minoxidil in Espumil Foam Base Geiger C.M, Sorenson B, Whaley P.A.	2013
3404	Journal Int J Pharm Compound 2013 ; 17, 2 : 162-164.	Stability of Rifampin in SyrSpend SF Sorenson B, Whaley P	2013
3436	Journal Int J Pharm Compound 2013 ; 17, 4: 336-338.	Stability of Captopril in SyrSPend SF. Geiger C. M, Sorenson B, Whaley P. A.	2013
3437	Journal Int J Pharm Compound 2013 ; 17, 4: 344-346.	Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry. Geiger C.M, Sorenson B, Whaley P.A.	2013
3535	Journal Int J Pharm Compound 2013 ; 17, 6 : 508-511.	Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles McPherson T. B, Neumann W L, Kolling W M.	2013
3536	Journal Int J Pharm Compound 2013 ; 17, 6: 515-519	Stability of Nitroglycerin 100 mcg/mL Stored in Polypropylene Syringes McCluskey S V, Vu N, Rueter J.	2013
3572	Journal Int J Pharm Compound 2014 ; 18, 1 : 78-82.	Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C. Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L.	2014
3622	Journal Int J Pharm Compound 2014 ; 18, 2 : 152-158.	Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride. Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L.	2014
3624	Journal Int J Pharm Compound 2014 ; 18, 2 : 169-174.	Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu.	2014
3666	Journal Int J Pharm Compound 2014 ; 18, 3: 248-252.	Investigation of Physical and Chemical Stability of an Ointment with Herbals Zdoryk Oleksandr A,Khokhlova Kateryna O,Georgiyants Victoriya A,Vyshnevska Liliia I.	2014
3667	Journal Int J Pharm Compound 2014 ; 18, 3: 253-255.	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Peacock Gina F,Sauvageot Jurgita	2014
3754	Journal Int J Pharm Compound 2014 ;18, 5: 418-426.	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation. Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H.	2014
3755	Journal Int J Pharm Compound 2014 ; 18, 5: 427-431.	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition. Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.	2014
3756	Journal Int J Pharm Compound 2014 ; 18, 5: 423-437.	Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers. McCluskey S.V, Sztajnkrycer M.D, Jenkins D.A, Zietlow S P, Berns K.S, Park Myung S.	2014
3789	Journal Int J Pharm Compound 2015 ; 19, 1: 73-77.	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions. Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Do Nascimento Afonso V.	2015
3810	Journal Int J Pharm Compound 2015 ; 19, 5 : 420-427.	Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF. Geiger C M, Sorenson B, Whaley P.	2015
3811	Journal Int J Pharm Compound 2015 ; 19, 5 : 428-431.	Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures. Nahata Milap C.	2015
3812	Journal Int J Pharm Compound 2015 ; 19, 5 : 432-436.	In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers. Bhattacharya S, Parekh S, Dedhiya M.	2015
3843	Journal Int J Pharm Compound 2016 ; 20, 1: 81-85	Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date. Peacock G.F, Sauvageot J, Hill A, Killian A.	2016
3856	Journal Int J Pharm Compound 2016 ; 20, 2:164-166.	Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Nahata M.C.	2016
3857	Journal Int J Pharm Compound 2016 ; 20, 2: 167-174.	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini H.C, Sharlene L, Claudio L,Ferreira A.O,Brand?o M.A.F.	2016
3865	Journal Int J Pharm Compound 2016 ; 20, 3 : 236-238.	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Vicky M, Samit S, Jaymin P, Michael C T.	2016
3866	Journal Int J Pharm Compound 2016 ; 30, 3 : 247-249.	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children. Nahata M C.	2016
3879	Journal Int J Pharm Compound 2016 ; 20, 4 : 328-332.	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures. Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E.	2016
3880	Journal Int J Pharm Compound 2016 ; 20, 4 : 338-342	Stability of Ampicillin in Normal Saline and Buffered Normal Saline. Maher M, Jensen Kara J,Lee David, Nix David E	2016
3881	Journal Int J Pharm Compound 2016 ; 20, 4 : 343-346	Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. Tomasello C, Leggieri A, Rabbia F, Veglio F, Baietto L,Fulcheri C, De Nicol? A, De Perri G, D'Avolio A.	2016
3901	Journal Int J Pharm Compound 2016 ; 20, 5 : 421-425.	Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A,Mandal Tarun K	2016
3902	Journal Int J Pharm Compound 2016 ; 20, 5 : 426-434.	Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions. Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.	2016
3903	Journal Int J Pharm Compound 2016 ; 20, 5 : 435-437.	Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light. Anderson Collin R, Collins D, Laursen T, Arave T, Helm M.	2016
3916	Journal Int J Pharm Compound 2016 ; 20, 6 : 514-516.	Stability of Fentanyl Citrate in Polyolefin Bags. Donnelly R F.	2016
3917	Journal Int J Pharm Compound 2016 ; 20, 6 : 521-525.	Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature. Larson B L, Bushman L R, Casciano M L, Oldland A R, Kiser J J, Kiser T H.	2016
3927	Journal Int J Pharm Compound 2017 ; 21, 1 : 66-75.	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate. Wu G,Yeung S,Chen F.	2017
3928	Journal Int J Pharm Compound 2017 ; 21, 1: 76-82.	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride. Wu G, Yeung S, Chen F.	2017
3961	Journal Int J Pharm Compound 2017 ; 21, 2: 150-153.	Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. McCluskey S.V,Kirkham K,Munson J.M.	2017
3963	Journal Int J Pharm Compound 2017 ; 21, 2: 160-163.	Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions. Kabiche D,Balde I.B,Majoul E,Kabiche S,Bourguignon E,Fontan J-E,Cisternino S,Schlatter J.	2017
3971	Journal Int J Pharm Compound 2017 ; 21, 2 : 164-170.	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs. Gorman G, Sokom S, Coward L, Arnold J J.	2017
3993	Journal Int J Pharm Compound 2017 ; 3: 251-254	Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes. McHenry A.R,Wempe M.F., Rice P.J.	2017
3994	Journal Int J Pharm Compound 2017 ; 3: 255-263	Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions. De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A.	2017
3996	Journal Int J Pharm Compound 2017 ; 21,3 : 240-241.	Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil. Dijkers E,Nanhekhan V,Thorissen A.	2017
3998	Journal Int J Pharm Compound 2017 ; 21:4 :347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia. Robert J, Sorrieul J, Rossignol E, Beaussart H, Kieffer H, Folliard C, Dupoiron D, Devys C.	2017
3999	Journal Int J Pharm Compound 2017 ; 21:4 :339-346	Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4. De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A.	2017
4000	Journal Int J Pharm Compound 2017 ; 21:4 :334-338	Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt. Graves R, Phan K.V,Bostanian L.A,Mandal T.K, Pramar Y.V.	2017
4001	Journal Int J Pharm Compound 2017 ; 21:4 :322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox). Ip K,Carvalho M,Shan A,Banov D.	2017
4029	Journal Int J Pharm Compound 2017 ; 21, 5: 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags. Marquis K, Hohlfelder B, Szumita Paul.	2017
4030	Journal Int J Pharm Compound 2017 ; 21, 5 : 430-435	Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt. Graves R, Phan K, Bostanian L, Mandal T, Pramar Y.	2017
4031	Journal Int J Pharm Compound 2017 ;21 , 5 : 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes. Kirkham K, Munson J, McCluskey S, Graner K.	2017
4061	Journal Int J Pharm Compound 2018 ; 22,1 :86-94	Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride. Wu George, Powers Dan, Yeung S, Chen F, Neelon K.	2018
4062	Journal Int J Pharm Compound 2018 ;22,1:76-85	Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection. Wu George, Powers Dan, Yeung S, Chen F, Neelon K.	2018
4063	Journal Int J Pharm Compound 2018 ;22,1:66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension. Manchanda A, Laracy M, Savji T, Bogner R.	2018
4112	Journal Int J Pharm Compound 2018 ;22,2:164-171	The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions. Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z.	2018
4121	Journal Int J Pharm Compound 2018 ;22,3:252-256	The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia. Cote B, Ross B, Fortner J, Rao D.	2018
4139	Journal Int J Pharm Compound 2018 ;22,4:326-328	Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspensions. Atkins J.R, Lull M.E, Decker A.S, Hutchinson D.J.	2018
4140	Journal Int J Pharm Compound 2018 ;22,4:340-344	Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes. Huffman J, Brown S, Lewis P, Lawson S, Ogle A, Peacock G.	2018
4163	Journal Int J Pharm Compound 2018 22;5:417-423	Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags. Nalenz H, K?pf E, Dietel E.	2018
4164	Journal Int J Pharm Compound 2018 ;22,5:412-416	Stability of Tranexamic Acid Mouth Rinse. Donnelly R.	2018
4170	Journal Int J Pharm Compound 2018 22,5:433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. Zhao F, Dave V.S, Mar M, Perri J.	2018
4174	Journal Int J Pharm Compound 2018 ;22,6:504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase). Ip K, Shan A, Yan W, Banov D.	2018
4177	Journal Int J Pharm Compound 2018 ;22,6:516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.	2018
4214	Journal Int J Pharm Compound 2019 ;23,1:70-76	Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.	2019
4215	Journal Int J Pharm Compound 2019 ;23,1:82-87	Stability Assessment of Topical Amitriptyline HCl Extemporaneously Compounded with Lipoderm Base and PLO Gel Mediflo 30. Shakshuki A, Agu R.U.	2019
4229	Journal Int J Pharm Compound 2017 ;24,6:519-527	Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure. Ma N, Perks W, Law S, John I, Walker S.	2017
4341	Journal Int J Pharm Compound 2019 ;23,5:414-417	Stability of Furosemide 5 mg/mL in Polypropylene Syringes. Van der Schaar JAJ, Grouls R, Franssen EJF, Crul M.	2019
4342	Journal Int J Pharm Compound 2019 ;23,5:434-437	Long-term Physicochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics. Lardinois B, Baltzis A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq JD, Galanti L.	2019
4374	Journal Int J Pharm Compound 2020 ;24,1:64-68	Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit. Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M.	2020
4375	Journal Int J Pharm Compound 2020 ;24,1:77-82	Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets. Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J.	2020
4376	Journal Int J Pharm Compound 2020 ;24,1:83-85	Compatibility of Melphalan in Iodinated Contrast Media. Shi Z, Abruzzo T, Wanasathop A, Li S K.	2020
4388	Journal Int J Pharm Compound 2020 ;24,2:140-147	The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment. Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D.	2020
4408	Journal Int J Pharm Compound 2020 ;24,3:252-262	Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4. Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E.	2020
4411	Journal Int J Pharm Compound 2020 ;24,3:238-241.	Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions. Wilder A.G, Foushee J.A, Fox L.M, Navalle J, Wright A.M, Greer M.A.	2020
4478	Journal Int J Pharm Compound 2020 ;24,5:413-419	Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Graves R.	2020
4646	Journal Int J Pharm Compound 2022 ;26,2:150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates). Brandin T, Wasilewski M, Panuccio C, Bouguergour C, Primas N, Lamy E, Jean C, Bertault-Peres P, Rathelot P, Curti C, Vanelle P.	2022
4528	Journal Int J Pharm Compound 2021 ;25,1:52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.	2021
4534	Journal Int J Pharm Compound 2021 ;25,5:422-426	Compatibility of Gestrinone, Nimesulide, and Piroxican in Pentravan for Transdermal and Transmucosal Application. Polonini H, De Oliveira Ferreira A, Dijkers.	2021
4530	Journal Int J Pharm Compound 2021 ;25,5:431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R.	2021
4533	Journal Int J Pharm Compound 2021 ;25,5:427-430	Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base. Lopalco A, Lopedota A, Aurelio F, La Forgia F, Fontana S, Franco M, Denora N.	2021
4544	Journal Int J Pharm Compound 2021 ;25,3:236-240	Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design. Lupatini , Sidhu R, Patel H, Bichar K.	2021
4606	Journal Int J Pharm Compound 2021 ;25,3:258-262	Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation. Odanak K, Kojima H, Nakagawa N.	2021
4575	Journal Int J Pharm Compound 2021 ;25,2:169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Richard A.	2021
4576	Journal Int J Pharm Compound 2021 ;25,2:163-168	Stability of Extemporaneously-compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes. Walsh A, Ziegler B, Lingertat-Walsh K, Law S, Walker S.	2021
4577	Journal Int J Pharm Compound 2021 ;25,2:156-162	Stability of Fagron's Phytobase Cream Compounded with Various Hormones. Wynn T, Taylor S, Zander C.	2021
4583	Journal Int J Pharm Compound 2021 ;25,3:246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Hui A, Yin J, Liu W, Zheng K.	2021
4593	Journal Int J Pharm Compound 2021 ;78,4:344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases. Teimouri A, Yeung P, Agu R.	2021
4598	Journal Int J Pharm Compound 2021 ;78,4:336-349	Compatibility of Estradiol, Estriol; Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base. Polonini H, Dijkers E, Ferreira A, Zander C, Taylor S.	2021
4691	Journal Int J Pharm Compound 2022 ;26,3:248-254	Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine. Catry E, Colsoul ML, Closset Me, Hubert J, Soumoy L, Bihin B, Thiry E, Jamart J, Hecq JD, Galanti L.	2022
4695	Journal Int J Pharm Compound 2022 ;24,6:342-351	Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Kader C, Morris T Graves R.	2022
4724	Journal Int J Pharm Compound 2022 ;26,6:522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide. Maktabi B, Howard MS, Baki G, Churchwell MD	2022
4667	Journal Int J Pharm Pharm Sci 2019 ;81(6):1140-114	Stability of Hydromorphone Hydrochloride and Morphine under Different Clinical Infusion Conditions. Ping L, juan H, Li R-L, Feng Z-Y, Zhou X-J, Liu M-F, Jing B, Jian L.	2019
122	Journal Int J Pharm Pract 1993 ; 2: 39-43.	Factors affecting the physical and chemical stability of morphine sulphate solutions stored in syringes. Grassby PF, Hutchings L.	1993
1263	Journal Int J Pharm Pract 1992 ; 1: 242-244.	The effect of buffering on the stability of reconstituted benzylpenicillin injection. Allwood MC, Brown PW.	1992
1288	Journal Int J Pharm Pract 1994 ; 3: 57-59.	Stability of injections containing diamorphine and midazolam in plastic syringes. Allwood MC, Brown PW, Lee M.	1994
1291	Journal Int J Pharm Pract 1995 ; 3: 253-255.	Long term stability of heparin in dextrose-saline intravenous fluids. Wright A, Hecker J.	1995
1292	Journal Int J Pharm Pract 1995 ; 3: 174-177.	Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags. Grassby PF, Roberts DE.	1995
2682	Journal Int J Pharm Pract 1991 ; 1: 19-22.	Formulation and stability of cefuroxime eye-drops. Oldham GB.	1991
2683	Journal Int J Pharm Pract 1993 ; 23: 163-167.	Shelf life of cefuroxime eye-drops when dispensed in artificial tear preparations. Hebron B, Scott H.	1993
2685	Journal Int J Pharm Pract 1995 ; 3: 169-173.	Stability of ipratropium bromide and salbutamol nebuliser admixtures. Jacobson GA, Peterson GM.	1995
124	Journal Int Pharm J 1993 ; 7: 14-19.	An in vitro interaction between promethazine hydrochloride and chloroquine phosphate. Abubakar AA, Mustapha A, Wambebe OC.	1993
979	Journal Int Pharm J 1995 ; 9: 57.	In vitro compatibility of granisetron with selected alkaline drugs. D'Arcy PF.	1995
3274	Journal Intensice Care Medecine 2011 ; 37, 11: 1899.	Stability of sildenafil (Revatio®) dolutions in dextrose 5%. Al HadithyF.F.Y, De Goede A.L; Eckhardt M, Hanff L, Koch B.C.P.	2011
2202	Journal Investig Clin Farm 2005 ; 2, 4: 195-203.	Estabilidad de parecoxib en dilucion con ostros farmacos y administrado en perfusion continua IV para el control del dolor postoperatorio. Acin Lazaro MP, bono Arino C, martinez Bazan R, manzanares Marin I, Faci Bouthelier A, Velamazan Blocona MJ, Facorro Gaspar E,	2005
3800	Journal Iranian J Pharm Res 2003 : 157-160.	Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop. Rahim Bahri Najafi, Soleyman Mohammadi Samania, Nahid Pishvab, Fateme Moheimania.	2003
88	Journal J Acquired Immune Defic Syndr 1992 ; 5: 354-358.	Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis. Mole L, Oliva C, O?Hanley P.	1992
2686	Journal J Am Acad Dermatol 1989 ; 21: 979-984.	Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate. Krochm?al L, Wang JCT, Patel B.	1989
3006	Journal J Am Acad Dermatol 1987 ; 16: 984-988.	Anthralin stability in various vehicles. Green PG, Kennedy CT, Forbes DR.	1987
1658	Journal J Am Pharm Assoc 2000 ; 40: 520-524.	Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium. Zhang Y, Xu QA, Trissel LA, Willimas KY.	2000
1659	Journal J Am Pharm Assoc 2000 ; 40: 509-514.	Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics. Xu QA, Trissel LA, Williams KY.	2000
1410	Journal J Am Pharm Assoc 1999 ; 39: 141-145.	Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. Trissel LA, Martinez JF, Simmons M.	1999
1411	Journal J Am Pharm Assoc 1999 ; 39: 146-150.	Physical and chemical stability of etoposide phosphate solutions. Zhang Y, Trissel LA.	1999
1421	Journal J Am Pharm Assoc 1999 ; 39: 505-509.	Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride. Johnson CE, Truong NM.	1999
1422	Journal J Am Pharm Assoc 1999 ; 39: 509-513.	Physical and chemical stability of gemcitabine hydrochloride solutions. Xu QA, Zhang Y, Trissel LA.	1999
1423	Journal J Am Pharm Assoc 1999 ; 39: 514-518.	Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. Trissel LA, Martinez JF, Gilbert DL.	1999
1840	Journal J Am Pharm Assoc 2002 ; 42: 428-431.	Stability of three cephalosporin antibiotics in autodose infusion system bags. Xu QA, Trissel LA, Saenz CA et al.	2002
1922	Journal J Am Pharm Assoc 2002 ; 42: 868-870.	Stability of methylprednisolone sodium succinate in autodose infusion system bags. Trissel LA, Zhang Y.	2002
1925	Journal J Am Pharm Assoc 2000 ; 40: 515-519.	Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. Trissel LA , Williams KY, Gilbert DL.	2000
2689	Journal J Am Pharm Assoc 1999 ; 39: 375-377.	Stability of amlodipine mesylate in two liquid dosage form. Nahata MC, Morosco RS, Hipple TF.	1999
2690	Journal J Am Pharm Assoc 2000 ; 40: 257-259.	Stability of mexiletine in two extemporaneously liquid formulations stored under refrigeration and et room temperature Nahata MC, Morosco RS, Hipple TF.	2000
2691	Journal J Am Pharm Assoc 2002 ; 42: 865-867.	Stability of nifedipine in two oral suspensions stored at two temperatures. Nahata MC, Morosco RS, Willhite EA.	2002
2692	Journal J Am Pharm Assoc 2007 ; 47, 6; 747-755.	Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K.	2007
4309	Journal J Am Pharm Assoc 2013 ; 53, 3: 304-306.	Stability of U-500 regular insulin in prefilled syringes Lull M.E, Piacentino J.J, Traina A.N.	2013
4314	Journal J Am Pharm Assoc 2017 ; 56, 4: 457-461.	Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection. DenHerder J.M, Reed R.L, Sargent J.L, Bobe G, Stevens J.F, Helen E Diggs H.E.	2017
4666	Journal J Anal Sci Tech 2020 ; 11: 32.	Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron. Lee C.H, Kim A.R, Lee M.K, Oh J.S, Lee D.K, Choi S.S.	2020
793	Journal J Antimicrob Chemother 1996 ; 37: 1165-1169.	Amphotericin B intralipid formulation: stability and particule size. Ranch?re JY, Latour JF, Fuhrmann C, Lagallarde C, Loreuil F.	1996
2037	Journal J Antimicrob Chemother 2005 ; 56: 951-953.	Stability of heparin and physical compatibility of heparin/antibiotic solutions ... Robinson JL, Tawfik G, Saxinger L, Stang L, Etches W, Lee B.	2005
2056	Journal J Antimicrob Chemother 2004 ; 53: 675-677.	Stability of benzylpenicillin during continuous home intravenous therapy. Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.	2004
2057	Journal J Antimicrob Chemother 2003 ; 51: 849-855.	Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. Droste JC, Jeraj HA, MacDonald A, Farrington K.	2003
2141	Journal J Antimicrob Chemother 2003 ; 51: 651-658.	Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.	2003
2231	Journal J Antimicrob Chemother 2008 ; 61, 2: 382-388.	Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.	2008
3112	Journal J Antimicrob Chemother 2010 ; 65: 1073-1075	Stability of meropenem and doripenem solutions for administration by continuous infusion Berthoin K, Le Duff, CS , Marchand-Brynaert J, Carryn S, Tulkens PM	2010
3154	Journal J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.	Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients. Carryn S, Couwenbergh N, Tulkens PM	2010
3385	Journal J Antimicrob Chemother 2013 ; 68: 1179-1182.	Stability and compatibility of vancomycin for administration by continuous infusion. Raverdi V, Ampe E, Hecq JD, Tulkens PM.	2013
1151	Journal J Chromatogr 1981 ; 212: 339-346.	High-performance liquid chromatographic determination of sodium nitroprusside. Baaske DM, Smith MD, Karnatz N, Carter JE.	1981
3296	Journal J Chromatographic Sci 2009 ; 47: 1-7.	Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection. Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F	2009
4274	Journal J Clin Anesth 2016 ; 35: 551-559.	Stability of suxamethonium in pharmaceutical solution for injection by validated stability-indicating chromatographic method. Beck W, Kabiche S, Balde I-B, Carret S, Fontan J-E, Cisternino S, Schlatter J.	2016
55	Journal J Clin Hosp Pharm 1982 ; 7: 181-186.	The compatibility of diazepam with infusion fluids and their containers. Smith A, Bird G.	1982
630	Journal J Clin Hosp Pharm 1985 ; 10: 67-72.	Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions. Das Gupta V, Stewart KR.	1985
633	Journal J Clin Hosp Pharm 1985 ; 10: 351-360.	The stability of sodium nitroprusside infusion during administration by motorized syringe-pump. Sewell GJ, Forbes DR, Munton TJ.	1985
636	Journal J Clin Hosp Pharm 1986 ; 11: 47-54.	Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures. Das Gupta V, Stewart KR.	1986
1021	Journal J Clin Hosp Pharm 1986 ; 11: 343-348.	Methotrexate in solutions - A stability test for the hospital pharmacy. Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J.	1986
1331	Journal J Clin Hosp Pharm 1986 ; 11 : 449-452.	Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution. Das Gupta V, Steward KR.	1986
1332	Journal J Clin Hosp Pharm 1981 ; 6: 209-211.	Absorption of isosorbide dinitrate by PVC infusion bags and administration sets. Lee MG, Fenton-May V.	1981
1333	Journal J Clin Hosp Pharm 1982 ; 7: 245-250.	The stability of amoxycillin sodium in intravenous infusion fluids. Cook B, Hill SA, Lynn B.	1982
1396	Journal J Clin Oncol 1993 ; 11: 197.	Ondansetron compatible with sodium acetate. Hauser AR, Trissel LA, Martinez JF.	1993
1651	Journal J Clin Pharm Ther 2002 ; 27: 205-209.	Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions. Ars?ne M, Favetta P, Favier B, Bureau J.	2002
1664	Journal J Clin Pharm Ther 1994 ; 19: 317-325.	Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections. King AD, Stewart JT, Warren FW.	1994
1665	Journal J Clin Pharm Ther 2002 ; 21: 39-45.	Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine. Öster Svedberg K, McKenzie J, Larrivee-Elkins C.	2002
1736	Journal J Clin Pharm Ther 1999 ; 24: 145-150.	Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations. Liu J, Chan Y, Ho PC.	1999
1757	Journal J Clin Pharm Ther 1998 ; 23: 311-314.	Determination of compatibility and stability of drugs used in palliative care. Schrijvers D, Tai-Apin C, De Smet MC, Cornil P, Vermorken JB, Bruyneel P.	1998
119	Journal J Clin Pharm Ther 1994 ; 19: 361-369.	Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices. Strong ML, Schaaf LJ, Pankaskie MC, Robinson DH.	1994
163	Journal J Clin Pharm Ther 1994 ; 19: 127-133.	Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens. Sewell GJ, Allsopp M, Collinson MP, Tyrrell C, Prentice AJ, Copplestone JA.	1994
196	Journal J Clin Pharm Ther 1991 ; 16: 203-207.	Stabilities of dobutamine, dopamine, nitroglycerin and sodium nitroprusside in disposable plastic syringes. Pramar Y, Das Gupta V, Neal Gardner S, Yau B.	1991
197	Journal J Clin Pharm Ther 1991 ; 16: 337-340.	The stability of four catecholamines in 5% glucose infusions. Allwood MC.	1991
219	Journal J Clin Pharm Ther 1997 ; 22: 283-290.	Study protocol : stability of morphine injected without preservative, delivered with a disposable infusion device. Oustric-Mendes AC, Huart B, Le Hoang MD, Perrin-Rosset M, Pailler FM, Darbord JC, Prognon, Gard C, Pradeau D.	1997
234	Journal J Clin Pharm Ther 1997 ; 22: 257-260.	Stability of refrigerated and frozen solutions of tropisetron in either polyvinylchloride or polyolefin infusion bags. Georget S, Vigneron J, Blaise N, Perrin A, Hoffman MA, Hoffman M.	1997
527	Journal J Clin Pharm Ther 1987 ; 12: 339-342.	Chemical stability of thiopental sodium injection in disposable plastic syringes. Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.	1987
585	Journal J Clin Pharm Ther 1988 ; 13: 199-205.	Chemical stabilities of cefaperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections. Das Gupta V, Bethea C, Dela Torre M.	1988
598	Journal J Clin Pharm Ther 1989 ; 14: 45-52.	The stability of amoxycillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states. Mc Donald C, Sunderland VB, Lau H, Shija R.	1989
68	Journal J Clin Pharm Ther 1989 ; 14: 451-456.	Stability of acyclovir sodium in dextrose and sodium chloride injections. Das Gupta V, Pramar Y, Bethea C.	1989
75	Journal J Clin Pharm Ther 1994 ; 19: 35-36.	Stability of foscarnet sodium in 5% dextrose and 0.9% sodium chloride injections. Mathew M, Das Gupta V, Bethea C.	1994
164	Journal J Clin Pharm Ther 1994 ; 19: 95-100.	Stability and compatibility of cisplatin and carboplatin with PVC infusion bags. Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Gressier B, Cazin JC.	1994
149	Journal J Clin Pharm Ther 1992 ; 17: 315-318.	Stability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirs. Rochard E, Barthes D, Courtois P.	1992
484	Journal J Clin Pharm Ther 1991 ; 16: 123-129.	The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions. Northcott M, Allsopp MA, Powell H, Sewell GJ.	1991
645	Journal J Clin Pharm Ther 1987 ; 12: 427-432.	The stability of carboplatin in ambulatory continuous infusion regimes. Sewell GJ, Riley CM, Rowland CG.	1987
646	Journal J Clin Pharm Ther 1999 ; 24: 365-368.	Stability of methacholine chloride in isotonic sodium chloride using a capillary electrophoresis assay. Henn S, Monfort P, Vigneron JH, Hoffman MA, Hoffman M.	1999
656	Journal J Clin Pharm Ther 1996 ; 21: 185-189.	Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.	1996
657	Journal J Clin Pharm Ther 1996 ; 21: 173-175.	Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes. Pramar YV, Loucas VA, Word D.	1996
666	Journal J Clin Pharm Ther 1994 ; 19: 261-262.	Stability of ciprofloxacin in 5% dextrose and normal saline injections. Mathew M, Das Gupta V, Zerai T.	1994
667	Journal J Clin Pharm Ther 1994 ; 19: 195-198.	Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes. Pramar YV, Moniz D, Hobbs D.	1994
686	Journal J Clin Pharm Ther 1990 ; 15: 279-289.	Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. Wood MJ, Irwin WJ, Scott DK.	1990
691	Journal J Clin Pharm Ther 1989 ; 14: 53-55.	Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions. Nahata MC, Zingarelli JR, Durell DE.	1989
693	Journal J Clin Pharm Ther 1988 ; 13: 329-334.	Chemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixtures. Das Gupta V, Parasrampuria J, Bethea C.	1988
896	Journal J Clin Pharm Ther 1992 ; 17: 223-227.	Sorption studies of dipotassium clorazepate salt (Tranxene®) and midazolam hydrochloride (Hypnovel®) in polyvinyl chloride and glass infusion containers. Bianchi C, Airaudo CB, Gayte-Sorbier A.	1992
913	Journal J Clin Pharm Ther 1995 ; 20: 319-325.	Stability of vancomycin in plastic syringes measured by high-performance liquid chromatography. Wood MJ, Lund R, Beavan M.	1995
916	Journal J Clin Pharm Ther 1993 ; 18: 343-345.	Stability of quinine dihydrochloride in commonly used intravenous solutions. Lerkiatbundit S.	1993
930	Journal J Clin Pharm Ther 1997 ; 22: 339-345.	Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chloride. Hor MMS, Chan SY, Yow KL, Lim LY, Chan E.	1997
931	Journal J Clin Pharm Ther 1997 ; 22: 353-356.	Long-term stability of vancomycin hydrochloride in intravenous infusions. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.	1997
932	Journal J Clin Pharm Ther 1997 ; 22: 405-410.	Stability of morphine sulphate in saline under simulated patient administration conditions. Hor MMS, Chan SY, Yow KL, Lim LY, Chan E, Ho PC.	1997
961	Journal J Clin Pharm Ther 1990 ; 15: 187-196.	Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion. Barnes AR.	1990
963	Journal J Clin Pharm Ther 1990 ; 15: 371-376.	Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside. Schaaf LJ, Tremel LC, Wulf BG, Vernon KK.	1990
1265	Journal J Clin Pharm Ther 1990 ; 15: 291-300.	Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. Wood MJ, Irwin WJ, Scott DK.	1990
1269	Journal J Clin Pharm Ther 1988 ; 13: 335-340.	Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units. DeMuynck C, De Vroe C, Remon JP, Colardyn F.	1988
1405	Journal J Clin Pharm Ther 1998 ; 23: 67-72.	Compatibility and stability of fentanyl admixtures in polypropylene syringes. Peterson GM, Miller KA, Galloway JG, Dunne PF.	1998
1420	Journal J Clin Pharm Ther 1999 ; 24: 125-132.	Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration. Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M.	1999
1819	Journal J Clin Pharm Ther 2002 ; 27: 139-142.	Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution. Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M.	2002
1820	Journal J Clin Pharm Ther 2003 ; 28: 471-474.	Stability of dopamine hydrochloride 0.5 mg/ml in polypropylene syringes. Braenden JU, Stendal TL, Fagernaes CB.	2003
1823	Journal J Clin Pharm Ther 2003 ; 28: 349-353.	Stability of intravesical epirubicin infusion: a sequential temperature study. Sewell GJ, Rigby-Jones AE, Priston MJ.	2003
1824	Journal J Clin Pharm Ther 2003 ; 28: 363-369.	Stability of reconstituted parecoxib for injection with commonly used diluents. Crane IM, Mulhern MG, Nema S.	2003
2014	Journal J Clin Pharm Ther 2005 ; 30: 455-458.	Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non PVC bags. Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D.	2005
2145	Journal J Clin Pharm Ther 2006 ; 31: 641-643.	Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®). Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C.	2006
2211	Journal J Clin Pharm Ther 2007 ; 32: 441-444.	Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients. Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B.	2007
2311	Journal J Clin Pharm Ther 2009 ; 34: 25-31.	Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.	2009
2361	Journal J Clin Pharm Ther 2009 ; 34, 4 : 423-428.	Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.	2009
2697	Journal J Clin Pharm Ther 1988 ; 13, 1: 73-76.	The formulation and stability of a unit-dose oral vitamin K1 preparation. Sewell GJ, Palmer AJ.	1988
2699	Journal J Clin Pharm Ther 1991 ; 16, 5: 341-345.	Stability of cefuroxime axetil in suspensions. Pramar Y, Das Gupta V, Bethea C, Zerai T.	1991
2702	Journal J Clin Pharm Ther 1994 ; 19, 1: 31-34.	Stability of metronidazole benzoate in suspensions Mathew M, Gupta VD, Bethea C.	1994
2704	Journal J Clin Pharm Ther 1994 ; 19, 4: 263-265.	Stability of rifampin in two suspensions at room temperature Nahata MC, Morosco RS, Hippie TF.	1994
2705	Journal J Clin Pharm Ther 1994 ; 19, 6: 391-396.	Stability of caffeine oral formulations for neonatal use. Barnes AR, Hebron BS, Smith J.	1994
2707	Journal J Clin Pharm Ther 1998 ; 23, 1: 41-47.	Stability of cefazolin sodium eye drops How TH, Loo WY, Yow KL, Lim LY, Chan EW, Ho PC, Chan SY.	1998
2708	Journal J Clin Pharm Ther 1999 ; 24: 299-302	Stability of ceftazidime in a viscous eye drop formulation Barnes AR, Nash R.	1999
2824	Journal J Clin Pharm Ther 2003 ; 28: 457-463.	Stability of extemporaneously prepared saquinavir formulations Tan LK, Thenmozhiyal JC, Ho PC.	2003
2828	Journal J Clin Pharm Ther 2008 ; 33, 3: 263-271.	Evaluation of the stability of morphine sulphate in combination with Instillagel®. Abdelmageed R, Labyad N, Watson DG, Pournamdari M, Cable CG, Stanley E.	2008
2951	Journal J Clin Pharm Ther 1994 ; 19: 313-315.	Stability of amoxicillin and potassium clavulanate in co-amoxiclav oral suspension. Mehta AC, Hart-Davies S, Payne J, Lacey RW..	1994
2986	Journal J Clin Pharm Ther 1988 ; 13: 165-169.	Chemical stabilities of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy. Gupta VD, Parasrampurian J, Gardner SN.	1988
2988	Journal J Clin Pharm Ther 2007 ; 32: 489-496.	Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study. Huyghebaert N, de Beer J, Vervaet C et al.	2007
3172	Journal J Clin Pharm Ther 2011 ; 36, 1: 99-102.	Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion. Xu F, Xu G, LSu L, Feng E.	2011
3188	Journal J Clin Pharm Ther 2011 ; 36, 2: 161-165.	Stability indicating HPLC assay for the determination of piritramide and droperidol in PCA solutions. Selbach S, Diederich WE, Fett, Fründ SD, Koch T, Eberhart LHJ.	2011
3279	Journal J Clin Pharm Ther 2012 ; 37, 1: 71-73.	A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care. Al-Tannak N.F, Cable C.G, McArthur D.A, Watson D.G	2012
3401	Journal J Clin Pharm Ther 2013 ;38, 2: 104-108	Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine. Helin-Tanninen, M., Lehtonen, M., Naaranlahti, T., Ven?l?inen, T., Pentik?inen, J., Laatikainen, A., Kokki, H.	2013
3802	Journal J Clin Pharm Ther 1998 ; 23: 451-456.	Stability of captopril in invert sugar solution Sam W.J, Ho P.C.	1998
4141	Journal J Clin Pharm Ther 2018 : 530-535.	Stability of dobutamine in continuous ambulatory delivery devices. Al Madfai F, Valah B, Zaidi S.T.R, Wanandy T, Ming M.C, Peterson G.M, Patel R.P.	2018
4166	Journal J Clin Pharm Ther 1978 3:211-214	Stability of heparin in sodium chloride solution. Bowie H.M, Haylor V.	1978
4352	Journal J Clin Pharm Ther 2019 ; 44: 875-882.	In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.	2019
4353	Journal J Clin Pharm Ther 2019	Physicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndrome. Lu D, Harmanjeet H, Wanandy T, Paine M, . PetersonG.M, Patel R.	2019
2894	Journal J Dermatolog Treat 2004 ; 15: 295-302.	A topical azythromycin preparation for the treatment of acne vulgaris and rosacea. McHugh RC, Sangha ND, Mc Carty MA et al.	2004
3455	Journal J Drug Deliv Sci Tecnol 2012 ; 22, 4: 347-352.	Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo. Tous S.S, El Sayed A.M, Abd El Mohsen M.G, Yoissef E.M.K, Agban M.N, Boushra M.F.	2012
4367	Journal J Glaucoma 2016 ; 25, 6: 477-481.	The Degradation of Mitomycin C Under Various Storage Methods. Kinast R.M, Akula K.K, DeBarber A.E, Barker G.T, Gardiner S.K, Whitson E, Mansberger S.L.	2016
3958	Journal J Infect Dis 1988 ; 157, 3: 600-601.	A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities . Henrickson K.J; . Powell K.R; . Schwartz C.L.	1988
909	Journal J Informed Pharmacother 2003 ; 13: 100-110.	Stability of hydrocortisone in extemporaneously compounded suspensions. Chong G, Decarie D, Ensom M.H.H.	2003
173	Journal J Infus Chemother 1994 ; 4: 140-142.	Precipitation of paclitaxel from continuous infusion fluids. Williams DA, Naik A.	1994
4205	Journal J Kor Soc Hosp Pharm 2006 ;23,3:219-224	Stability of Carboplatin in normal saline : dependence on initial dilution concentration and storage time. Choi S, O La H, Kim K, Kim S, Hwangbo S.	2006
2717	Journal J Liquid Chrom 1995 ; 18: 3117-3128.	Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation. Barnes AR.	1995
2165	Journal J Liquid Chrom Rel Technol 2006 ; 29, 16: 2353-2365.	Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis. Kumar V, Madabushi R, Derendorf H, Boothby LA, Breland BD, Hatton RC, Doering PL.	2006
2166	Journal J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.	HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine. Nassr S, Dubuc MC, Lavoie P, Brazier JL.	2003
4457	Journal J Obstet Gynaecol Can 2016 ;38,10:936e944.	Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes. Houlihan, S, Decarie, D, Benes, C, Cleve, R, Vidler M, Magee L.A, Ensom M.H.H, vonDadelszen P.	2016
2720	Journal J Ocular Pharm Ther 2007 ; 23, 3: 292-303.	Formulation of sirolimus eye drops corneal permeation studies. Buech G, Bertelmann E, Pleyer U, Siebenbrodt I, Borchert HH.	2007
3155	Journal J Ocular Pharm Ther 2010 ; 26, 5: 485-490.	Stability of Fortified Cefazolin Ophthalmic Solutions Prepared in Artificial Tears Containing Surfactant-Based Versus Oxidant-Based Preservatives. Rojanarata T, Tankul J, Woranaipinich C, Potawanich P, Plianwong S, Sakulma S, Saehuan C.	2010
1661	Journal J Oncol Pharm Practice 2002 ; 8: 27-32.	Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott’s B Solution for intrathecal use. Trissel LA, King KM, Zhang Y, Wood AM.	2002
1662	Journal J Oncol Pharm Practice 2002 ; 8: 33-37.	Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. Trissel LA, Saenz CA, Ingram DS, Ogundele AB.	2002
485	Journal J Oncol Pharm Practice 1995 ; 1: 19-24.	Stability of mitomycin C in different infusion fluids: compatibility with heparin and glucocorticosteroids. Dorr RT, Liddil JD.	1995
658	Journal J Oncol Pharm Practice 1996 ; 2: 101-105.	Stability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection. Xu QA, Zhang YP, Trissel LA, Martinez JF.	1996
1408	Journal J Oncol Pharm Practice 1998 ; 4: 143-149.	Stability of three cytotoxic drugs infusions in the Graseby 9000 ambulatory infusion pump. Priston MJ, Sewell GJ.	1998
1425	Journal J Oncol Pharm Practice 1999 ; 5: 75-82.	Stability of topotecan infusion solutions in polyvinylchloride bags and elastomeric portable infusion devices. Krämer I, Thiesen J.	1999
1817	Journal J Oncol Pharm Practice 2003 ; 9: 109-112.	Stability and compatibility of 5-fluorouracil infusions in the Braun Easypump®. Roberts S, Sewell GJ.	2003
1950	Journal J Oncol Pharm Practice 2004 ; 10: 191-195.	Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration. Trissel LA, Yanping Z.	2004
2172	Journal J Oncol Pharm Practice 2006 ; 12, 4: 211-222.	Physical and chemical stability of paclitaxel infusions in different container types. Donyai P, Sewell GJ.	2006
2191	Journal J Oncol Pharm Practice 2007 ; 13: 33-37	Stability of a heparin-free 50% ethanol lock solution for central venous catheters. Pomplum M, Johnson JJ, Johnston S, Kolesar JM.	2007
2203	Journal J Oncol Pharm Practice 2007 ; 13: 119-126.	A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'. Kaestner S, Sewell G.	2007
2204	Journal J Oncol Pharm Practice 2007 ; 13: 99-103.	Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C. Cadrobbi J, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2007
2241	Journal J Oncol Pharm Practice 2000 ; 6, 3: 115-121.	Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags. Thiesen J, Krämer I.	2000
2531	Journal J Oncol Pharm Practice 2021 ; 27, 2: 288-296.	Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. Sanogo S, Silimbani P, Gaggeri R, Masini C.	2021
2671	Journal J Oncol Pharm Practice 2010 ; 16: 53-61.	Stability of irinotecan-loaded eluting beads (DC Bead) used for transarterial chemoembolization. Kaiser J, Thiesen J, Krämer I.	2010
3082	Journal J Oncol Pharm Practice 2009 ; 15: 195-200.	Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C. Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2009
3262	Journal J Oncol Pharm Practice 2011 ; 17, 4: 395-399.	Conditions causing gemcitabine crystallization. Manners S, Galettis P, de Souza P.	2011
3313	Journal J Oncol Pharm Practice 2012 ; 18, 2: 218-221.	Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions. Kaiser J, Krämer I.	2012
3402	Journal J Oncol Pharm Practice 2013 ; 19, 1: 65-74.	Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment. Hecq, J.-D., Lewis, A.L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., Chung, T.	2013
3420	Journal J Oncol Pharm Practice 2014 ; 21, 3: 178-187.	Stability of an extemporaneously prepared bleomycin-lidocaine-epinephrine intradermal admixture used in dermatology El Kateb N, Chaussard M, Bellenger P, Petit A, Faure P.	2014
3610	Journal J Oncol Pharm Practice 2014 ; 20, 1: 51-57.	Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion. Zhang, Y., Kawedia, J.D., Myers, A.L., McIntyre, C.M., Anderson, P.M., Kramer, M.A., Culotta, K.	2014
3611	Journal J Oncol Pharm Practice 2014 ; 20, 1: 58-64.	Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T.	2014
3691	Journal J Oncol Pharm Practice 2016 ; 22: 21-25	Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S.	2016
3707	Journal J Oncol Pharm Practice 2014 ; 20: 183-189	Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions. Spindeldreier K, Thiesen J, Lipp H.P, Krämer I.	2014
3760	Journal J Oncol Pharm Practice 1996 ; 2: 107-112.	An evaluation of the stability of granulocyte colony stimulating factor on the short-term storage and delivery from an elastomeric infusion system. Tivnann H, Gaines-Gas R, Thorpe R et al.	1996
3830	Journal J Oncol Pharm Practice 2016 ; 22: 31-36.	Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags. Myers A.Ls, Zhang Y-P, Kawedia L, Trinh V.A, Tran H, Smith J.A, Kramer M.A.	2016
3868	Journal J Oncol Pharm Practice 2016 ; 22: 571-572	Incompatibility of busulfan with 1 ml Luer-Lock syringes. Loboda C, Lider P, Vigneron J.	2016
3918	Journal J Oncol Pharm Practice 2016 ; 22: 749-756.	Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. Sarakbi I, Krämer I.	2016
4021	Journal J Oncol Pharm Practice 2017 ;25,2: 303-308	Long-term stability of ganciclovir in polypropylene containers at room temperature. Guichard N, Bonnabry P, Rudaz S, Fleury S.	2017
4040	Journal J Oncol Pharm Practice 2017 ;25,2: 269-278	The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion. Lamanna W.C, Heller K, Schneider D, Guerrasio R, Hampl V, Fritsch C, Schiestl M.	2017
4047	Journal J Oncol Pharm Practice 2017 ;25,2: 339-350	Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period. Kim S.H, Krämer I.	2017
4102	Journal J Oncol Pharm Practice 2018 ;25,4:831-840.	Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care. Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y.	2018
4120	Journal J Oncol Pharm Practice 2018 25,5:1076?1081	Stability of carboplatin infusion solutions used in desensitization protocol. Vazquez-Sanchez R, Sanchez-Rubio-Ferrandez J, Cordoba-Diaz D, Cordoba-Diaz M, Molina-Garcia T.	2018
4123	Journal J Oncol Pharm Practice 2018 ;24,3:201-208	Storage and transport of reconstituted omacetaxine mepesuccinate: Considerations for home administration. Parikh A, Van de Rijn J, Melville C, Sarkari M, Peltier S, McKean R.	2018
4397	Journal J Oncol Pharm Practice 2021 ;27,1:78–87	Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF in glass and plastic syringes. Lingertat-Walsh K, Weilnau J, Cober M P, Ostrenga A, Poon B, Pacita S, Law S, Dupuis LL, Walker SE.	2021
4334	Journal J Oncol Pharm Practice 2020 ; 26, 3: 641-646.	Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag. Sundaramurthi P, Sean Chadwick S, Narasimhan C.	2020
4455	Journal J Oncol Pharm Practice 2020 online first	Physical and chemical stability of cytarabine in polypropylene syringes. Ben Ayed W, Drira C, Ali Soussi M, Ouesleti H, Hamdene B, Khrouf M, Safta F, Fradi I.	2020
4479	Journal J Oncol Pharm Practice 2020 ;27,6:1328-1332	Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5 +/- 3°C. Closset M, Goderniaux N, Colsoul M-L, Soumoy L, Bihin B, Jamart J, Odou P, Hecq J-D, galanti L.	2020
4493	Journal J Oncol Pharm Practice 2020	Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion. Le Guyader G, Vieillard V, Paul M.	2020
4510	Journal J Oncol Pharm Practice 2020 ;26,8:1894–1902	Stability studies of parenteral nutrition with a high dose of vitamin C. Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.	2020
4636	Journal J Oncol Pharm Practice 2022 ;	Design and stability of pediatric oral formulation of imatinib Hinterlang M, Gendron A, Fleury F, Rieutord A, Vrana A , Schlatter J, Annereau M.	2022
4735	Journal J Oncol Pharm Practice 2023	Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags. Closset M, Onorati S, Colsoul M-L, Goderniaux N, Bihin B, Jamart J, Soumoy L, Hecq J-D, Odou P, Galanti L.	2023
531	Journal J Oral Maxillofac Surg 1994 ; 52: 393-396.	Stability of reconstituted methohexital sodium. Beeman CS, Dembo J, Bogardus A.	1994
2721	Journal J Pad Ophtalmol Strabismus 2000 ; 37, 6: 333-337.	Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children With Amblyopia Nahata MC, Morosco RS, Leguire LE.	2000
3785	Journal J Pain Palliat Care Pharm 2014 ;,28, 4: 367?370.	Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl Prohotsky D.L, . Juba K.M, Zhao F.	2014
3847	Journal J Pain Palliat Care Pharm 2016 ; 29, 4: 370-373.	A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution. Raphael C.D, Zhao F, Hughes S.E, Juba K.M.	2016
346	Journal J Pain Symptom Manage 1994 ; 9: 308-311.	The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. Wulf H, Gleim M, Mignat C.	1994
929	Journal J Pain Symptom Manage 1998 ; 16: 52-58.	Stability of midazolam and fentanyl in infusion solutions. Wilson KM, Schneider JJ, Ravenscroft PJ.	1998
1867	Journal J Pain Symptom Manage 2001 ; 22, 6: 1042-1047.	Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system. Hildebrand KR, Elsberry DE, Anderson VC.	2001
1869	Journal J Pain Symptom Manage 2003 ; 25, 5: 464-471.	Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system. Hildebrand KR, Elsberry DD, Hassenbusch SJ.	2003
1901	Journal J Pain Symptom Manage 2004 ; 27, 5: 471-475.	The compatibility and stability of midazolam and dexamethasone in infusion solutions. Good PD, Schneider JJ, Ravenscroft PJ.	2004
1908	Journal J Pain Symptom Manage 2004 ; 28, 1: 4-6.	Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C. Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.	2004
1928	Journal J Pain Symptom Manage 2004 ; 28, 3: 268-272.	Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture. Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P.	2004
1948	Journal J Pain Symptom Manage 2004 ; 28, 6: 603-611.	Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system. Classen AM, Wimbish GH, Kupiec TC.	2004
1974	Journal J Pain Symptom Manage 1996 ; 12, 3: 168-171.	Combined administration of opoids with selected drug